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Tobacco use remains the leading preventable cause of morbidity and mortality in both the 
United States and worldwide. Twin and family studies have demonstrated that both 
genetic and environmental factors are important contributors to tobacco use behaviors. 
Understanding how genes, the environment, and their interactions is critical to the 
development of public health interventions that focus on the reduction of tobacco-related 
morbidity and mortality. However, few studies have examined the transition from 
adolescent to young adulthood – the time when many individuals are experimenting with 
and developing patterns of tobacco use.  This thesis seeks to provide a comprehensive 
set of studies looking at risk for tobacco use behaviors and nicotine dependence using 
samples of young adults. The first aim is to examine the joint contributions of genetic 
liability and environmental contexts on tobacco use in adolescence and young adulthood 
xiii 
 
using classical twin study methodologies.  The second goal is to identify genetic variants 
and quantifying genetic risk for tobacco use in young adulthood and examining their 
interaction with environmental context across development. Accordingly, the thesis is 
divided up into the following sections: i) reviews of existing literature on genes, 
environment, and tobacco use; ii) twin studies of genetic and environmental influences 
on tobacco use behavior phenotypes; iii) prevalence, correlates, and predictors of 
tobacco use behaviors; iv) genetic analyses of tobacco use behaviors; v) a commentary 
on the emergence of alternative nicotine delivery systems and its public health impacts; 
and vi) plans for an internet-based educational intervention seeking to reduce tobacco 
use (and nicotine dependence) by providing students attending university with information 
on genetic and environmental risk factors for nicotine dependence. 
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CHAPTER ONE: GLOBAL INTRODUCTION 
Elizabeth K. Do 
Introduction 
Tobacco use remains the leading preventable cause of morbidity and mortality in the 
United States (US), as well as worldwide. In 2015, an estimated 36.5 million adults in the 
US currently smoked cigarettes. Cigarette smoking accounts for an estimated $96 billion 
in direct medical costs and $97 billion in lost productivity annually3. Although there has 
been a slight overall decline in current smoking prevalence between 2005-2011, 
especially among adults aged 18 to 24 years (from 24.4% to 18.9%), and a decline in the 
prevalence of cigarette smoking4, there has been an increase in the use of emerging 
tobacco products in recent years2. The National Adult Tobacco Survey, the Food and 
Drug Administration (FDA) analyzed data between 2013 and 2014 and found that young 
adults aged 18-24 reported the highest prevalence of use of emerging tobacco products, 
such as water pipes/hookah and e-cigarettes5.  
Specifically, within the United States, between 13.6% and 32.1% of adults report trying 
one or more other tobacco products6,7. A more recent study indicates that nearly half of 
current adolescent and young adult tobacco users engage in dual and multiple tobacco 
product use, many of which fall outside of current FDA regulatory authority8. Given the 
increased morbidity and mortality associated with tobacco use, disrupting the transition 
to regular use of tobacco products among young adults is likely to result in a number of 
lives saved and disease prevented at the population level9.  
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There exists a widespread assumption within the public health community that tobacco 
use is largely fixed by age 18, since most cigarette smokers report either having first tried 
or experimented with smoking by age 182. However, for many young adults, tobacco use 
patterns continue to change following age 18. For some, the period of young adulthood 
is marked by the transition from occasional adolescent smoking to regular or established 
smoking10. Many users who first try smoking at younger ages do not become “regular” or 
daily users until much later, typically between the ages of 20-2111. Furthermore, studies 
suggest that both the proportion and intensity of smoking rise substantially after the age 
of 1712. The possible escalation and continuation of tobacco use may make it more 
difficult for users to stop using13. Thus, young adulthood is a critical period in the 
development of tobacco use behavior that needs to be studied. 
Given the high prevalence of tobacco use, the addictive nature of nicotine, and high 
healthcare costs attributed to tobacco-related morbidity and mortality, developing 
effective methods to aid individuals reduce tobacco use is critical. However, before this 
is possible, a better understanding of the etiology of tobacco use and addiction, which 
involves the complex interplay of genetic and environmental factors across development, 
is needed – especially among those at elevated risk of developing patterns of regular 
tobacco use.  
To date, only a handful of studies have focused on the transition from adolescent to young 
adulthood – the time at which many individuals are experimenting with and developing 
patterns of tobacco use. As a means to contribute to the literature, this dissertation seeks 
to provide a comprehensive set of studies looking at risk for tobacco use behaviors and 
nicotine dependence using samples of young adults, keeping in mind two aims: (1) 
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examining the joint contributions of genetic liability and environmental contexts on 
tobacco use in adolescence and young adulthood using twin methodologies and (2) 
identifying genetic variants and quantifying genetic risk for tobacco use in young 
adulthood and examining its interaction with environmental context across development. 
In efforts to address these aims, the proposal is divided up into a few different sections: 
reviews of existing literature on genes, environment, and tobacco use; twin studies of 
genetic and environmental influences on tobacco use behavior phenotypes; prevalence, 
correlates, and predictors of tobacco use behaviors; molecular genetic analyses of 
tobacco use behaviors; a commentary on the emergence of alternative nicotine delivery 
systems and its public health impacts; and, plans for an internet-based educational 
intervention seeking to reduce tobacco use (and nicotine dependence) by providing 
students attending university with information on genetic and environmental risk factors 
for nicotine dependence.  
Reviews of Existing Literature on Genes, Environment, and Tobacco Use 
Chapter 2 (Narrative Review of Genes, Environment, and Tobacco Use) and chapter 3 
(Genotype x Environment Interaction in Smoking Behaviors: A Systematic Review) are 
reflective of efforts to understand the state of the science on the influences of genes, 
environments, and their interactions on tobacco use behaviors, and provide a 
comprehensive foundation for the specific aims of this dissertation. Whereas the narrative 
review provides a description of gene variants and environmental factors associated with 
cigarette use, and a broad overview of studies examining gene-environment interaction, 
the systematic review takes a more technical approach by looking at variability in tobacco 
use behavior phenotype definitions and methodological approaches across existing 
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studies of gene by environment interactions. Together, this set of studies suggest the 
need for more studies of gene by environment interaction, with the caveat that variations 
in methodological approaches within the existing literature make it difficult to interpret and 
summarize findings across studies, and that future studies need better strategies for the 
harmonization and standardization of tobacco use behavior phenotypes. 
Twin Studies of Genetic and Environmental Influences on Tobacco Use Behavior 
Phenotypes 
Chapter 4 (Genetic and Environmental Influences on Smoking Behavior across 
Adolescence and Young Adulthood in the Virginia Twin Study of Adolescent Behavioral 
Development and the Transitions to Substance Abuse Follow-Up) and  chapter 5 (A Twin 
Study of the Genetic and Environmental Relationship of Stressful Life Events and 
Smoking Initiation Using the Virginia Twin Studies of Adolescent Behavioral 
Development) were conducted to investigate the role of genetic and environmental factors 
contributing to two tobacco use behaviors: smoking initiation and current quantity smoked 
within the Virginia Twin Studies of Adolescent and Behavioral Development (VTSABD). 
The study described in chapter 4 was conducted to address the existing gap in the 
literature regarding the underlying relationship between smoking initiation and current 
quantity smoked by applying a common causal contingency model. The aims of this study 
were to determine whether: (1) the genetic and environmental factors contributing to 
smoking initiation and current quantity smoked are the same, (2) the magnitude of genetic 
and environmental factor contributions is the same across adolescence and young 
adulthood, and (3) if qualitative and quantitative differences in the sources of variance 
between males and females exist. Meanwhile, chapter 5 takes a different approach by 
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focusing on smoking initiation and its relation to stressful life events. Given that no 
genetically informed studies of the association between stressful life events and smoking 
initiation have been conducted, it is unclear whether shared genetic or environmental 
factors contribute to the covariation between stressful life events and smoking initiation, 
and whether the covariation structure between these two traits differ from early 
adolescence to young adulthood and across sex. To address this gap in the literature, the 
study described in chapter 5 utilizes twin modeling analyses applied to VTSABD data. 
Prevalence, Correlates, and Predictors of Tobacco Use Behaviors 
Chapter 6 (Prevalence and Correlates of Tobacco Use and Nicotine Delivery Systems 
among Young Adults in a University Setting), chapter 7 (Initial Experiences with Nicotine 
and its Association with Recent Use of Tobacco and Nicotine Dependence), and chapter 
8 (An Exploration of Sex Differences in Responses to Items of the Fagerström Test for 
Nicotine Dependence) investigate the prevalence, correlates, and predictors of tobacco 
use behaviors, with a focus on the following tobacco use behavior phenotypes: ever 
tobacco use, age of initiation/onset, current use, regular use, the  Fagerström Test for 
Nicotine Dependence (FTND), in addition to two items of the FTND – cigarettes per day 
and time to first tobacco use after waking. The main objectives of chapter 6 are to: 
determine how prevalent tobacco use and nicotine delivery systems are among students 
currently attending university and whether this differs by sex or race/ethnicity, and 
examine whether tobacco use phenotypes are correlated with other environmental 
factors, such as parental autonomy granting, parental involvement, and the experience 
of stressful life events prior to university enrollment.  
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Examining differences in tobacco use and the negative health outcomes resulting from 
tobacco use by race/ethnicity is an important understudied area of research. Although 
previous studies have identified biological predispositions and social determinants 
associated with traditional cigarette use among adult Black/African Americans not found 
for White/Caucasian Americans, there are few twin and family studies with a sizeable 
number of non-White participants to determine whether heterogeneity exists in the 
heritability of tobacco use behaviors14.   
Chapter 6 provides a background chapter on Spit for Science: The VCU Student Survey 
(S4S) – the sample that was used for all the molecular genetic analyses of tobacco use 
behaviors in this dissertation. Chapter 7 leverages data from S4S and the VTSABD to 
determine whether initial experiences with tobacco use differs by tobacco product used 
and are associated with recent tobacco use and meeting criteria for nicotine dependence, 
as well as determine whether any of these associations differ by sex. The study described 
in chapter 8 was conducted to test sex differences in the response to FTND items within 
African and White/Caucasian Americans, and to investigate the psychometric properties 
of FTND items across these groups. Taken together, these chapters are meant to 
describe phenotypic definitions for subsequent genetic analyses and to identify correlates 
and predictors of multiple tobacco use behaviors, while also providing information on the 
prevalence of emerging alternative tobacco products and nicotine delivery systems within 





Molecular Genetic Analyses of Tobacco Use Behaviors 
Chapter 9 (Genetic Analyses of Tobacco Use Behaviors Among an Ethnically Diverse 
University Sample) and chapter 10 (Polygenic Risk Scores for Tobacco use Behaviors: A 
Comparison of Methodologies, Applied to a University Sample) utilizes genotypic data 
from the Spit for Science sample to address the second aim of this dissertation: to identify 
genetic variants and quantify genetic risk for tobacco use in young adulthood and to 
examine its interaction with environmental context across development. More specifically, 
chapter 9 examines several tobacco use behaviors (e.g. initiation, age of onset, current 
use, regular use, cigarettes per day, time to first tobacco use, and the FTND) among a 
diverse sample of young adults attending university in efforts to calculate the heritability 
of tobacco use behaviors within this sample, and to identify genetic variants contributing 
to tobacco use behaviors in young adulthood by means of conducting genome wide 
association analyses on each of these phenotypes. Chapter 10 expands on the work 
conducted in chapter 9 by describing the development polygenic risk scores using two 
methodological approaches, determining whether these polygenic risk scores are 
predictive of tobacco use behaviors, and to assess gene-by-environment interactions 
between these polygenic risk scores and environmental variables (parental autonomy 
granting, parental involvement, and stressful life events).  
Commentary on the Emergence of Alternative Nicotine Delivery Systems and its 
Public Health Impacts 
Chapter 11 (A Moving Target: The Emergence of Alternative Nicotine Delivery Systems 
and Public Health Impact) is a commentary regarding the growing prevalence of 
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alternative tobacco products and nicotine delivery systems, policy implications of tobacco 
product regulation, and what this might mean for future directions of research. It remains 
unclear whether these alternative tobacco products and nicotine delivery systems will be 
replacing traditional tobacco products without expanding patterns of nicotine use among 
adolescents and young adults – the main target of tobacco company advertising and 
public health harm reduction and prevention efforts. And, as information is collected 
regarding how much and how these products are being used, the availability and 
marketing of these products will continue to grow and change with user preferences. It is 
for this reason that it is important that more attention is given to the relationship between 
alternative tobacco products, nicotine delivery systems, and traditional cigarette use. 
More work needs to be done to better understand the increasing complexity of tobacco 
use among adolescents and young adults to promote effective public health planning and 
to ensure that the regulation of alternative tobacco products (or lack thereof) does not 
undermine current anti-tobacco regulatory efforts 
Plans for an Internet-Based Educational Intervention Seeking to Reduce Tobacco 
Use (and Nicotine Dependence)  
Chapter 12 (Plans for a Pilot Randomized Control Trial of Internet-Based Educational 
Intervention for Reduction of Tobacco Use and Nicotine Dependence) contains 
information on the planning of a feasibility study involving an Internet-based educational 
intervention examining how providing college students with information on the influence 
of genes and the environment on tobacco use behaviors and nicotine dependence 
impacts subsequent patterns of tobacco use behavior. To date, few interventions are 
specifically aimed at young adult smokers, even though tobacco use is common among 
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college students, and college is a critical time for experimentation with and development 
of patterns of tobacco use. The study described in this chapter applies principles of the 
Health Belief Model (HBM), which assumes health behavior is determined by perceptions 
of perceived threat, perceived susceptibility and severity, perceived benefits, perceived 
barriers and the strategies available to decrease its occurrence. By applying the HBM 
concept and constructs to our intervention, which seeks to reduce tobacco use (and risk 
for nicotine dependence) in young adult tobacco users, we seek to increase their 
perceived threat, susceptibility, and severity of nicotine dependence while decreasing 
their perceived barriers to reducing tobacco use among college student participants by 
providing knowledge of genetic and environmental risks for nicotine dependence and 
means to decrease barriers to reducing tobacco use. 
Altogether, this set of studies contributes to the literature by providing a better 
comprehensive understanding of how genes, the environment, and their potential 
interactions influence many tobacco use behavior phenotypes by keeping in mind two 
aims: (1) examining the joint contributions of genetic liability and environmental contexts 
on tobacco use in adolescence and young adulthood using twin methodologies and (2) 
identifying genetic variants and quantifying genetic risk for tobacco use in young 
adulthood and examining its interaction with environmental context across development.  
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CHAPTER 2:   
NARRATIVE REVIEW OF GENES, ENVIRONMENT, AND TOBACCO USE 1 
 
Elizabeth K. Do and Hermine H. Maes 
 
INTRODUCTION 
Tobacco use remains the leading cause of preventable death in the United States and 
results in nearly $170 billion in direct medical care for adults and greater than $156 billion 
in lost productivity due to premature death and exposure to secondhand smoke1. These 
costs emphasize the need to understand what genes and environments are involved in 
the establishment of cigarette use behavior2. Knowing what genes and environmental risk 
factors impact cigarette use can help to reduce its prevalence by shaping prevention and 
intervention efforts. However, to date, many studies on cigarette use have focused solely 
on genes and environments contributing independently to risk for cigarette use and its 
health consequences. Fewer studies have investigated the effects of gene-environment 
interaction (GxE), which can be conceptualized as the difference in the contribution of 
genetic factors, conditional on environmental exposure3. Since cigarette use involves 
both motivational and reward systems that develop through interactions between genes 
and the environment, studies of the joint effects of multiple genetic mutations across 
different environments could be useful in understanding the range of genetic susceptibility 
to environmental risk factors influencing cigarette use and its health consequences4. GxE 
                                                          
1 This chapter was previously published as an original research article in the Annals of Medicine. 
To cite information from this chapter, please use the following citation: Elizabeth Do & Hermine 





studies have been useful in determining whether genetic effects are more or less 
important under particular environmental conditions5. For example, restricting the 
availability of tobacco has been found to reduce the effect of genes influencing whether 
individuals initiate and maintain smoking behaviors. Alternatively, under environments 
where there are fewer restrictions, the importance of the role of genes is expected to 
increase since individuals are able to express the full range of phenotypes6, inclusive of 
nicotine dependence and tobacco-related health conditions such as heart disease and 
cancer. Quitting cigarette use can effectively reduce the risk of these tobacco-related 
outcomes for each individual smoker, while also substantially reducing excess health-
care utilization and improved labor supply on a larger scale4. However, to improve 
strategies for disease prevention and intervention efforts focused on smoking cessation, 
a better understanding of genetic, social environment, and individual determinants of risk 
contributing to cigarette use are needed. In other words, we need to be able to disentangle 
the etiology of cigarette use and identify the conditions under which genes, the 
environment, and their interaction impact cigarette use behaviors. Through this narrative 
review, we seek to integrate twin and molecular genetic studies of GxE in cigarette use. 
Specifically, this narrative review provides a brief overview of studies investigating genetic 
and environmental factors influencing cigarette use separately, and then summarizes 
gene-environment interactions in cigarette use behaviors.  
Phenotypic Measures of Cigarette Use 
It is important to understand how cigarette use has been measured before getting into 
details about how we can determine how much of cigarette use is attributed to genes, the 
environment, and their interactions. The most common phenotypic measures of cigarette 
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use include: initiation; adolescent smoking; cigarettes per day; regular smoking; nicotine 
dependence; and smoking cessation. Initiation is usually a self-report measure that is 
assessed using a yes or no question, such as “Have you ever smoked an entire 
cigarette?”7. Although adolescent smoking is often treated as binary (yes/no) variable, the 
way in which it is assessed differs across studies. One study may measure adolescent 
smoking by asking the question, “Have you ever smoked (or tried smoking)?” to which 
adolescents can respond either yes or no8. While another study may ask adolescents to 
choose from a nine-point scale with multiple response categories, ranging from “I have 
never smoked, not even one puff” to “I smoke at least once a day” and recode responses 
to either no (non-smoker) to yes (smoker)9,10. There is also some variation in how to 
assess cigarettes per day: some studies collect the average number of cigarettes smoked 
per day, while others collect the maximum number of cigarettes per day11. Nicotine 
dependence is most often assessed using the Fagerström Test for Nicotine 
Dependence12. Smoking cessation is assessed in a variety of ways, though the most 
common seems to be through self-reports of abstinence (e.g. 7-day point prevalence 
abstinence, 30-day prolonged abstinence, 6-month prolonged abstinence) or by asking 
about quit attempts. These different stages of cigarette use vary in their heritability, 
suggesting that different points along smoking trajectories may be influenced by different 
etiological factors13. Distinguishing between these phenotypes helps to provide insight 
into the nature of cigarette use, which may provide guidance for potential interventions 





Quantitative Studies of Inferred Genetic Susceptibility for Cigarette Use 
Classic twin methodologies have been useful in quantifying genetic and environmental 
factors associated with cigarette use phenotypes. Generally, twin study methods have 
been used to compare the agreement in the behavior of monozygotic or identical twins 
that share the same genetic make-up and dizygotic or fraternal twins who share, on 
average, 50% of their genetic make-up. Statistical models estimate the percentage of 
variance in the trait explained by genes (i.e. heritability) and by common environment (i.e. 
experiences that render family members more alike) and unique environment (i.e. 
experiences that cause dissimilarity between family members)15. Heritability estimates 
differ according to phenotype and age. For the initiation of cigarette use, shared 
environmental factors account for a small proportion of the liability16, relative to additive 
genetic factors, which account for ~60% of the variance17. Data from one meta-analysis 
showed differences in the heritability of initiation by sex, suggesting that genetic and 
environmental factors may contribute differently to individual differences in initiation in 
male and female smokers. Whereas the weighed mean heritability for females reached 
~50%, the weighted mean heritability for males was ~40%18.  Meanwhile, heritability 
estimates for smoking persistence range from 50% to 70%, for smoking quantity from 
40% to 60%, for nicotine dependence from 60% to 80%, and for smoking cessation 
~50%19–21. It has also been suggested that the liability to smoking initiation, regular 
tobacco use, and nicotine dependence are correlated. Specifically, more than 80% of the 
variance in liability to initiation and regular use is shared, while a smaller proportion is 
shared between regular use and nicotine dependence17. Added to this, age-dependent 
genetic effects have been identified, whereby the genetic liability influencing later 
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cigarette use behaviors is more influential when cigarette use is initiated during 
adolescence22, implying a gene-environment interaction with the environment being 
operationalized as age. 
Gene-Finding Efforts for Cigarette Use 
While twin and family studies were able to establish that cigarette use phenotypes were 
heritable, technological advances made it possible to sequence the human genome and 
look for the genes underlying these twin and family heritability estimates. Gene finding 
methods are used to determine the locations of gene variants that differentially impact the 
liability to traits. In general, these gene-finding methods are statistical in nature, such that 
researchers infer the probability that a locus in the genomic region under investigation 
contributes to liability for the trait (e.g. cigarette use phenotypes) from an examination of 
the distribution of genetic markers within either families, as in linkage studies, or 
populations, as in genome-wide association studies (GWAS)23. Genome-wide linkage 
studies were first used to identify chromosomal regions that could have contained loci 
contributing to cigarette use phenotypes, involved with either the neurotransmission of 
neuromodulators or the rewarding efforts of nicotine on the mesolimbic system24. 
Candidate gene studies investigated associations between measures of cigarette use 
initiation, intensity, and dependence and genes involved with nicotine receptors, 
dopaminergic transmission, and serotonin transporters. Despite some regions showing 
suggestive linkage in multiple studies, results have been heterogeneous. Added to this, 
genes implicated in candidate gene studies have not been reliably associated with 
cigarette use phenotypes in larger GWAS, the effects of most candidate genes for 
cigarette use remain largely ambiguous. Replication of candidate gene studies remains 
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a problem because of small sample sizes in each individual study, differences in 
measures of cigarette use, and differences in genetic and environmental backgrounds25. 
GWAS simultaneously analyzes common genetic variants across the entire genome and 
has have been used since the early 2000s to identify genetic variants contributing to 
cigarette use phenotypes26. Gene-finding efforts have identified associations between a 
variety of cigarette use phenotypes and single nucleotide polymorphisms (SNPs) within 
neuronal nicotinic acetylcholine receptor genes (nAChRs), the initial physiological targets 
of nicotine in the central and peripheral nervous system27–29, and variable-number-of-
tandem-repeats (VNTR) polymorphisms located in dopaminergic genes and serotonin 
transporter genes30. 
Nicotinic receptor genes 
Although nAChRs in CHRNA7, CHRNA9, CHRNA5, CHRNB3, and CHRNA4 were found 
to be significantly associated with nicotine addiction in early candidate gene studies, 
GWAS failed to provide support for these findings31. Instead, independent GWAS have 
provided evidence for association between common variants within the CHRNA5-
CHRNA3-CHRNB4 gene cluster located on chromosome 15 and nicotine dependence. 
The studies identified in this review investigated the following SNPs within this cluster: 
rs1696996832,33, rs68024433, rs374307832, and rs105173034,35 which is in near-perfect 
linkage disequilibrium with rs16969968 in Caucasian samples. Numerous studies have 
demonstrated the association between functional variant rs16969968 and cigarettes per 
day (CPD) and nicotine dependence27,29,36, heavy smoking28,37 and decreased response 
to nicotine antagonists in vitro34. The same locus was associated with the risk of lung 
cancer and chronic obstructive pulmonary disease in several GWAS22. SNP rs680244 
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has been associated with variability in CHRNA5 mRNA levels33. SNP rs3743078 is a 
proxy for variant rs578776, which has also been associated with nicotine dependence32. 
Gene variant rs1051730 has been previously associated with smoking quantity and 
increased susceptibility for lung cancer and vascular disease among smokers.  
Dopaminergic genes  
The dopaminergic system is also believed to play an important role in nicotine 
dependence, since nicotine increases dopaminergic activity in the brain to induce feelings 
of pleasure or reward. Candidate genes include: dopamine receptors (D2 and D4), 
dopamine transporter gene (DAT1), ankyrin repeat and kinase domain containing 1 
(ANKK1), tetratricopeptide repeat domain 12 (TTC12), and the serotonin transporter gene 
(5-HTTLPR). ANKK1 contains a TaqIA1 C>T polymorphism (rs1800497) that has 
previously been associated with reduced dopamine D2 receptor availability and binding 
capacities in the brain, which is believed to cause carriers of the allele to compensate for 
the reduced state of reward following nicotine use. It is also weakly associated with 
adolescent smoking initiation9. Dopamine receptor D4 is a G protein-coupled receptor 
encoded by the DRD4 gene that is activated by the neurotransmitter dopamine. The 48-
base pair variable-number-of-tandem-repeats polymorphism in exon III of the DRD4 gene 
ranges from 2 to 11 repeats. Previous studies have indicated that the longer the repeat, 
the more dampened the response to dopamine. The DAT1 transporter gene regulates re-
uptake of dopamine into presynaptic terminals, terminating dopaminergic 
neurotransmission, and maintaining dopamine homeostasis. DAT1 contains a 
polymorphic 40-base pair VNTR which has been previously associated with lower risk of 
early smoking onset and current smoking. The gene cluster TTC12-ANKK1-DRD2 plays 
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a central role in modulating dopamine reward system, by mediating the reinforcing effect 
of all known addictive substances34.  
Serotonin transporter gene  
It has been demonstrated that 5-HTTLPR plays a role in nicotine dependence via 
mediating rewarding effects in the dopaminergic reward system; two common variants (a 
14-repeat short (S) variant having less transcriptional activity and lower serotonin uptake 
and a 16-repeat long (L) variant) seem to have differential effects. While the S allele has 
a significant effect on smoking behavior, the L allele contributes more to smoking rate38. 
It has been suggested that the differential effects are due to interactions with other 
polymorphisms, though results are inconclusive39.  
Meta-Analyses, Missing Heritability, and Why Studying GxE is Important 
Although independent genome wide association studies have identified variants 
associated with cigarette use, these variants currently explain very little of the phenotypic 
variation because genetic effects due to common alleles are quite small and the detection 
of signals requires very large sample sizes. GWAS are underpowered to detect these 
effects. To overcome the issue of power and false-positive findings, meta-analysis 
statistically synthesizes information from multiple studies40. The largest genetic meta-
analysis of cigarette use conducted by the Tobacco and Genetics Consortium included 
sixteen GWAS and found five significant loci. Each of the five loci was associated with 
only one specific smoking phenotype: nonsynonymous rs6265 on BDNF and smoking 
initiation (OR = 1.06, 95%CI: 1.04, 1.08, p-value = 1.8 x 10-8); nonsynonymous rs1051730 
in 15q25 on nicotinic receptor gene CHRNA3 (β = 1.03, SE = 0.053, p-value = 2.8 x 10-
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73), rs1329650 on 10q25 (β = 0.367, SE = 0.059, p-value = 5.7 x 10-10), and rs3733829 in 
9p13 of EGLN2 (β = 0.333, SE = 0.058, p-value = 1.0 x 10-8) and number of cigarettes 
per day, and rs3025343 near DBH on chromosome 9 and smoking cessation (OR = 1.12, 
95%CI: 1.08-1.18, p-value = 3.6 x 10-8)11. Still, the variance attributed to these genetic 
variants only explains a small proportion of phenotypic variation in cigarette use, which 
does not correspond to estimates of heritability calculated from twin and family studies. A 
portion of this “missing heritability” might be explained by gene-environment interaction41, 
emphasizing the importance of studying GxE. Although reliable demonstration of GxE 
requires very large sample sizes, studies of GxE can be helpful in determining why 
heritability estimates for cigarette use phenotypes vary, and could explain why the search 
for susceptibility genes from GWAS have not been especially successful. Identified 
genetic loci from the current literature contribute only modestly to the variability in 
cigarette use phenotypes. Once we can identify more genes contributing to cigarette use, 
studies of GxE could be used to shape smoking cessation therapies and tobacco control 
efforts, through interventions tailored to genotypes or environmental factors contributing 
to tobacco use. 
Social and Environmental Risk Factors for Cigarette Use 
Although it is clear from the literature that genes influence cigarette use, the motivation 
to begin smoking is also strongly impacted by the social environment, especially during 
adolescence42. As twin and family studies have demonstrated, shared environmental 
factors also account for a replicable proportion of the variation in initiation specifically16, 
and smoking behaviors more generally43. Thus, research on genetics and cigarette use 
should consider social and environmental factors that may modify genetic risk, especially 
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when we consider cigarette use as a dynamic process in which individuals can move from 
initiation, to intermittent use, to regular use, and/or dependence. Understanding the 
genetic and environmental factors that interrupt progress along this trajectory or 
potentiate continued use could be useful for intervening with cigarette use and promoting 
either prevention of initiation or cessation after continued cigarette use44. Below, we 
review epidemiological findings of key environmental covariates that may influence 
cigarette use and should be considered for genetic research on cigarette use.  
Sociodemographic Characteristics. Sociodemographic characteristics should be 
considered potential environmental covariates in genetic research on cigarette use 
because the prevalence of smoking tends to be higher among disadvantaged groups. 
Additionally, disadvantaged users of cigarettes may be more likely to initiate use, less 
likely to be successful in quit attempts and face higher exposure to the harms of tobacco45. 
Groups that are at higher risk for smoking include the poor, semi-skilled manual 
occupation groups, the unemployed, poor educational achievers, and single mothers12,46. 
Smoking prevalence among these groups may be due to reduced support for quitting, low 
motivation to quit, stronger addiction to tobacco, targeted marketing by tobacco 
companies, and psychological differences regarding self-efficacy in the ability to quit45, 
which could be intensified by high feelings of anxiety47, hopelessness, lack of social, 
communication, and refusal skills, and low self-esteem48, or experiencing highly stressful 
events in childhood49. These are all potential points of intervention for cessation efforts 
and have the potential to reduce health costs associated with cigarette use. Cigarette use 
also varies by sex between countries, making it difficult to determine whether males or 
females are more likely to smoke50. However, according to a review paper of 12 studies 
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published between 1980 and 2010 assessing smoking initiation, boys had a lower age of 
smoking initiation relative to girls51. Meanwhile, according to longitudinal studies, girls and 
boys have similar levels of overall substance use during early adolescence, but boys have 
greater increases in substance use during middle and late adolescence after initiation52. 
Studies of adult smokers have also demonstrated that women tend to smoke fewer 
cigarettes per day, use cigarettes with lower nicotine content, and do not inhale as deeply 
as men. However, it remains uncertain whether this may be due to differences in 
sensitivity to nicotine or differences in other social factors associated with the experience 
of cigarette use53.      
Family Cigarette Use.  Although family influences play an important role on the 
development of cigarette use, most of the research done has focused the role of parents 
and siblings on experimentation with and the onset of cigarette use54–56. As evidenced by 
previous studies, negative family environments characterized by low connectedness or 
cohesion57 high levels of parent-child conflict, inadequate parental monitoring, and family 
violence contribute to tobacco use58.  Individuals with negative family environments may 
be less likely to comply with parental requests to abstain from smoking and their initial 
use may go undetected or unpunished59. Alternatively, an authoritative, positive parental 
style60, and parental anti-smoking socialization (i.e. messages about smoking, reactions 
to smoking, household smoking rules), parental expectations and opinions about the 
choice to smoke61–63 may help prevent early adolescents from smoking. Added to this, 
there is consistent evidence demonstrating that parental smoking is a risk factor for 
adolescent smoking58,64. However, one study found that the effect of parental disapproval 
both in smoking and nonsmoking parents was stronger and more robust than that of 
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parental smoking and even attenuated the effect of peer smoking, suggesting that 
parental disapproval makes adolescents more resistant to peer smoking65. However, it 
remains unclear to what extent this is pure environment and passive gene-environment 
correlation. The presence of gene-environment correlation would imply that non-smoking 
parents pass on their “non-smoking” genes but also create a non-smoking environment. 
Siblings also influence the initiation and escalation of cigarette use, such that having older 
siblings who smoke increases a child’s risk of smoking even after adjusting for parents’ 
smoking66. Risk of initiation increases substantially as the number of smokers in an 
adolescent's environment increases, with adolescent females more likely to smoke than 
adolescent males56,67. Besides their smoking behavior, social connectedness between 
siblings appears to moderate shared environmental influences on smoking frequency and 
any subsequent changes on smoking frequency68. Given that few longitudinal studies 
have examined how these family influences shape cigarette use following 
experimentation and initiation, information that could inform the development of effective 
cigarette use prevention programs addressing family influences remains limited54.  
Peer Cigarette Use. Peer relationships, especially those during adolescence, contribute 
to an individual’s initiation, progression, and trajectories of cigarette use69. In fact, 
adolescent smoking is more strongly associated with peer smoking, relative to parents’ 
smoking56,70–73. It has also been suggested that parental smoking does not moderate the 
association between friends smoking and adolescent smoking; although, parental 
behaviors may effect smoking progression through their impact on the selection of 
friends72 and limiting increases in the number of friends who smoke61. It has been 
previously suggested that adolescents who frequently smoke in the presence of others, 
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use smoking as a way to achieve social belonging74 and are more likely to smoke when 
their best friends smoke. However, there is debate about whether peer influence leads to 
smoking (e.g. socialization) or whether individuals who smoke tend to seek out other 
smokers (e.g. selection)75. Added to this, cigarette use initiation is more likely to occur in 
schools with higher smoking rates76, since smoking may seem more normative and 
acceptable77 and more social sources of cigarettes may exist78. This might explain why, 
despite legislation that prohibits tobacco sales to minors, adolescents are still able to 
acquire cigarettes through direct purchase from others or from older friends79. It is also 
unclear to what extent this is pure environment, rather than active gene-environment 
correlation whereby individuals are acting on their propensity to use cigarettes by seeking 
out friend groups that permit cigarette use. Longitudinal study designs of adolescents and 
their peer groups may help to determine whether gene-environment correlation is present, 
while disentangling whether socialization or selection has a stronger impact on 
trajectories of cigarette use. Findings from these longitudinal studies may be helpful in 
the design of interventions. For example, interventions may want to focus on cognitive 
factors as a means to mitigate effects of peer group influences on cigarette use through 
social skills or altering social norms69. 
Age of onset. Approximately 90% of adult smokers first tried cigarettes before the age 
of 18, and practically all began using cigarettes before the age of 2680. In addition to being 
at higher risk for nicotine dependence81, individuals who have an earlier onset of cigarette 
use are at increased risk for heavy smoking22 and worse tobacco-related health outcomes 
in adulthood82. Added to this, one study conducted on students in grades 9-12 in Canada 
found that a delay of one year in the age of smoking onset was associated with lower 
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odds of being a current smoker (adjusted OR = 0.76, 95% CI= 0.73-0.79). Increasing the 
age of onset also seems to increase the likelihood of successful smoking cessation, as 
results from another study found that the likelihood of smoking cessation was greater in 
smokers who had begun cigarette smoking after age 13, relative to individuals who had 
begun earlier83. These findings suggest that early prevention and intervention are needed 
to avoid early-onset cigarette use to reduce negative consequences associated with 
cigarette use, such as nicotine dependence and tobacco-related health outcomes in 
adulthood82. 
Public policy. Given the toll taken by cigarette use, several public policies have been 
implemented to control tobacco use. The choice of public policy varies considerably 
between and within countries, allowing for a natural experiment in the study of the effects 
of tobacco control on the demand for and use of cigarettes. Examples of tobacco control 
policies include prohibition of paid-for advertising for tobacco products, promotion of 
smoke-free policies, and excise taxes on tobacco products84. Since countries do differ 
greatly in the prevalence of cigarette use, potentially due to differences in cultural norms 
and attitudes towards cigarette use, results might not replicate across countries. In 
general, studies have found that smoking restrictions in public places have a negative 
effect on average cigarette consumption by smokers, such as smoking restrictions in 
restaurants, limited cigarette sale through vending machines, and smoking restrictions in 
shopping areas85 and workplaces86. And, as summarized from one systematic review, 
increasing taxes on tobacco products independently reduces smoking prevalence among 
youth and adults, while banning smoking in public places reduces the prevalence of 
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smoking among the general population, and mass media campaigns reduce the initiation 
of smoking in youths and prevalence in adults87.  
Religion. Although religion seems to be inversely related to all measures of tobacco use 
(i.e. lifetime, occasional, and regular use), findings suggest that religion’s primary 
influence on cigarette use is the negative effect it has on ever use88. Importance of religion 
and attendance in worship services are negatively associated with smoking, such that the 
more religious a teenager perceives him or herself to be, the less likely it is that he or she 
would smoke89. Furthermore, private religiosity is protective against initiation of regular 
smoking among nonsmokers as well as the initiation of experimental smoking, but only 
when the young person attends religious services or a religious youth group frequently. 
Meanwhile, public religiosity predicts the reduction and cessation of cigarette use among 
regular smokers90. It has been suggested that religiosity may discourage the use of 
substances through adolescents’ exposure to religious doctrines discouraging the use of 
substances, which implies that religious individuals may be more likely to hold 
conservative attitudes towards substance use, such as cigarette use, and will affiliate with 
peers that are similar to them91. 
Evidence of Gene-Environment Interaction in Cigarette Use 
From the previous sections of this manuscript, it is clear that genes and environments 
contribute to risk for cigarette use. However, it is important to remember that cigarette 
use phenotypes are complex traits arising from interactions among social-environmental, 
psychological, and genetic factors92 and these interactions need to be taken into 
consideration when developing downstream public health interventions. Despite progress 
made in the prevention of and treatment for cigarette use, available treatments are 
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effective for only a portion of smokers. Whereas the identification of specific genetic 
variants is necessary in determining the underlying biological mechanism of risks for 
cigarette-related health outcomes, understanding how these variants interact with 
aspects of the environment to influence cigarette use has the potential to more effectively 
tailor interventions to smokers’ individual risks and needs93. In studies of gene-
environment interaction, genetic effects can be modeled either as latent variables in twin 
and family studies or as genuine measured genes in molecular genetic studies. When 
genetic effects are modeled latently, the contribution of gene effects is inferred based on 
observed correlations between people with different degrees of sharing across genes or 
the environment5. These correlations are used to study whether the heritability is the 
same in different groups. Meanwhile, molecular genetic studies focus mostly on one 
specific gene of interest, rather than the aggregate effect of genes influencing a trait. 
Despite awareness of the importance of gene-environment interactions in tobacco use, 
studies available on the subject are currently limited. Evidence from twin studies have 
predominantly focused on the importance of genetic factors influencing cigarette initiation, 
as it relates to family environment, school environment, neighborhood characteristics, and 
religion, while molecular genetic studies of social policy and the environment have 
investigated whether genetic influences on initiation, daily smoking, and cessation are 
moderated by social policy and the environment. All studies discussed in this section still 
await replication. 
Family environment. One Finnish twin study demonstrated that at age 14, the effect of 
genes on cigarette use increased and common environmental effects decreased as 
adolescents reported less parental monitoring. Specifically, genetic factors accounted for 
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more than 60% of the variance at the extreme low end, but less than 15% at the extremely 
high end of parental monitoring. Meanwhile, common environmental effects accounted 
for 20% and 80% of the variance at extremely low and high ends of parental monitoring, 
respectively8. Parental monitoring seems to have an effect on genes contributing to 
nicotine dependence as well, as demonstrated by a significant interaction found between 
rs169169968 and parental monitoring (p =0.009) in the Collaborative Genetic Study of 
Nicotine Dependence, whereby nicotine dependence increased with the risk genotype 
when combined with the lowest quartile of parental monitoring32. This suggests that 
parents moderate the likelihood of an individual at genetic risk for adolescent smoking 
and nicotine dependence in later life, through the restrictiveness of the social environment 
provided by parents. Variation in rs3743078 did not contribute to this association, as no 
significant interaction was found between parental monitoring and rs3743078 (p=0.80). 
Meanwhile, whether parents smoke may have less of an effect on adolescent smoking, 
as interactions between measures of environmental smoking, conceptualized as paternal 
smoking, maternal smoking, or sibling smoking, and genetic variants of DRD2, DRD4, or 
DAT1 of the dopaminergic system did not significantly contribute to variation in adolescent 
smoking9. Furthermore, only one significant interaction found between maternal smoking 
and rs1051730 influenced occasional smoking at 14 years34. One study investigated the 
effect of smoking-specific parenting messages across: how often parents talked with their 
child about smoking- related issues in the past 12 months (e.g. “frequency”), how 
respectful parents were to children about communicating about smoking-related issues 
(e.g. “quality), and whether there were smoking-specific rules at home (e.g. “house 
rules”). The effect of these smoking-specific parenting messages seems limited, as the 
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Dutch study found no evidence for interaction between smoking-specific parenting in 
terms of frequency, quality, or house rules, and dopaminergic genes on adolescent 
smoking behavior10. Dopaminergic genetic variants DRD2, DRD4, and DAT1 were 
chosen for their associations with smoking from previous studies. 
School environment. Two twin studies investigated the moderating effect of school-level 
variables on heritability of adolescent smoking behavior94,95. Findings from Daw et al. 
(2013) suggest that an individual’s susceptibility to school-level patterns of smoking is 
conditional on the number of short alleles in 5-HTTLPR. The greater the number of short 
alleles, the stronger the individual’s response to the school health behavioral 
environment38. No interaction effects were found between dopaminergic genes and peer 
smoking9. Institutional control, which incorporated measures of school smoking policies 
implemented by adults and whether teachers could smoke on school grounds, was not 
found to significantly interact with genetic influences on daily smoking among youth94. 
There was also no evidence for interaction between state-level smoking by adults, 
measured by the percentage of adults reporting regular use in the Behavioral Risk Factor 
Surveillance System (1992-1993), and genetic influences on regular use during 
adolescence. This was not the case for state-level smoking by youth, measured by the 
percentage of 9th to 12th graders reporting frequent smoking, which was found to be 
negatively associated with genetic influences on regular smoking. Within schools, the 
effect of genes on daily smoking decreased as the prevalence of smoking among popular 
students increased, suggesting that social pressures within schools moderate the 
heritability of daily smoking. These interactions were not found for smoking onset94. One 
study also tested whether the response to a substance use prevention/intervention 
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program varied based upon a set of five markers (rs16969968, rs1948, rs578776, 
rs588765, and rs684513) and found that there was a main effect of both the intervention 
(b=-0.24, p-value<0.05) and genotype at rs16969968 (b = 0.14, p-value <0.05) on high 
school smoking. The genotype x intervention interaction effect was also found, where 
those with the A/A and G/A genotypes reduced their levels of smoking to levels similar to 
those with G/G genotypes following the intervention phenotype (G/G vs. A/A: b = -0.67, p 
< 0.05; A/G vs. A/A: b = -0.61, p < 0.05; G/G vs. A/G n.s.)96. 
Neighborhood environment. Neighborhood-level factors have previously been 
associated with the risk of smoking initiation. To test whether genetic factors and social 
context influence cigarette use, one molecular study investigated the interaction between 
an aggregated genotypic risk score (GRS) combining the top genetic variants (i.e. all 
SNPs reaching a p-value threshold of <5 x 10-7) from a meta-analysis previously 
conducted on African Americans, and neighborhood-level effects on smoking behavior. 
Among individuals who had ever smoked cigarettes, the GRS significantly predicted the 
number of cigarettes smoked per day (measured by “In the past 30 days, on those days 
when you smoked, on average, how many cigarettes did you smoke per day?”) and 
accounted for ~3% of the variance. Significant interactions were observed between the 
GRS and number of traumatic events experienced and average neighborhood social 
cohesion, but not neighborhood physical disorder. The association between the GRS and 
cigarettes per day increased with increasing number of traumatic events and decreased 
with increasing levels of neighborhood social cohesion97. 
Religion. Most studies investigating the effect of religion on cigarette use have focused 
on the association between measures of religiosity and smoking initiation. Only one twin 
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study investigating the moderating effect of religion on cigarette use was identified, which 
investigated the interaction between self-rated religiousness, religious affiliation, and 
organizational religious activity and smoking initiation heritability. This study provided no 
evidence for interaction between religious affiliation or organizational religious activity and 
genetic influences of smoking initiation. It did, however, find that high levels of self-rated 
religiousness attenuated the additive genetic component for smoking initiation7. 
Public Policy. Given that smoking ranks highly among public health problems in the 
world, public policy initiatives have been implemented to decrease smoking prevalence, 
while also emphasizing the negative health consequences of cigarette use. Examples of 
legal and regulatory policies related to tobacco include prohibition of smoking in public 
places and workplaces, restrictions on sale and marketing of tobacco products (especially 
to children), and federal legislation giving government agencies the authority to regulate 
tobacco98. One study conducted in the Netherlands explored whether a change in 
environmental conditions – that is, smoking policies such as cigarette pack warnings 
about health consequences and bans on smoking advertisements – led to a change in 
the relative contribution of genetic factors to smoking initiation by comparing data on two 
cohorts of young adult twins. This study found that although the changes in policies and 
attitudes towards smoking led to a decrease in the prevalence of smoking, it did not 
change the heritability of smoking. These findings did not provide support for GxE 
between initiation and public policy initiatives99. Meanwhile, a few studies demonstrate 
interactions between policy initiatives and the heritability of daily and regular smoking 
have found evidence for GxE95,100,101, suggesting that historical time periods can be 
characterized as distinct social environments that moderate the contribution of genes to 
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cigarette use102. One study using twin pairs from the National Survey of Midlife 
Development in the United States found that the timing of the first Surgeon General’s 
Report coincides with an increase in the genetic influences on regular smoking, but 
subsequent legislation prohibiting smoking in public places reduced these influences100. 
Another study conducted using data from the National Longitudinal Study of Adolescent 
Health, investigated interactions between state-level measures characterizing social and 
institutional effects on smoking and daily smoking and smoking onset of adolescents. At 
the state level, the effect of genes on daily smoking were lower in states with relatively 
high taxes on cigarettes and greater controls on vending machine and cigarette 
advertising, while there was no variation in heritability estimates for smoking onset among 
adolescents95. Fletcher (2012) also found that variation in the SNP rs2304297 of nicotinic 
acetylcholine receptor CHRNA6 moderated the influence of tobacco taxation on multiple 
measures of tobacco use, such that individuals with the protective G/G polymorphism 
responded to taxation while others had no response.  Only one study investigated GxE 
between policy and cessation, as a study by Boardman et al. (2011) demonstrated that 
the genetic influences on smoking desistance (measured using a pair-wise measure 
indicating the length of time in years for a twin to quit smoking after his/her sibling had 
quit) increased in importance following restrictive legislation on smoking behaviors during 
the early and mid-1970s102. 
Pharmacological treatment. Studies provide support for the role of genetic variation in 
response to bupropion and nicotine replacement therapy for smoking cessation. 
Generally, variations in genes within the dopamine and opioid pathways and in nicotine-
metabolizing enzymes appear to play a role in the efficacy of nicotine-replacement 
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therapy, while variation in dopamine pathway genes are important for response to 
bupropion93. In the one study investigating pharmacological treatment on genetic risk for 
smoking cessation, genetic variants rs16969968 and rs680244 were used to categorize 
patients into three haplotypes: (1) low smoking risk allele at rs16969968 and low mRNA 
expression allele at rs680244, (2) low smoking risk and high mRNA expression, and (3) 
high smoking risk and high mRNA expression. These haplotypes are located CHRNA5-
CHRNA3-CHRNB4 on chromosome 15 and were chosen for their consistent association 
with measures of smoking heaviness and nicotine dependence in other studies, and 
potential relation with cessation likelihood.  In the smoking cessation trial, haplotype 
interacted with treatment in affecting success of cessation, in that active treatment was 
strongly associated with a lower risk of relapse in individuals with haplotype 3 (relative 
hazard = 0.48, p-value = 9.7x10-7) and haplotype 2 (relative hazard = 0.48, p-value = 
2.7x10-8), but not haplotype 1 (relative hazard ratios = 0.83, p-value = 0.36). No significant 
differences were found in the effect of haplotype on abstinence/relapse between 
bupropion only, nicotine replacement therapy only, and combined therapies treatment 
groups33. Exposure to environmental smoking-related cues may also play an important 
role in promoting relapse, as individual differences in response to the sight or smell of a 
lit cigarette may be mediated by the DRD4 VNTR polymorphism. Participants who were 
homozygous or heterozygous for the seven repeat or longer allele demonstrated 
significantly higher craving, more arousal, less positive affect, and more attention to the 
smoking cues than participants for whom this polymorphism was absent103. The 
integration of genetic testing into standard clinical practice would be premature now, but 
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pharmacologic studies of treatments for nicotine dependence eventually may guide 
individualized smoking-cessation treatments.  
DISCUSSION AND CONCLUSION 
Both twin/family and molecular genetic studies provide preliminary evidence that gene-
environment interactions have differential effects on cigarette use over the course of 
development. Twin and family studies demonstrate that the relative contributions of 
genetic and environmental factors to cigarette use changes across time from 
adolescence, when most smokers initiate cigarette use, through adulthood, when many 
smokers have established patterns of cigarette use. Familial and environmental factors 
contribute to whether individuals initiate cigarette use. However, as individuals move from 
initiation to more established patterns of use, the importance of common environmental 
factors decreases while the influence of genes increases. As the contribution of genes to 
cigarette use increases, the influence of environmental factors does not go away, but 
rather, environmental factors begin playing a different, but still important role – that is, as 
a moderator of the influence of genetic susceptibilities104. This implies the presence of a 
gene-environment interaction, such that certain environments allow for greater 
expression of genetic effects, possibly due to the availability of opportunities for 
individuals to show their genetic predispositions6. While twin studies of gene-environment 
interaction have been useful in explaining how the effect of genes may change as a 
function of the environment, molecular genetic studies of gene-environment interaction 
have been useful in parsing out the role of specific genes influencing cigarette use 
behaviors through the testing of the main effect of a specific gene of interest from 
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candidate and genome wide association studies on a given cigarette use phenotype and 
the testing of interactions between the specific genes of interest and the environment.  
From this review of the literature on the influence of genes, environments, and their 
interaction on cigarette use, we find that significant GxE interactions vary across cigarette 
use phenotypes. Let us first consider gene-environment interactions contributing to 
cigarette initiation. Religion was the only environmental variable found to moderate 
genetic influences on initiation during adolescence7. More specifically, of the studies 
investigating gene-environment interaction contributing to initiation7,94,95,105, only one twin 
study yielded a significant interaction between aggregated genetic risk and self-rated 
religiousness. The Timberlake et al. (2006) study was the only twin study that included 
this very specific environmental factor on smoking initiation, even though previous 
associations have been found between religion and decreased risk for smoking initiation 
in epidemiological studies7. To our knowledge, the interaction between specific genetic 
variants and self-rated religiousness has not been tested in molecular genetic studies and 
none of the genetic association studies investigating gene-environment interaction 
contributing to initiation yielded positive GxE results9,10. These findings suggest a few 
different things: either the contribution of genes on initiation remains consistent across 
different environmental contexts, the effect of GxE in twin studies is quite small, and/or 
current genetic association studies investigating GxE in cigarette initiation are 
underpowered to detect effects. Under the first scenario, the environment would have no 
effect on genetic influences contributing to initiation and encouraging a change in the 
environment (e.g. increasing self-rated religiousness) would not necessarily reduce 
cigarette prevalence. The second scenario suggests that the effect of gene-environment 
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interaction is small and certain environments provide only a minimally greater expression 
of genetic effects. In the context of religiousness, this might be explained by the fact that 
genetic influences on smoking have been found to be low or nonexistent among 
individuals raised with a strong religious upbringing 7. The third scenario implies a problem 
with power, so investigators will need to look towards increasing their sample sizes in 
future studies of gene-environment interaction in cigarette initiation to detect an effect if it 
is there. 
Gene-environment interactions contributing to other cigarette use behaviors, such as 
adolescent smoking, cigarettes smoked per day, nicotine dependence, and cessation 
have yielded significant findings as well. A couple of measures of the parental 
environment moderated genetic influences on adolescent smoking8,34. Specifically, 
significant interactions were found between parental monitoring and rs16969968 of 
CHRNA532 and maternal smoking during pregnancy and rs1051730 of CHRNA334 for 
smoking at age 14. Meanwhile, social pressures to smoke, prevalence of smoking among 
popular students, marketing and vending restrictions on the sale of cigarettes, and school-
level smoking moderated the heritability of daily smoking among adolescents38,94,95. Only 
one molecular genetic study investigated and found a significant interaction between 5-
HTTLPR and school tobacco use in influencing tobacco use frequency, such that the 
greater the number of short alleles, the stronger the individual’s response to the school 
health behavioral environment38. In adulthood, the experience of traumatic events and 
neighborhood social cohesion interacted with aggregated genetic risk to influence the 
number of cigarettes smoked per day. The interaction between the experience of 
traumatic events and neighborhood social cohesion and aggregated genetic risk seemed 
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to be largely driven by a single variant (rs203652) located on the CHRNA5-CHRNA3-
CHRNB4 gene cluster97. Parental monitoring also interacted with genetic variant, 
rs16919968, to determine nicotine dependence in adulthood32, while treatment status 
interacted with genetic risk for smoking cessation33.  
From these studies, we can see that the environment moderates the effect of genes 
across different cigarette use phenotypes. However, the extent to which the environment 
moderates the genetic influences across different cigarette use phenotypes varies. There 
are a couple of reasons why it is the case that GxE is found for some cigarette use 
phenotypes and not others. It could be that the genes influencing initiation may be 
different from the genes influencing other cigarette use behaviors95,106,107, such as 
adolescent smoking, daily smoking, number of cigarettes smoked per day, nicotine 
dependence, and smoking cessation. It is also possible that, the effect of certain 
environmental measures of smoking that are potentially influenced by both genes and 
environment [e.g. smoking status of father, sibling, friend, or best friend34] seems to vary 
among carriers of nicotinic receptor genes, but not among carriers of dopaminergic gene 
variants - possibly, suggesting that either: the effect of nicotinic receptor genes is larger 
than that of dopaminergic genes or that the effect of dopaminergic genes does not vary 
as a function of environmental context. Under these assumptions, we might hypothesize 
that cigarette use initiation may be more heavily influenced by genes predisposing 
individuals to addictive behaviors via effects on neurotransmitter pathways, such as 
genetic variants that contribute to novelty seeking108, while daily smoking, the number of 
cigarettes smoked per day, and nicotine dependence may have more to do with genes 
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that contribute to nicotine response, such as genes influencing nicotine metabolism109–
111.  
However, we are unable to conclude from some small GxE studies that the phenotypes 
are not genetically the same, if GWAS on the same phenotypes do not come up with the 
same list of associated genes. As such, we remain unable to make definitive claims 
regarding the nature of changing gene-environment interaction contributing to cigarette 
use due to the limited availability of studies investigating this phenomenon. Each study 
reviewed here examined the association between specific cigarette use phenotypes and 
a given environmental measure within either adolescents or adults. This made it difficult 
to determine how environmental contexts differentially influence genetic factors that 
contribute to cigarette use phenotypes such as initiation, daily use, nicotine dependence, 
and cessation and demonstrates how the use of various cigarette use phenotypes may 
complicate the literature and comparability of findings across studies. Added layers of 
complexity are found in the fact that there is a great deal of variability in heritability across 
each cigarette use phenotype95 and heritability estimates may be contingent on social 
and institutional characteristics of the environment, such as temporal changes in genetic 
epidemiology of smoking, changes in smoking norms, changes in the cost of smoking, 
and legal limits placed upon smokers102. Using longitudinal data with repeated measures 
of different cigarette use phenotypes and environmental contexts would allow researchers 
to evaluate genetic contributions to the inter-individual variability of each cigarette use 
phenotype and assess the stability or change of individual differences in each cigarette 
use phenotype over time. The same longitudinal data could be used to predict cigarette 
use behaviors over time112. Future studies might also want to include a range of nicotinic 
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receptor, dopaminergic, and serotoninergic gene variants to parse out the effect sizes of 
main effects on cigarette use phenotypes and interaction effects with different 
environmental contexts. 
In this review of the literature, only a handful of significant gene-environment interactions 
influencing cigarette use were identified and none were replication studies. To ensure 
that these findings are not false positives, replication studies using alternative samples 
are needed. It has been suggested elsewhere that gene-environment interaction studies 
will be underpowered to detect effects under the following conditions: when the estimated 
main effects of genes are weak, when the genetic effect is found only among individuals 
exposed to a particular environmental risk, and when environmental influences are not 
detected because risk is only conferred among individuals with genetic liability6. 
Replications of findings from studies that have identified significant gene-environment 
interactions influencing cigarette use would imply that the under-examined role of genetic 
factors in response to particular environments would be an important step in efforts to 
further reduce smoking rates101.  
Currently, efforts to reduce smoking rates have focused on the implementation of policies 
that restrict availability or use of cigarettes in public places. Anti-smoking policies directed 
at adolescents address onset of cigarette use, while emphasizing the role of immediate 
social influences and refusal skills, which have been shown to reduce initiation by 30%113. 
However, it is possible that these policies may only be effective for those who are not 
genetically susceptible to smoking. Furthermore, although restrictions on smoking in 
public places, anti-tobacco ads, and increased costs of purchasing cigarettes through 
excise taxes have also aided smokers in quitting, there remain concerns that policies 
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have focused too heavily on implementing social restrictions on cigarette use, while doing 
less to help genetically vulnerable smokers quit95. To address this gap in the literature 
and further reduce smoking rates, greater focus needs to be placed on determining the 
extent to which individual differences are due to genes, environmental factors, or their 
interaction. Gene-environment interaction studies may help us to better understand how 
prevention and intervention efforts can be tailored to genotypes under different 







CHAPTER 3:  
GENOTYPE X ENVIRONMENT INTERACTION IN SMOKING BEHAVIORS: A 
SYSTEMATIC REVIEW2 
 
Elizabeth K. Do and Hermine H. Maes 
 
BACKGROUND  
    This article presents a systematic review of the evidence for gene-environment 
interaction (GxE) in smoking behaviors, inclusive of smoking initiation, smoking 
frequency, smoking quantity, nicotine dependence, and smoking cessation. Smoking 
remains the most preventable cause of morbidity and mortality, yet approximately six 
million people die from tobacco consumption annually1. Twin and family studies have 
demonstrated that, like other complex traits, smoking behavior is influenced by both 
genetic and environmental risk factors2. Added to this, heritability estimates seem to differ 
according to the smoking behavior being studied. For smoking initiation, heritability 
estimates account for approximately 60% of the variance3, while heritability estimates for 
smoking persistence ranges from 55 to 69%, smoking quantity ranges from 40 to 56%, 
nicotine dependence ranges from 60 to 76%, and smoking cessation is approximately 
50%4–6. Although this suggests that smoking behavior is moderately to highly heritable, 
few genetic association studies have identified robust associations between specific 
genes and smoking behavior, aside from studies investigating genes in the CHRNA5-
CHRNA3-CHRNB4 gene cluster and nicotine dependence7–11. Alternatively, 
environmental risk factors for smoking behavior have been well documented and include: 
socioeconomic status12,13, parental smoking14,15, lack of parent-child involvement as 
                                                          
2 This paper was previously published as: Genotype x Environment Interaction in Smoking 
Behaviors: A Systematic Review. Elizabeth K. Do; Hermine H. Maes, Nicotine & Tobacco 
Research (2016): doi: 10.1093/ntr/ntw153. 
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evidenced by low connectedness or cohesion16, having siblings who smoke17, and having 
friends who smoke18,19. 
     Exposure to these environments does not necessarily guarantee the development of 
smoking behaviors, which brings up the question of what role individual differences in 
genetic vulnerability to adverse environments plays in shaping smoking behaviors. The 
study of gene-environment interactions, in part, addresses this question by examining 
whether individuals with specific genotypes are sensitive to the effects of their 
environment. Given that genetic factors and one’s social context may jointly shape one’s 
risk for smoking behaviors20–23, the study of gene by environment interactions (GxE) is 
essential to fully understand the etiology of smoking behaviors and has become an active 
area of research.  
     To our knowledge, no systematic review of GxE studies of smoking behavior has been 
previously published. Thus, the aim of the current article is to identify and summarize 
studies that test for GxE in relation to smoking behavior among adolescents and adults 
systematically. We focused specifically on study characteristics related to methods and 
findings.   
METHODS 
     Systematic review search strategy. A systematic review of the English language 
literature exploring GxE in smoking behaviors was undertaken. Studies were identified 
using the electronic databases of Google Scholar, PubMed, ScienceDirect, and Elsevier 
and included articles on twin-based and molecular genetic studies through May 2014. 
Search terms included combinations of “smoking”, “smoking behavior”, “smoking 
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cessation “, “genetic factors”, “environmental factors”, “twin”, “gene by environment”, 
“gene-environment”, “interaction”, and “moderation.” To be included in this review, the 
article had to measure smoking behavior as an outcome of interest and investigate the 
effect of some environmental factor on the heritability of a given smoking behavior. We 
allowed for the inclusion of both twin and molecular genetic studies. Initial searches were 
supplemented by reviewing the reference sections of identified studies. Through these 
searches, we located sixteen studies.   
     Extraction of references. Titles and abstracts of all references were initially assessed 
for relevance. For completeness, bibliographies of extracted references were manually 
searched for further relevant references. Where relevant references were found, their 
bibliographies were also manually searched. 
     Data extraction. All data were extracted for the following variables: (1) study name, (2) 
study population, (3) study design, (4) definition of environmental risk factor, (5) definition 
of genetic risk factor, (6) definition of smoking behavior (i.e. outcome of interest), (6) 
statistical parameters utilized, and (7) primary results presented. Focus was placed on 
measures of association (i.e. odds ratios, hazards ratios). Data were extracted into a 
prepared, structured Microsoft Excel database (Microsoft; Redmond, WA, USA). 
RESULTS 
     For the purposes of describing the current state of smoking-related GxE research, we 
summarize the research design and study samples, measurements of outcome, 
environment, and genotype, and main study findings of these sixteen studies below.  
Research Design and Study Samples 
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     Research Design. The research design varied across studies. Samples were obtained 
from an assortment of sources including: national registries24–26, population-based case-
control27, longitudinal studies with school based-study designs21,23,28, longitudinal 
community samples20,29–31, hospital samples32, epidemiological studies22,33, and 
randomized smoking cessation trials34. Of the identified studies, six utilized twin 
samples21,22,24,25,35, while the remainder were molecular genetic studies20,23,26,27,29–34. 
Although many of these studies collected longitudinal data, associations between 
environmental exposures and outcome were not always determined prospectively. Three 
studies utilized cross-sectional data27,32,34, while four studies assessed the environmental 
exposures repeatedly25,26,29,30 and seven studies accounted for gene-environment 
correlation20,24,28–31,35.    
     Sample. All sixteen studies differed in their sample size, both within and between 
molecular and family studies of smoking behavior. The sample size of family studies 
ranged from 1,31022 to 4,12021 individuals, while molecular genetics study samples 
ranged from 36529 to 14,56023 individuals. The identified twin and molecular genetic 
studies included eight unique samples from the United States [i.e. The National Health 
and Nutrition Health Examination III (NHANES) Phase 2 study (1991-1994)33, the 
National Longitudinal Study of Adolescent Health21,23,28,35, 1995 National Survey of Midlife 
Development in the United States22, Collaborative Genetic Study of Nicotine 
Dependence27, Detroit Neighborhood Health Study20, 1987 Atherosclerosis Risk in 
Communities Study34, the Smoking Cessation Trial of the University of Wisconsin 
Transdisciplinary Tobacco Research Center34, and a combined sample from the 
University of Connecticut Health Center, Yale University School of Medicine, Medical 
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University of South Carolina, Mclean Hospital of Harvard Medical School, and the 
University of Pennsylvania School of Medicine32. A handful were European studies 
conducted in the Netherlands [i.e. Family and Health Study29,30 and Netherlands Twin 
Register25], and Finland [i.e. Finntwin1224 and the 1966 Northern Finland Birth Cohort26]. 
One study used data obtained from the Dunedin Multidisciplinary Health and 
Development Study of New Zealand31.  
    Race/ethnicity. Studies also varied with respect to the amount of racial/ethnic diversity 
in the samples. Most studies exclusively focused on participants that were Caucasian, 
except for one study that investigated a sample residing in Detroit that was predominantly 
African American20.  
     Sex. Studies seemed to be balanced with respect to sex and none of the identified 
studies limited their sample to only males or females. 
     Age. Some studies focused on adolescent samples, followed longitudinally21,24,28–30, 
while others focused on adult samples, aged 18 and older20,22,25,27,34,35. Two studies 
included individuals in early adolescence to young adulthood, ranging from age 11 to 31 
years23,26. More specific details for each of the studies identified in this systematic review 
can be found in the online supplementary material, under Supplementary Table 3.5: Twin 
Studies of Gene by Environment Interaction of Smoking Behavior and Supplementary 






Measurement of Smoking Behavior 
     Outcome measures. The studies assessed smoking behavior by smoking initiation or 
onset25,28,35, adolescent smoking24,26,29,30, smoking frequency, including: number of 
cigarettes smoked in the past month23,28, regular smoking22, and cigarettes smoked per 
day20; nicotine dependence27,31,32, and age at smoking cessation and relapse34, as 
described in Table 3.1: Measures of Smoking Behavior.  
Table 3.1: Measures of Smoking Behavior 
Phenotype How was it measured?  
Smoking initiation 
Did you ever smoke?  
(1) Yes 
(2)  No/A Few Times to Try 





Lifetime measure of adolescent smoking, measured by adolescents reporting on smoking level based on a nine-
point scale: 
(1) I have never smoked, not even one puff 
(2) I smoke at least once a day 
Adolescent smoking at age 14, measured by “Have you ever smoked (or tried smoking)? 
(1) Yes 
(2) No 
If indicated “yes” then asked, “How many cigarettes have you smoked altogether up to now?” 
(1) Only one 
(2) About 2-10 
(3) About 11-50 
(4) Over 50 
These variables were recoded into one variable with five categories: 
(1) No 
(2) Yes, only one 
(3) Yes, about 2-10 
(4) Yes, about 11-50 
(5) Yes, over 50 
Measure of whether adolescents smoked at age 14 and how much, which was categorized into: 
(1) Nonsmokers: adolescents who had never smoked or had smoked once/twice in their lives 
(2) Occasional smokers: adolescents smoking occasionally or about twice per week 
(3) Regular smokers: everyone else 
Daily Smoking Ever smoking at least once cigarette every day for 30 days 
Smoking 
Frequency 
Total number of cigarettes smoked by the respondent in the past month derived by multiplying responses to the 
following two questions:  
(1) “During the past 30 days, on how many days did you smoke cigarettes” 
(2) “During the past 30 days, on days you smoked, how many cigarettes did you smoke each day?” 
Regular Smoking 
Regular smoking was measured using two questions: 
(1) “Have you ever smoked cigarette regularly – that is, at least a few cigarettes every day?” and 
(2) If yes, “On average, about how many cigarettes did you smoke per day during the one year in your life 
when you smoked most heavily?” 
 
These two questions were dichotomized into: 
(1) Never been regular smokers: smoked less than three cigarettes per day during the time of heaviest 
smoking 





Respondents provide a quantitative measure to the following question: “In the past 30 days, on those days when 
you smoked, on average, how many cigarettes did you smoke per day?” 
Nicotine 
Dependence 
 Fagerström Test for Nicotine Dependence scores, dichotomized by: 
(1) Nicotine dependent: FTND scores ≥ 4  
(2) Not nicotine dependent: FTND scores < 4 
Smoking 
cessation Self-reported age of smoking cessation measured by asking, “How old were you when you stopped smoking?” 
Smoking relapse Any smoking on seven consecutive days after the target quit date 
     
Data collection methods. Data on the outcomes of interest were collected by six studies 
exclusively through self-reported survey response24–26,33–35, while other studies collected 
data through in-home face-to-face interviews21,30, semi-structured interviewing (i.e. Semi-
Structured Assessment for Drug Dependence and Alcoholism (SSADDA))32, family 
reports31, and school reports28. Two studies used a combination of these methods23,29. 
Three studies indicated that data were collected through telephone interviews, though 
information regarding the background of the interviewer is not clear20,22,27. Only two of 
these studies investigated a biochemical indicator of smoking behavior33,34. However, of 
these two studies, only one indicated that the biochemical indicator was laboratory-based 
serum cotinine levels (mg/ml)33. 
Measurement of genes 
     Heritability estimates. In contrast to estimates of genetic variance based on measured 
genotypic data, biometrical genetic methods rely on the expected variance and 
covariance estimates of MZ and DZ twins. The expected variance and covariance 
estimates of MZ and DZ twins were used to estimate the latent genetic influences for the 
liability of smoking behaviors in different ways across twin and family studies. While two 
studies calculated heritability estimates from comparisons of correlations of identical and 
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fraternal twins24,25, three studies estimated heritability based on extended twin pair 
designs that included full and half siblings28,28,35. 
     Polymorphisms examined. Eight single nucleotide polymorphisms (SNPs) were 
investigated across two studies23,33. These SNPs included variants in neuronal nicotinic 
acetylcholine receptor genes (nAChRs; including rs16969968, rs680244, rs3743078, 
rs1051730, and rs2304297), variable-number-of-tandem-repeats (VNTR) polymorphisms 
in dopaminergic genes (rs1800497) and serotonin transporter genes (5-HTTLPR).  One 
study focused on the polymorphic region of the promoter region of the serotonin 
transporter gene (SLC6A4), 5-HTTLPR23. Another study divided individuals based upon 
their CHRNA6 genotype (C/C, C/G/, G/G in the rs2304297 SNP), noting that the G/G 
genotype has previously been related to lower likelihood of tobacco use33. These 
polymorphisms were chosen because of their potential role in the development of nicotine 
addiction. Specifically, nAChRs are the initial physiological targets of nicotine in the 
central and peripheral nervous system, while the dopamine and serotonin mediates 
feelings of pleasure or reward within the dopaminergic reward system36, such that 
dopaminergic activity in the brain is increased by exposure to nicotine.  
      Data Collection Methods and Genotyping. Three studies used blood or saliva samples 
for genetic analysis. Limited information was provided by these studies on which specific 
cell lines were used and it seems to be the case that none of the studies utilized the same 
processing facilities, with more specific details described in Table 3.2: Genotyping Data 




Table 3.2: Genotyping Data Collection Methods 
Study Genotyping Data Collection Methods 
Xie (2012) Extracted DNA from immortalized cell lines directly from blood or saliva and implementing the Taqman method to genotype SNP rs16969968 at the Yale University School of Medicine 
Hiemstra et al. 
(2013) 
Taqman analyses performed on the 7500 Fast Real-Time PCR system and scored genotypes using the 
algorithm and software supplied by Applied Biosystems 
Ducci et al. 
(2011) 
Did not disclose the type of samples used but explained that genome-wide genotyping was performed on 
DNA available at the Broad Institution Biological Sample Repository using Illumina Infinium 370cnvduo array 
Meyers et al. 
(2013) 
Isolated DNA from whole blood, or saliva if unavailable, which was then sent to the Applied Genomics 
Technology Facility (Wayne State University, Detroit, MI, USA) for genotyping using the humanomniexpress 
Beadchips (Illumina, San Diego, CA, USA) 
Chen et al. 
(2009) 
Collected blood samples for genotypic analyses with initial genotyping performed by Perlegen Sciences 
using custom arrays, and follow up genotyping done by Center for Inherited Disease Research (CIDR) using 
Illumina Golden Gate technology with focus on two SNPs 
Chen et al. 
(2012) 
Genotyping performed by the Center for Inherited Disease Research at Johns Hopkins University using 
Illumina Omni2.5 microarray, with data cleaning led by the GENEVA coordinating center at the University of 
Washington 
Daw et al. 
(2013) Did not indicate how samples were collected 
 
Measurement of the environment 
     Types of environmental exposures assessed. The types of environmental risk factors 
assessed were diverse. Five studies investigated the role of family level factors, such as 
parental monitoring24,27, maternal smoking during pregnancy26, smoking-specific 
parenting including frequency, quality of communication, and house rules regarding 
smoking30, and environmental smoking by father, mother, and siblings29. Three studies 
examined the role of school and peer level factors, including social pressure to smoke 
within schools28, institutional control over smoking in schools28, prevalence of youth 
smoking23,28and youth drinking23, and smoking by friends and best friends29. Two studies 
investigated childhood adversity32 and childhood maltreatment31. Two studies observed 
the role of neighborhood level factors, inclusive of social cohesion, physical disorder, 
lifetime trauma20, and socioeconomic status as measured by marital status of mothers 
during pregnancy, socioeconomic status of cohort collected at age 31 years, and family 
socioeconomic status based upon occupation of father during pregnancy and at age 14 
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years26. One study investigated the role of treatment status34 and another focused on the 
role of religion, as measured by religious affiliation, organizational religious activity, and 
self-rated religiousness35. Four studies assessed the role of public policy initiatives, 
examining the effect that cigarette restrictions, tobacco control, prevention budgets, 
excise tax per pack of cigarettes21, cohort effects25, and tobacco taxation policies33 have 
on heritability estimates of smoking behavior. More detail about the measures of 
environmental exposures is provided in Table 3.3: Measures of Environmental Exposure. 
Table 3.3: Measures of Environmental Exposure 









Was GxE present? If so, with what 





Adolescent report on the degree to which the parent:  
(1) Discuss with them their daily plans,  
(2) Know of their interests and activities, and  
(3) Know their whereabouts and the identity of their 
associates when they are not at home  
Measure was standardized and treated as a semi-
continuous measure  
3 
Dick et al. 
(2007) 
Finland 
Yes, heritability of adolescent smoking 
changed with varying levels of 
parental monitoring for smoking at age 
14. 
Adolescent report on the degree to which the parent: 
(1) Expected a specific time for them to come home 
(2) Noticed them coming home later than expected 
(3) Arrived home soon after they arrived home from 
school 
and the degree to which the adolescent: 
(4) Told parent when they would be back 
(5) Left a note about where they were going 
(6) Checked in with parent before going out again 
(7) Knew how to get in touch with parent 
(8) Talked with parent about their plans for the coming 
day 
Low parental monitoring defined by the lowest quartile in 
the parent monitoring sum of scores (treated as ordinal 
9 






Yes, interaction found between SNP 
(rs16969968) and parental monitoring 
influencing nicotine dependence.  
 
Nicotine dependence increased with 
the risk genotype when combined with 
lowest quartile of parental monitoring. 
 
No evidence of interaction between 




Adolescent report indicating stage of smoking, ranked on 
an 8-point scale (“My father/mother have never smoked” to 
“My father/mother smokes more than 31 cigarettes a day”)  
Self-report indicating which stage of smoking applied to 
them (“I have never smoked, not even one puff” to “I 
smoke at least once a day”) 
Recoded into three categories: “Never smoked”, “former 





No evidence for interaction between 




Adolescent report indicating stage of smoking, ranked on 
an 8-point scale (“My father/mother have never smoked” to 
“My father/mother smokes more than 31 cigarettes a day”)  
Self-report indicating which stage of smoking applied to 
them (“I have never smoked, not even one puff” to “I 
smoke at least once a day”) 
Recoded into three categories: “Never smoked”, “former 





No evidence for interaction between 




Maternal smoking during (2nd month of) pregnancy, 
classified as nonsmokers, light smokers (1-10 cigarettes 
per day), and heavy smokers (>10 cigarettes per day) 
1 
Ducci et al. 
(2011) 
Finland 
Yes, significant interaction detected 
between maternal smoking during 
pregnancy and TTC12 (rs10502172) 




Frequency: average of adolescent reported scores 
assessing how often parents talked with child about 





No moderating effects of the 
dopaminergic genes by the frequency 
of smoking-specific parenting were 
found. 
Quality: average of adolescent reported scores on quality 




No moderating effects of the 
dopaminergic genes by quality of 
smoking-specific parenting were 
found. 
House Rules: average of adolescent reported scores 




No moderating effects of the 




How many of your siblings smoke, on a scale from 0 to 4 
(None of my brothers/sisters smokes to four of my 
brothers/sisters smokes) 
Answers were dichotomized into “having no smoking 





No evidence for interaction between 
sibling smoking status and DRD2, 





Pressure to smoke within a school: characterizes the 
popularity status of smokers and nonsmokers and 
indicates the extent to which the most popular students 
smoke by asking all students to write down the names of 
their five closest female friends and five closest male 
friends and linking these names to self-reports on smoking 
during the past year  
2 
Boardman 
et al. (2008) 
USA 
Yes, attending a school where more 
popular students are more likely to 
smoke increases heritability of 
smoking daily. 
 
Each student was asked: “During the past twelve months, 
how often did you smoke cigarettes?” Responses ranged 
from 0 to 6 (never to nearly every day)  
School-specific mean response used for analysis 
1 
Daw et al. 
(2013) 
USA 
Yes, adolescents smoke more 
cigarettes when attending schools with 
higher rates of tobacco use. 
Institutional 
Control 
School smoking policy: measured by summing 
administrator responses regarding disciplinary action of the 
school upon first and second incidences of smoking on 
school grounds, inclusive of verbal warming, minor action, 
in-school suspension or expulsion 




et al. (2008) 
USA 
No evidence for interaction, though 
the heritability estimate is reduced 
within schools where normative 
pressures to avoid smoking are 




Adult Smoker Prevalence: State-level measure of the 
percentage of adults who reported regular smoking (i.e. 
those who have smoked at least 100 cigarettes and smoke 
currently), obtained from the Behavioral Risk Factor 
Surveillance System (1992-1993) 
Adolescent Smoker Prevalence: percentage of 9th to 12th 
graders who reported frequent smoking (i.e. those who 
have smoked a cigarette on at last 20 of the past 30 days), 





No evidence for interaction between 
state-level smoking by adults and 
genetic influence on regular smoking. 
 
State-level smoking by youths 
negatively associated with genetic 
influences on regular smoking. 
Adolescent Smoker Prevalence: Proportion of students 
reporting that they have ever smoked a cigarette by the 
date of the in-school survey 
1 
Boardman 
et al. (2008)  
USA 
Yes, attending a school where more 
popular students are likely to smoke 
increases the heritability of daily 
smoking.  
Racial 
Composition Proportion of students who are non-Hispanic and white 1 
Boardman 
et al. (2008)  
USA 
Yes, heritability of daily smoking is 
reduced within school where most 
students are non-Hispanic and white.   
Friend’s 
smoking 
How many of your friends smoke, ranging from 1 to 5 (no 
one to all of them) 
Answers were dichotomized into “having no smoking 





No evidence for interaction between 




Adolescent report indicating stage of smoking, ranked on 
an 8-point scale (“My best friend has never smoked” to 
“best friend smokes more than 31 cigarettes a day”)  
Self-report indicating which stage of smoking applied to 
them (“I have never smoked, not even one puff” to “I 
smoke at least once a day”) 
Recoded into three categories:  





No evidence for interaction between 
best friend’s smoking and DRD2, 






Asks respondents whether they agree or disagree on a 4-
point scale (strongly agree to strongly disagree) with the 
following statements: 
(1) This is a close-knit or unified community 
(2) People around here are willing to help their 
neighbors 
(3) People in this neighborhood generally do not get 
along with each other (reverse coded) 
(4) People in this neighborhood do not share the 
same values (reverse coded) 
(5) People in this neighborhood can be trusted 
Items were summed and then averaged by neighborhood 






Yes, significant interactions were 
found between genetic risk score and 
average neighborhood social cohesion 




Items were adapted from the New York City IMPACT 
neighborhood evaluation scale and then factor analyses 
were conducted, yielding 3 factors:  
(1) Presence of buildings with broken windows; 
boarded-up windows, or boarded-up doors 
(2) Presence of buildings with outside damage that 
can only be corrected by major repairs 
(3) Presence of entirely vacant buildings 
Principal component values for each block group were 






No evidence for interaction between 




Family SES: Based on occupation of father, collected 
during pregnancy and at age 14 years. Classified as 
professionals; skilled-workers; unskilled workers and 
farmers.  
SES of Cohort: collected at age 31 years and classified as 
professionals skilled workers; unskilled workers farmers; 
and others 
Marital status of mothers during pregnancy dichotomized 
as married or unmarried (including divorced and widowed). 
3 
Ducci et al. 
(2011) 
Finland 
No evidence for interaction between 
socioeconomic status and 
TTC12(rs10502172). 
Maternal SES: Proportion of student’s mothers who have 
complete college  1 
Boardman 
et al. (2008) 
USA 
No, maternal smoking was not found 




Traumatic Events: Checklist of 19 items occurring in the 
individual’s entire lifetime. Number of items endorsed was 
summed to create score from 0 to 19. Higher scores reflect 






Yes, significant interactions were 
found between genetic risk score and 




Semi-Structured Assessment for Drug Dependence and 
Alcoholism (SSADDA) Environmental section, which asked 
whether either of their parents died before they were 6 
years old and whether before the age of 13 they had 
witnessed or experienced a violent crime, had been 
sexually abused, or had been physically abused. 
4 
Xie et al. 
(2012) 
USA 
Yes, childhood adversity significantly 
increased ND risk in both women and 
men, and the effect in women was 




These were randomly assigned, as it was part of a clinical 
trial. Groups included: placebo, nicotine patch, nicotine 
lozenge, sustained-release bupropion, nicotine patch and 
nicotine lozenge, or bupropion and nicotine lozenge. 
1 
Chen et al. 
(2012) 
USA 
Yes, smokers with high-risk haplotype 
were three times as likely to respond 
to pharmacologic cessation treatment 





Individuals were characterized as those who had any 
affiliation and those who did not (inclusive of atheists, 
agnostics, and those without any affiliation). 




Frequency of religious attendance and participation in 
special activities in the past 12 months, with responses 
coded from 0 to 6 (never to more than once a week). Items 
were summed.  
2 Timberlake et al. (2006) No evidence for interaction. 
Self-rated 
religiousness 
Indicates the importance of religious faith and extent of 
being a religious person, with responses ranging from 0 to 
3 (not important/not religious at all to more important than 
anything else/very religious).  
2 Timberlake et al. (2006) 
Yes, high levels of self-rated 
religiousness attenuated the additive 





Sum of two characteristics: restrictions on the location of 
vending machines selling cigarettes and prohibition of 






Yes, marketing and vending machine 
restrictions slightly reduce genetic 







Number of staff that are dedicated to tobacco control, not 




No evidence for interaction. 
Prevention 
budget 
Total amount spent in logged dollars on tobacco control 




No evidence for interaction. 
Excise Tax per 
pack of 
Cigarettes 
Derived from data from the Centers for Disease Control 
and Prevention State Tobacco Activities Tracking and 
Evaluation System (reflecting legislation active as of 





Yes, state-level excise tax on 
cigarettes reduce genetic influences 






Rates were matched to data at the state and year-levels 
and are not adjusted for inflation for the four years of data.  1 
Fletcher 
(2012) 
Yes, G/G polymorphism of CHRNA6 
responded to state-level taxation while 
others did not.  
Birth Cohort 
Four birth cohorts (1920-1939, 1940-1949, 1950-1959, and 
1960-1970) 1 
Boardman 
et al. (2010) 
USA 
For those born in the 1940s and 
1950s, genetic factors do not 
significantly contribute to the risk of 
regular smoking. While for those born 
in the early 1930s and mid-1950s, 
genetic influences are the most 
pronounced. 
Two birth cohorts (1993-1995 and 2009-2010) 1 
Vink et al. 
(2011) 
Netherlands 
No, the heritability of smoking initiation 
did not change as a function of 
environmental exposure. 
   
   Classification of exposures. There was considerable variation in how studies treated 
exposure status in the analysis. In one study, the environment was treated as a binary 
variable (i.e. Exposed versus unexposed to childhood adversity)32. In another study, the 
environmental variables, which measured sociodemographic factors such as father’s 
occupation and mother’s marital status during pregnancy, were treated as categorical26. 
Most studies (62.5% or n=10) used continuous measures or scales, derived using sum 
scores of different sets of items20,21,23,24,27–31,33,35, while two studies utilized proportions of 
smokers in contact with respondents as a measure of environmental smoking 
exposure28,31. One randomized control trial randomly assigned participants to one of six 
environmental exposures or treatments (i.e. Placebo, nicotine patch, nicotine lozenge, 
bupropion SR, nicotine patch and nicotine lozenge, or bupropion and nicotine lozenge)34. 
Classification of exposure was unclear in two studies investigating genetic influences on 
smoking by birth cohort22,37.  
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     Data collection methods. The most commonly employed method for obtaining 
information about environmental exposures were questionnaires. The remaining studies 
relied on interviews, review of epidemiological data, or a combination of approaches. Like 
data obtained on smoking behavior outcomes, data on environmental exposures were 
collected by: self-reported survey response24–26,33–35; in-home face-to-face interviews21,30; 
semi-structured interviewing (i.e. Semi-Structured Assessment for Drug Dependence and 
Alcoholism (SSADDA)32; Semi-Structured Assessment for Nicotine Dependence 
(SSAND), Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA); 
Composite International Diagnostic Interview (CIDI)27); telephone interviews20,22,27; family 
reports31; school reports28; or a combination of these methods23,29. 
Main study findings 
     There was considerable heterogeneity in the methods and analyses used across 
studies to test for GxE, making it difficult to summarize this research and provide a 
synthesis of main findings. Thus, statistical significance is emphasized over the 
magnitude of effects. 
     Main effect of genotype. Thirteen (87.5%) of the sixteen identified studies found 
significant main effects for either specific genes or genetic factors associated with 
smoking behaviors20–24,26–31,33–35; three did not30,32,37. More specifically, SNPs 
rs16969968 of CHRNA5 and rs3743078 of CHRNA3 were associated with nicotine 
dependence27, while 5HTTLPR23, CHRNA5-CHRNA3-CHRNB434, and a genetic risk 
score20 were associated with smoking heaviness or number of cigarettes smoked, and 
DRD4 was associated with smoking onset29. Interestingly these main effects were not 
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necessarily consistent across studies, as no main effect of rs16969968 on nicotine 
dependence was reported in one study32. No significant main effect for DRD2 or DAT1 
on smoking onset was reported29,30.  
     Main effect of environment. Eight studies found significant main effects for at least one 
of the environmental variables20,21,23,24,26–29,32 and all but two of these studies21,28 reported 
the effect sizes of these main effects. Two studies found the main effects to be 
nonsignificant30,38. The remaining three studies did not provide sufficient information to 
make this determination22,35,37. 
     Gene by environment interaction effects. Of the sixteen studies identified, thirteen 
studies found at least one significant GxE effect (p≤0.05). Significant interactions were 
detected between environmental factors and SNPs within the CHRNA5-CHRNA3-
CHRNB4 gene cluster [i.e. Parental monitoring and rs16969968 of CHRNA5 for nicotine 
dependence27 and maternal smoking during pregnancy and rs1051730 of CHRNA3 for 
smoking at age 1426]. Another significant interaction was detected between school-
tobacco use and the serotonin promoter polymorphism, 5-HTTLPR for tobacco use 
frequency23. However, no significant interactions between environmental factors and 
dopaminergic genes were identified29,30. 
    Effect Size. It was not clear from some studies whether the effect for genotype or 
environment was larger, due in part to studies not reporting the main effect of genotype 
and environment21,22,28,31. Studies that did report this information tended to find that the 
effects of the environment were larger relative to genetic effects and GxE effects.  
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     Effects by developmental period. Of the studies focused on adolescent samples, only 
two did not find at least some evidence for GxE29,30. Only one study investigating adult 
samples did not find at least some evidence for GxE25.      
     Results demonstrate heterogeneity in both conceptual and methodological 
approaches to conducting tests for gene by environment interactions related to smoking 
behavior. This heterogeneity could be an artifact of the cross-disciplinary nature of GxE 
research and may reflect differences in conceptual understanding and methodological 
conventions adopted across academic disciplines. Given these differences in approach, 
it was difficult to synthesize findings, which remains a major limitation to the current 
literature on smoking-related GxE. This is emphasized further in a meta-analysis of 103 
gene by environment interaction studies conducted in the first decade of this millennium 
by Duncan and Keller (2011). Results from the meta-analyses are “consistent with the 
existence of publication bias, low statistical power, and a high false discovery rate39. What 
this means is that thus far, gene by environment research might not have produced many 
reliable results40.  
     Despite the differences in approach and difficulty to synthesize findings, we can come 
away with a few general conclusions/themes regarding the role of GxE interaction in 
smoking behavior. Specifically, the influence of parents and peers seem to moderate the 
genetic and environmental influences contributing to the initiation and maintenance of 
smoking behaviors, such that greater influence from parents or peers attenuates the 
relative importance of genetic versus environmental factors. The magnitude of this 
moderation is dependent upon the outcome of interest (e.g. initiation, frequency, nicotine 
dependence, cessation, or relapse). Thus, more attention needs to be paid to the 
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outcomes of interest and how results are being reported, particularly since the heritability 
estimates vary by the smoking behavior being measured and the age at which these 
outcomes are collected.  
     Studies of GxE interaction demonstrate that the influence of genes may change as a 
function of the environment and the phenotype being measured, but also suggests that 
restricting the availability of tobacco (whether through parental monitoring, prevalence of 
smoking among peers, or public policy initiatives to reduce tobacco use through restriction 
of use in public spaces or taxation) generally decreases the influence of genes that 
influence the initiation and maintenance of smoking behaviors. 
     Although we can come away with these conclusions, it is still the case that differences 
in methodological approaches are likely contributors to potential discrepancies of GxE 
effects across studies, and prevents the field from a deeper understanding of GxE 
interactions regarding smoking behavior. In efforts to guide future research and address 
the current challenges that exist in synthesizing findings of GxE in smoking behavior, we 
offer the following suggestions focused on: (1) choice of measurement for environmental 
variables, (2) testing and reporting of main and interaction effects, (3) testing for artifactual 
interaction via conducting sensitivity analyses and checking for scaling artifacts, (4) 
treatment of covariates, and (5) reporting gene-environment correlation (rge). Table 3.4. 
Assessing Validity of Gene by Environment Interaction demonstrates how each study 





Table 3.4. Assessing Validity of Gene by Environment Interaction  
























No No No Yes No No 
Chen et al. 
(2009) No No No No Yes No Yes 








No No No Yes No Yes 







time 1 and 
DAT1. 
No No No Yes Yes Yes 
Ducci et al. 









No No No No No Yes 
Daw et al. 
(2013) No No Yes No No No Yes 
Meyers et al. 
(2013) Yes No Yes No Yes No Yes 
Xie et al. 
(2012) No No No No Yes No Yes 
Chen et al. 
















No No No No No Yes 
Vink et al. 
(2011) No No No No Yes Yes Yes 
Boardman 
(2009) No No No No No (gives SE) No Yes 
Boardman et 




(2012) No No No No Yes No Yes 
57 
 
Choice of measurement for environmental variables 
     The choice of measurement for environmental variables varied across studies 
identified in this systematic review. Few studies from this systematic review overlapped 
in their measurement of environmental constructs making it difficult to compare findings 
across studies. Only two studies investigated the effects of parental monitoring24,27 and 
two other studies investigated the effect of the prevalence of smoking among youth21,28. 
However, the findings of these studies do demonstrate a general trend: increasing the 
restrictiveness of an environment (e.g. increasing parental monitoring, decreasing the 
prevalence of smoking among youth, increasing self-rated religiousness) decreases the 
influence of genes on an individual’s behavior, such as smoking, as seen in Figure 3.1. 
Moderation of the Heritability of Smoking by Environmental Measures.  
Figure 3.1. Moderation of the Heritability of Smoking by Environmental Measures 
 
     Furthermore, studies investigating the same environmental constructs did not use the 
same means of measurement. In the study conducted by Dick et al. (2007), parental 
monitoring was measured using responses from three items, standardized and then 
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treated as a semi-continuous measure24, while the study conducted by Chen et al. (2009) 
used a sum score from eight items, defined the lowest quartile, and treated the measure 
of parental monitoring as an ordinal variable27. As for the prevalence of adolescent 
smokers, one study utilized a state-level measure of the percentage of 9th to 12th graders 
reporting frequent smoking from the Youth Risk Behavior Surveillance study21, while the 
other calculated the proportion of students reporting they had ever smoked a cigarette by 
the date of the in-school survey28. These observations suggest that there may be “noise” 
in the assessments of environments. Thus, more rigorous methods need to be 
undertaken to establish both reliable and valid assessments of environmental exposures 
across studies.  
     There was also wide variation in the timing of exposures assessed across studies in 
terms of the temporal relationship between exposure and outcome (i.e. Prospective 
versus cross-sectional) and the developmental period considered (i.e. Adolescence 
versus adulthood). A couple of studies tried to demonstrate causality through cross-
lagged methodologies, but most studies measured exposures and outcomes 
simultaneously. To better understand timing of environmental exposures, future studies 
may want to incorporate more rigorous research designs, including experimental and 
quasi-experimental approaches that utilize the longitudinal nature of the data being used 
in many of these studies. 
     Obtaining consistent environmental variables would make it much easier to synthesize 
study findings. However, as can be seen from the studies included in this systematic 
review, comparable results found across slightly different environmental variables 
measuring the same construct can also provide some evidence of a moderating effect. 
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Additionally, it would be beneficial for future studies to focus on a broader array of 
proximal environments, since very little attention was paid to protective factors, such as 
neighborhood social cohesion41. However, it is important that genetic factors do not 
influence these proximal environments (i.e. gene-environment correlation is limited) and 
attention must be paid to developmental period of measurement, since certain 
environments are more salient at specific ages (i.e. family and peer influences during 
adolescence).  
Testing and reporting of main and interaction effects 
     Few studies fully described their methods and analyses, including how tests for 
interaction were conducted and the nature of the association between exposure and 
outcome. Many studies indicated that they used moderated regression analysis or twin 
modeling approaches, but few provided citations or details for how estimates were 
calculated. Future research should report basic descriptive information that may be 
suggestive of GxE, such as a data table reflecting genotype by exposure by outcome. 
This recommendation is made based on the finding that some studies did not include 
univariate analyses on environmental exposures and smoking outcomes.  
     Future studies should explicitly note the scale (i.e. additive or multiplicative) used to 
detect GxE effects, as it has been previously demonstrated that the way that outcome 
measure is scaled and whether the GxE effect is tested on the additive or multiplicative 
scale influences whether a GxE effect is observed. Under the simple definition of gene-
environment interactions, which suggest that either a different effect of an environmental 
exposure on disease risk in persons with different genotypes or a different effect of a 
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genotype on disease risk in persons with different environmental exposures, the presence 
or absence of interactions may depend on the scale of measurement (e.g. whether effects 
are additive or multiplicative). Where risks are measured on an additive scale, the effect 
of the environmental exposure differs among persons with different genotypes, but if risk 
factors are measured on a multiplicative scale, the effect of the exposure differs among 
people with different genotypes42. Thus, changing the scale of the outcome may create 
interactions that may not have previously existed or eliminate interactions that were once 
present. For example, binary outcomes have been shown through simulations to 
incorrectly detect GxE effect when none existed, thus raising concerns about the validity 
of results based on diagnoses43.   Most of the identified studies of GxE in smoking 
behavior provided confidence intervals of effect estimates with p-values20,22–25,27,29–34; 
though, several studies provided standard error estimates with p-values instead21,26,28. 
Only a few of the studies reported the number of tests conducted22,25,26, and all but one 
of the studies reported non-significant GxE. 
     There remains a need for more thorough reporting standards, especially as they apply 
to conducting tests for interaction. This should include regression coefficients for all 
parameters included in a regression model and explicitly noting what variables were 
included. Investigators should be cautious about interpreting any genotype or 
environmental main effect reported in previous studies, unless authors explicitly describe 
parameters in regression models.  
 
Tests for artifactual interaction 
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     Only one study tested for artifactual interactions by conducting sensitivity analyses23, 
suggesting that this has not been a predominant concern. However, this remains an 
important task, as it brings to question the validity of findings. There are various ways to 
check for artifactual interaction, including: substituting genotype, conducting sensitivity 
analyses, and running analyses with transformed variables43,44. Substituting the genotype 
entails trying to remove a significant interaction by replacing genotypic data with a 
similarly distributed polymorphism that has no association with smoking behavior. 
Conducting sensitivity analysis entails testing whether or not using different measures 
that share construct validity for the behavior of interest still reveals an interaction44. Had 
GxE been observed in one of a set of measures, but not the other, then it would have 
suggested the occurrence of a scaling artifact45. The transformation entails trying to 
remove the interaction effect by re-running analyses with transformed variables and 
checking to see if the detected interaction is still significant. This can be done different 
ways, including monotone transformations [e.g. taking a logarithm or square root]. If the 
significance of the interaction is removed through transformation, an additive relationship 
between variables on different scales is implied. If not removable, the interaction effect 
could be interpreted as: a robust fan-shaped interaction not removable by transformation, 
a crossover effect, or a qualitative interaction44.  
Treatment of covariates 
     The treatment of covariates was not uniform across studies, as studies controlled for 
a combination of the following: age, sex, race/ethnicity or ancestry (measured by principal 
components), smoking behavior of parents, socioeconomic status, and education. The 
covariates of sex, age or developmental period, and race/ethnicity or ancestry should be 
62 
 
included more explicitly in future GxE research. These factors are important for 
understanding the etiology of smoking behavior, as well as environmental exposure 
patterns, and may be related to differences in genotypic frequency.  
    Sex. Most studies controlled for or stratified results, though the studies did not always 
note whether they found different GxE effects for males when compared to females. 
     Age. Exploration of the importance of age for GxE is necessary for several reasons. 
Some environmental exposures are age-specific. For example, parental monitoring 
decreases over time and may peak around early adolescence. Without accounting for 
explicitly exploring how age influences GxE effects, research may be biased. Added to 
this, there is now substantial evidence that genetic risks for smoking problems have age-
dependent effects. Specifically, genetic risk of heavy smoking is greater in early-onset 
smokers (i.e. Prior to 16 years) when compared to later-onset smokers (i.e. 16 years or 
older). This association in early-onset smokers is consistent with the epidemiologic 
observation of increased vulnerability to dependence among early-onset smokers46. 
     Race/ethnicity or ancestry. By not controlling for race/ethnicity, studies may lead to 
biased results. This is related to population stratification whereby different allele 
frequencies may exist among different sub-populations or ancestral groups. Ideally, 
research should describe methods to assess or address population stratification and 
control for self-reported race/ethnicity and conduct sensitivity analyses to test whether 
GxE effects vary by race.  
Reporting of gene-environment correlation 
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          Only about half of the identified studies accounted for gene-environment correlation 
(rge)20,24,28–30,35, which refers to the phenomenon where an individual’s genotype also 
influences his/her exposure to the environment. This implies that individuals shape their 
environments through heritable behaviors and that the relationship between 
environmental exposure and behavior may be confounded by genotype. If rge is not 
accounted for in studies of GxE, it is unclear whether the environment is moderating 
genetic effects or if genes influencing a trait are more likely to be present in a given 
environment47. Conducting tests for rge can be accomplished through simple tests of 
association between environmental exposures and genotype, but may be limited by 
genotypes measured. To account for rge, researchers can: limit studies to moderators 
that are uncorrelated with the outcome43, utilize a moderator in means model to remove 
genetic effects shared by a trait and moderator from covariance48, or explicitly model rge 
in a bivariate model. The studies accounting for rge did so in a variety of ways including 
model adjustment for rge24, controlling for passive and active rge via inclusion of 
maternal28,29, paternal29, and peer smoking28 as covariates, and providing Pearson’s30 or 
cross-trait Spearman correlations35. However, no explanations were provided for why 
these specific methodologies were used in the studies. We recommend that future 
research test and report whether rge is present.  
CONCLUSION 
     This systematic review of the literature was conducted in attempts to understand the 
state of the science on GxE research of smoking behavior, focused on methodological 
approaches used across studies. A total of sixteen studies were identified, with thirteen 
finding at least some evidence to suggest a GxE effect. However, among these thirteen 
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studies, none of the findings seemed to overlap. The heterogeneity in results is likely 
related to the variation in conceptual and methodological approaches used to test for 
GxE. Studies varied in the populations sampled, methods used to assess environmental 
exposures, and means by which they tested for GxE effects. Methodological 
heterogeneity made it difficult to interpret and summarize findings. However, we hope 
that the recommendations provided will help to guide future studies towards reducing 
heterogeneity and capturing the joint contribution of genetic and environmental factors to 





Supplementary Table 3.5: Twin Studies of Gene by Environment Interaction of Human Smoking Behavior 













(at age 14) 
Parental monitoring NR Yes 
As parental monitoring 
increases, C and A decrease, 
and E increases 













Social pressure to 











Social pressures within 
schools moderate the 
heritability of daily smoking, 
but not smoking onset. As 
prevalence of smoking among 
popular students increased, 
the heritability of daily 
smoking increased. As the 
proportion of non-Hispanic 
Whites increased, the 
heritability of daily smoking 
increased. 















staff equivalent for 
tobacco control; 
Prevention budget; 
Excise Tax per pack 








As marketing and vending 
machine restrictions 
increased, genetic influences 
on regular smoking increased.  
Genetic influences on regular 
smoking increased as: state-
level excise tax on cigarettes 
increased and prevalence of 
state-level smoking by youths 
increased. 









National trends in 
cigarette consumption NR NR 
Timing of first Surgeon 
General’s Report coincides 
with increase in genetic 
influences on regular 
smoking, while subsequent 
legislation reduced influences. 
For those born in the 1940s 
and 1950s, genetic factors do 
not significantly contribute to 
the risk of regular smoking. 
While for those born in the 
early 1930s and mid-1950s, 
genetic influences are the 
most pronounced. 










Changes in policy and 
smoking attitudes NR NR 
Heritability of smoking 
initiation did not change as a 
function of environmental 
exposure. 




















As self-rated religiousness 
increased, genetic influences 






Supplementary Table 3.6: Genetic Association Studies of Gene by Environment Interaction of 
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Chen et al. (2009): Population-based case-control from Collaborative Genetic Study of Nicotine Dependence (United States, 









































































30) for smoking at 
age 14. 
Hiemstra et al. (2013): Longitudinal cohort/family-based design using sibling dyads from five waves of data from the Dutch 

















































genes were not 
found. 
Hiemstra et al. (2014): Longitudinal cohort/family-based design using sibling dyads from five waves of data from the Dutch 





























































Daw et al. (2013): Longitudinal cohort/school-based study design from Wave I and II from the National Longitudinal Study of 



































More short alleles 
are associated 
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but not average 
neighborhood 
physical disorder 
Chen et al. (2012): Prospective epidemiologic study and randomized placebo-controlled smoking cessation trial from the 1987 
Atherosclerosis Risk in Communities Study (United States) and the Smoking Cessation Trial of the University of Wisconsin 







































on abstinence or 
relapse between 
treatment groups 
Belsky et al. (2013): Prospective, longitudinal study of a representative birth cohort obtained from the Dunedin Multidisciplinary 
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higher genetic risk 
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to cope with 
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others did not.  
Xie et al. (2012): Subjects recruited for linkage and association studies of the genetics of drugs and alcohol dependence at give 
US sites:  the University of Connecticut Health Center (n=1102), Yale University School of Medicine (n=866), the Medical 
University of South Carolina (n=155), McLean Hospital of Harvard Medical School (n=57), and the University of Pennsylvania 
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in both men and 
women, with the 
effect in women 
being two times 
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CHAPTER 4:  
GENETIC AND ENVIRONMENTAL INFLUENCES ON SMOKING BEHAVIOR 
ACROSS ADOLESCENCE AND YOUNG ADULTHOOD IN THE VIRGINIA TWIN 
STUDY OF ADOLESCENT BEHAVIORAL DEVELOPMENT AND TRANSITIONS TO 
SUBSTANCE ABUSE FOLLOW-UP3 
 
Elizabeth K. Do, Elizabeth C. Prom-Wormley, Lindon J. Eaves, Judy L. Silberg, Donna R. 
Miles, Hermine H. Maes 
 
BACKGROUND 
Cigarette smoking is the leading cause of preventable death in the US and has been 
associated with considerable economic, social, and personal costs. Annually, tobacco 
use costs the nation an estimated $193 billion, inclusive of lost productivity and direct 
health care expenditures1. Yet, 19% of all US adults, or approximately 43.8 million people, 
smoke cigarettes2. Of these adult smokers, 70% began smoking regularly by age 183.  
Despite notable declines in cigarette smoking over the past 40 years, smoking behavior 
among adolescents remains a huge public health concern. Every day, about 3,900 
children under the age of 18 try their first cigarette. Of these children, an estimated 950 
will become new, regular daily smokers4; approximately half will die as a result of nicotine 
addiction and other smoking-related causes5. Twin studies have suggested that both 
genetic and environmental factors contribute to smoking behavior. However, many of 
                                                          
3This chapter was previously published as an original research article in Twin Research and 
Human Genetics. To cite information from this chapter, please use the following citation: Do EK; 
Prom-Wormley EC; Eaves LJ; Silberg JL; Miles DR; Maes HH, 2015. Genetic and Environmental 
Influences on Smoking Behavior across Adolescence and Young Adulthood in the Virginia Twin 
Study of Adolescent Behavioral Development and the Transitions to Substance Abuse Follow-




these twin studies investigate the influences of genes and the environment on cigarette 
use among adults, so less information is known regarding the genetic and environmental 
influences of cigarette use in adolescents. 
Early twin studies investigating the genetic and environmental influences of smoking 
behavior of adolescents analyze various stages of smoking behavior such as initiation, 
progression, dependence, and addiction separately6–8. These studies find that the 
initiation of tobacco use in adolescence is primarily explained by shared environmental 
factors9,10 while genetic factors contribute more to individual differences in other smoking 
behaviors, such as daily quantity of cigarettes smoked6 or smoking progression, which 
has an estimated heritability of 0.809,11,12. Furthermore, population based twin studies 
provide evidence that genetic influences come to play a larger role in smoking behavior 
by late adolescence, when the etiological structure of smoking initiation closely resembles 
that of adult samples13,14.  
Among adult samples, heritability estimates for smoking initiation range from 0.32 to 0.78, 
making it a moderately heritable trait8,15–20. On average, estimates are higher in women 
relative to men8,21–23, suggesting that the heritability of smoking initiation may differ by 
gender. However, this finding has not been replicated across all studies18.  
As a consequence of analyzing smoking behavioral factors separately, we lack 
information on whether any overlap exists across stages20. Although we know from adult 
studies that utilize multivariate analyses that significant genetic and environmental 
covariance exists between initiation and dependence8,18,24,25, it remains unclear whether 
the genetic and environmental factors influencing the relationship between smoking 
initiation and progression in adulthood are the same across adolescence into early 
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adulthood6,21,26. We also do not know if qualitative and quantitative sex differences found 
in adult samples exist in adolescent samples21–27.  
Thus, this study seeks to answer these questions by: examining the relationship between 
smoking initiation and current quantity smoked from adolescence to early adulthood, 
determining if qualitative and quantitative sex differences exist in this relationship, and 
estimating the contributions of genetic and environmental factors to smoking initiation and 
current quantity smoked in this younger age group. 
MATERIALS & METHODS 
Sample. Data were obtained from the Virginia Twin Study of Adolescent Behavioral 
Development (VTSABD) and its young adult follow-up, Transitions to Substance Use 
(TSA). The VTSABD is a multi-wave, cohort-sequential prospective study of adolescent 
psychopathology and its risk factors, in over 1,400 Caucasian juvenile twin pairs aged 8 
to 17 years and their parents28, greater detail about the ascertained sample have been 
provided elsewhere29. To be included the present study, individual twins had to have 
responded to questions regarding smoking initiation and current quantity smoked. The 
total sample size of this study was 2,804 twins (including 632 MZ male twins, 829 MZ 
female twins, 367 DZ male twins, 389 DZ female twins, and 587 DZ opposite sex twins). 
Data obtained for the 22 to 32-year age group (N = 1,074) was obtained from one wave 
of the TSA, to which all participants of earlier waves of the VTSABD were invited.  
Measures. Data from each of the five waves of the VTSABD were merged and then re-
categorized into age groups to ensure that there was an adequate sample size (i.e. 12-
13 years, 14-15 years, and 16-17 years). However, since there was only one assessment 
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during age period from 22-32 years, subdividing the TSA sample by age was not 
warranted. Two main variables of interest were recoded across each of these age groups: 
one measuring whether twins had ever smoked at least one whole cigarette and another 
measuring the current quantity of cigarettes smoked daily. The “ever smoke” variable was 
binary, coded as 0 for those who had never smoked at least one whole cigarette and 1 
for those who had indicated that they had ever smoked at least one whole cigarette. If 
respondents indicated that they had “ever smoked” in a given age group (i.e. 14-15 years), 
they would be given a value of 1 for “ever smoke” in that age group and every subsequent 
age group (i.e. 14-15 years, 16-17 years, and 22-32 years). Otherwise, if the respondents 
indicated that they had not “ever smoked” across all age groups, they were given a value 
of 0 for “ever smoke”.  To measure current quantity smoked, respondents had to indicate 
the number of cigarettes smoked daily, in the past three months. Free responses were 
coded into three categories. These categories indicated: zero cigarettes smoked daily 
(“non-current smoker”), one to five cigarettes smoked daily (“current, light smoker”), and 
five or more cigarettes smoked daily (“current, heavy smoker”). Only responses where 
twins indicated that they had smoked before under the “ever smoke” variable were 
included in the quantity of cigarette use variable. Otherwise, responses for individuals 
who had indicated that they had never tried cigarettes were coded as missing for the 
quantity of cigarette use variable.  
Descriptive Statistics. Prevalence estimates for smoking initiation and quantity are 
reported using percentages.  
Genetic Analyses. All data analyses were conducted using the open-source structural 
equation modeling software OpenMx30,31. Due to inadequate sample size for smoking 
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quantity in 12-13-year-olds, only univariate genetic analysis on smoking initiation was 
conducted in this age group. Causal-common-contingent (CCC) models were fit, 
individually, for smoking initiation and smoking quantity across all other age groups (i.e. 
14-15 years and 16-17 years in the VTSABD, and 22-32 years in the TSA).  
Using the causal-common-contingent (CCC) model originally developed by Kendler and 
colleagues (1999) [Are you sure? I think it’s Neale (2006)], smoking behavior was 
conceptualized as a two-stage process incorporating initiation and current quantity 
smoked. This model was chosen because it allows for estimating the relative magnitude 
of the contributions of genetic and environmental factors to smoking liability, as well as 
for testing the strength of the association between initiation and current quantity smoked 
stages for smoking via a beta pathway between the two stages18,24,26,32,33.  
The significance of an estimated beta pathway between the two stages is used to assess 
whether the two stages are independent or correlated processes. Specifically, if an 
estimated beta coefficient is found to be not significant, the liabilities for initiation and 
current quantity smoked are said to be independent of one another, implying that smoking 
initiation and current quantity smoked have separate genetic and environmental risk 
factors. Otherwise, if the estimated beta coefficient is significant, the liabilities for smoking 
initiation and current quantity smoked are said to share genetic and environmental risk 
factors. In this case, the beta coefficient provides an estimate of the magnitude of strength 
of association between smoking initiation and current quantity smoked. The greater the 
estimated beta coefficient, the larger the magnitude of the strength of the association 
between smoking initiation and current quantity smoked (i.e. beta coefficient of zero 
suggests that the two stages do not share genetic and environmental risk factors while a 
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beta coefficient of one suggests that the genetic and environmental risk factors for these 
two stages are identical). The estimated 95% confidence intervals around the beta 
coefficient give further information regarding the degree of overlap between the two 
stages. Again, lower limits approaching zero (or below) support independent liabilities and 
upper limits approaching 1 provide support for identical liabilities.  
Using this model also allows for the direct estimation of additive genetic effects (a2), 
shared/common environmental effects (c2), and unique environmental effects (e2) on both 
smoking initiation and current quantity smoked. However, since current quantity smoked 
is modeled conditionally upon smoking initiation, the genetic and environmental 
influences unique to current quantity smoked are estimated after those on initiation are 
taken into account. Thus, the proportion of variance in current quantity smoked explained 
by the respective influences on initiation can be calculated by multiplying them by the 
squared beta coefficient. The proportion of the variance in liability to current quantity 
smoked that is explained by genetic factors is the sum of the proportion of variance in 
initiation explained by genetic factors multiplied by the squared beta parameter and the 
proportion of variance explained by unique genetic factors contributing only to the current 
quantity smoked stage, with the same principle applied for environmental factors.  
Nested models were fitted to test specific hypotheses about the nature of association 
between the two stages of smoking initiation and current quantity smoked. More explicitly, 
to determine whether qualitative sex differences exist in the relationship between smoking 
initiation and current quantity smoked, we tested the significance of the genetic and 
shared environmental correlations between male and female factors. A model 
constraining the correlation between males and females to 1, suggesting that the same 
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factors contribute to male and female smoking behavior, was compared to a model that 
freely estimated correlations between male and female factors, suggesting that different 
factors contribute to male and female smoking behavior. This was done separately to test 
whether the same genes or same environmental factors contribute to the liability of 
smoking initiation and current quantity smoked in males and females. 
Quantitative sex differences were tested for simultaneously to answer the question of 
whether genetic and environmental factors explain the same proportion of the liability of 
smoking initiation and current quantity smoked in males and females. To test for 
quantitative sex differences, a model equating all parameters (i.e. genetic, shared 
environmental and unique environmental factors, but not thresholds) for males and 
females and was compared to one allowing for free estimation of parameters for males 
and females separately. If the model equating parameters between males and females fit 
the data best, it was concluded that quantitative sex differences did not exist. This process 
was repeated for each age group.  
Following these tests for qualitative and quantitative sex differences, other alternative 
models were fit to the data. Specifically, nested models were created to test if there is a 
direct relationship between smoking initiation and current quantity smoked and whether 
genetic or common environmental factors could be dropped from initiation and current 
quantity smoked stages. Where the beta pathway could be dropped from the model 
without significant loss to goodness-of-fit to the data, it was determined that smoking 
initiation and current quantity smoked had independent liabilities. Alternatively, when 
dropping the beta pathway led to significant loss to goodness-of-fit, smoking initiation and 
current quantity smoked were said to have shared liabilities. Regardless of whether this 
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finding was significant, we moved on to test whether we could drop genetic or shared 
environmental factors from either initiation or current quantity smoked. Where genetic or 
environmental factors could not be dropped without significant loss to goodness-of-fit, the 
factor was said to contribute significantly to the smoking phenotype. 
Nested models were compared using likelihood ratio chi-square (LRC) statistics, in which 
the degrees of freedom equal the difference between the degrees of freedom of the full 
and nested sub models. LRC is calculated as the difference in -2 log likelihood (-2LL of a 
comparison model and the -2LL of a reduced nested model34,35. Where the LRC 
comparing the two models is non-significant, the reduced model is selected as the better 
fitting model. Akaike Information Criterion (AIC) was also used as an index of model fit, 
as well as an index of parsimony36,37. 
RESULTS 
Smoking prevalence.  At age 12-13 years, 10.4% of the total sample had indicated that 
they had ever smoked. This increased to 27.4% by age 14-15 years, 46.6% by age 16-
17 years, and 79.1% by age 22 to 32 years. Across all age groups, most respondents 
indicated that they were not current smokers (i.e. indicated that in the past 3 months, they 
smoke zero cigarettes daily).  Although the majority (approximately 71%) of adolescents 
who tried smoking did not become ‘current, heavy smokers’, the proportion of ‘current, 
light smokers’ and ‘current, heavy smokers’ did increase consistently from the younger to 





Table 4.1: Smoking Initiation and Current Quantity Smoked Prevalence of Sample  
 
Qualitative and quantitative sex differences. Genetic analyses indicated that no 
significant qualitative or quantitative sex differences existed in the contribution of genetic 
or environmental factors to liability of smoking initiation and current quantity smoked, and 
in the relationship between smoking initiation and current quantity smoked for any of the 
age groups in this sample (Table 4.2). More specifically, the same genes and 
environmental factors contributed to the liability of smoking initiation and current quantity 
smoked in males and females, and genetic and environmental contributions could be 
equated across sex across ages 14-15, 16-17, and 22-32. (Ages 12-13 were not included 
78 
 
in these analyses due to inadequate sample size and ages 22-32 were combined to 
ensure adequate sample size for analyses.)  
Table 4.2: Model Fit Statistics from CCC Models 
 
Relationships between smoking initiation and current quantity smoked. The 
relationship between smoking initiation and current quantity smoked could not be 
assessed for ages 12-13, due to inadequate sample size for the smoking quantity 
variable. Instead, univariate genetic analysis was conducted on the smoking initiation 
variable. The best fitting model for this age group did not include additive genetic factors, 
suggesting that common environmental (71.7%; 95% CI: 58.7%, 81.8%) and unique 
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environmental factors (28.2%; 95% CI: 18.2%, 41.2%) best explained the variance in 
smoking initiation at age 12 to 13 years.  
Across ages 14-15 and 16-17 years, dropping the beta parameter from the CCC model 
did not result in significantly worse model fit. This implied that smoking initiation and 
smoking quantity had independent liabilities at these age groups. The best fitting models 
were not the same across these age groups, however. For age 14 to 15 years, the best 
fitting models were an ACE model for smoking initiation and a CE model for current 
quantity smoked, suggesting that genetic (53.5%) and environmental factors (shared: 
28.6%; unique: 17.8%) contributed to smoking initiation while environmental factors 
contributed to current quantity smoked (shared: 84.8%; unique: 15.2%), as measured by 
quantity smoked.  For age 16 to 17 years, the best fitting model for smoking initiation was 
an AE model, while a CE model still fitted the data best for current quantity smoked, 
suggesting that genetic (84.8%) and unique (15.2%) environmental factors contributed to 
smoking initiation, while environmental factors (shared: 88.7%; unique: 11.3%) 









Figure 4.1: Best Fitting CCC Models and Variance Component Estimates 
 
For ages 22-32 years, the beta parameter between the initiation and current quantity 
smoked stages was significant, and the best fitting model was an AE model for both 
initiation and current quantity smoked. This suggested that smoking initiation and smoking 
current quantity smoked shared liabilities to a moderate extent (β = 0.48) and was no 
longer independent, as with the earlier age groups. Additionally, genetic and unique 
environmental factors contributed to both smoking initiation and current quantity smoked, 
but shared environmental factors no longer exerted a signification impact on liability to 
smoking. Thus, of the genetic variance in liability to current quantity smoked, 
approximately 77.3% of the genetic variance was specific to current quantity smoked and 
23.0% was shared with smoking initiation. In other words, mostly different genetic factors 
contributed to the liabilities of smoking initiation and current quantity smoked across 
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adolescence, but in young adulthood, there was some overlap between the factors 
influencing initiation and current quantity smoked. 
DISCUSSION 
No qualitative or quantitative differences were found between males and females 
regarding the genetic and environmental influences on individual differences in smoking 
initiation and current quantity smoked across adolescence into early adulthood, lending 
support for similar findings in other studies6,18. However, at age 22-32, when testing for 
qualitative sex differences, models constraining the genetic correlation to 1, indicating the 
same genes influence smoking initiation and current quantity smoked in males and 
females, fitted the data only slightly better than models that allowed for the free estimation 
of the genetic correlation. Thus, it is possible that qualitative sex differences do exist in 
later adulthood and that we did not have the power to detect them in the current sample. 
This might explain why other studies utilizing adult samples have found qualitative sex 
differences in the genetic and environmental influences in smoking behavior8,16,21,27.  
Unfortunately, due to sample size constraints, we were unable to determine whether 
genetic or environmental factors contributed more significantly during the earliest ages of 
adolescence (ages 12-13). However, we did find that different factors contribute to 
smoking initiation and current quantity smoked across mid-adolescence into early 
adulthood. More specifically, smoking initiation and current quantity smoked seemed to 
have independent liabilities until adulthood, when liabilities were shared. Genetic, shared 
and unique environmental factors were found to significantly contribute to smoking 
initiation during early adolescence (i.e. ages 14-15), but not during later adolescence (i.e. 
ages 16-17) or adulthood (i.e. ages 22-32 years), when genetic and unique environmental 
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factors significantly contribute. Shared environmental influences may be more important 
for 14-15 year olds relative to older age groups because they experience greater 
limitations on the access to and availability of cigarettes. Although 14-15 year olds and 
16-17 year olds experience the same legal age restriction on the purchasing of cigarettes, 
14-15 year olds might still have a harder time in gaining access to cigarettes among their 
peer groups if they have fewer friends who are of the legal age to buy cigarettes.  
Additionally, genetic influences were not found to contribute significantly to smoking 
initiation until later adolescence into adulthood (beginning at age 14-15 years), much in 
the same way other studies suggest9,10,13. However, contrary to other findings, which find 
greater genetic influence on heavier/problem substance use, we found that genetic 
factors do not contribute significantly to the variance in current quantity smoked across 
all age groups until young adulthood (i.e. ages 22-32 years). Interestingly, it is also during 
this time that the liabilities of smoking initiation and quantity smoked are no longer 
independent of one another, but rather correlated. Again, this might be a function of 
access and availability to cigarettes. As access and availability of cigarettes increase, the 
expression of genetic predispositions towards increased smoking frequency and potential 
addiction may also increase, following initiation. Or, it could be the case that using a 
recent estimate of quantity smoked rather than an estimate from heaviest period of use 
is less stable and representative of adolescent youth relative to adults, and that our choice 
of measures for the analysis in this study could influenced the estimate of the variance 
components. 
Limitations and Strengths. Results of this study must be interpreted in the context of a 
couple of limitations. First, due to low prevalence of smoking behavior among early 
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adolescents in this sample, the power of the current study was limited. This was apparent 
when we found that only univariate genetic analysis could be conducted on the smoking 
initiation variable among 12-13 year olds as there were too many missing values for the 
current quantity smoked variable and consequently, a CCC model could not be fit. It is 
also possible that using self-reported data underestimated the prevalence for smoking 
behaviors, because of social desirability bias, which could have also influenced genetic 
analysis. Furthermore, this study is not generalizable to all populations, as the sample 
included only Caucasians. 
Despite these limitations, the present study does include both males and females. It is 
also one of only a few studies investigating the relationship between smoking initiation 
and current quantity smoked within an adolescent sample and adds to the literature by 
investigating this relationship across various age groups. Future studies could include the 
use of measures related to smoking progression, other than current quantity smoked to 
investigate their effects on the relationship between smoking initiation and current 
quantity smoked. It would also be interesting to see if the same relationships are found 
among other adolescent datasets, using different populations than the one described in 
the present study and if these relationships are affected by the addition of environmental 
covariates, such as parental monitoring or peer influences. 




A TWIN STUDY OF THE GENETIC AND ENVIRONMENTAL RELATIONSHIP OF 
STRESSFUL LIFE EVENTS AND SMOKING INITIATION USING THE VIRGINIA TWIN 
STUDIES OF ADOLESCENT BEHAVIORAL DEVELOPMENT 
 
Elizabeth K. Do and Hermine H. Maes 
 
INTRODUCTION 
Tobacco use is the leading cause of preventable morbidity and mortality. Despite 
substantial decreases in the prevalence of smoking in the last 50 years, on average, one 
in three adults under the age of 26 continues to use tobacco and nearly half of current 
users - equivalent to approximately 12.8% of the population in the United States - are 
nicotine dependent. The direct medical costs due to tobacco-related morbidity totals $130 
billion annually1. Given this expenditure of public resources, a better understanding of the 
etiology of tobacco use is essential for the development of effective prevention efforts.  
Smoking, in particular, has been identified as a mechanism for coping with stress2,3 
among young users4 and adults2,3. Smoking initiation for adult users typically occurs 
during adolescence5, when unhealthy and maladaptive behaviors can develop as a result 
of life changes and stress6. Although smoking initiation may occur because it is fun and 
pleasurable, it can also be a mechanism by which adolescents cope with stressful life 
events. Additionally, retrospective accounts of life events reveal that smokers report more 
stressful life events relative to non-smokers4,7–9. Added to this, stressful life events (SLEs) 
have been associated with smoking initiation and smoking progression6,10–12. Specific 
SLEs, such as adverse childhood experiences13, parental divorce14, sexual abuse, a 
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vulnerable family environment, and parental death during childhood are associated with 
lifetime history of smoking initiation15.  
Some studies investigating stress and smoking initiation suggest that these effects may 
be sex limited. For example, one study determined that the effect of early life stress on 
the risk of smoking initiation by adolescents was only significant among girls at high 
incidence of stressful life events. Specifically, girls who experienced high levels of stress 
at 7 years of age had nearly three times higher odds of tobacco use (OR = 2.94, 95% CI 
= 1.26, 6.83), relative to those that did not. This association was not observed for boys16. 
Another study found that the association between family related stress and smoking 
initiation seems to be stronger for girls11.  
However, the causes underlying these associations remain unclear and to our knowledge, 
no genetically informed studies of the association between stressful life events and 
smoking initiation have been conducted. This study seeks to address this limitation in the 
literature by examining a large population-based sample of Virginia twins to assess 
whether SLEs and smoking initiation (SI) are influenced by shared genetic and/or 
environmental factors. Specifically, we seek to address the following questions: (1) Is 
there evidence of a shared genetic and/or environmental liability for the association 
between SLEs and SI, (2) Does the structure of genetic and environmental influences on 






MATERIALS & METHODS 
Sample. Data were obtained from the Virginia Twin Studies of Adolescent Behavioral 
Development, which includes the Virginia Twin Study of Adolescent Behavioral 
Development (VTSABD) and its two follow-up studies, which drew upon participants from 
the VTSABD: The Young Adult Follow-Up (YAFU) and Transitions to Substance Abuse 
(TSA) Follow-Up studies. The VTSABD is a cohort-longitudinal epidemiological study of 
the development and maintenance of childhood psychiatric disorders using a genetic twin 
design16. Adolescent male and female twins aged 8 to 16 years were ascertained through 
Virginia schools. In the first wave, 1412 Caucasian families participated (2775 individual 
twins in 1384 complete pairs). Twins under age 18 were followed every 18 months up to 
4 times. All twins were targeted for a young adult assessment. 1185 pairs have been 
followed up in YAFU at a median age of 21 years; 399 pairs (1084 individuals) in TSA at 
a median age of 25 years. More details regarding the ascertainment of the sample is 
given elsewhere17. To be included in the present study, individual twins had to have 
provided responses to the Life Experiences Interview regarding questions on stressful life 
events and smoking initiation. Analytic samples included: 319 monozygotic male (MZM), 
418 monozygotic female (MZF), 180 dizygotic male (DZM), 193 dizygotic female (DZF), 
and 293 dizygotic opposite sex (DZO) twins from the VTSABD; 263 MZM, 347 MZF, 144 
DZM, 158 DZF, and 225 DZO twins from the YAFU, and 106 MZM, 201 MZF, 55 DZM, 
70 DZF, and 53 DZO twins from the TSA. 
Measures. The two variables of interest included smoking initiation and stressful life 
events. Smoking initiation was measured by the question, “Have you ever smoked, even 
if you were trying just one cigarette?” Responses included: no (coded as 0), yes (coded 
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as 1), and no answer provided (coded as missing). Stressful life events included 
measures regarding major family conflict, divorce/separation, and death. Responses to 
each of these stressful life events items was: yes (coded as 1), no (coded as 0) or missing. 
Since the items used to measure stressful life events differed between VTSABD, YAFU, 
and TSA, we summed relevant item responses and then the variables were categorized 
to be ordinal. 
Statistical Analyses 
Prior to conducting analyses, data were cleaned and recoded using SAS 9.3 (SAS 
Institute Inc., 2003).  Data were then prepared for use as raw ordinal data and analyzed 
using the statistical modeling package OpenMx18. This approach assumes that the ordinal 
categories are representative of an underlying normal distribution of liability, with 
thresholds in liability discriminating between categories. For twin models, the liability to 
traits can be attributed to several latent sources of variance: additive genetic factors (A); 
shared environment (C), or environmental factors that lead to similarity between twin 
pairs; and non-shared environment (E), or environmental factors that lead to dissimilarity 
between twin pairs. Estimates of each of these variance components are calculated by 
comparing the phenotypic correlation between monozygotic twins, who share all their 
genes, with dizygotic twins, who share half of their genes, on average, identical by 
descent.  
Bivariate analyses examining the association between stressful life events and smoking 
initiation were conducted separately for data from the VTSABD and its two follow-up 
studies, the YAFU and TSA. Cholesky bivariate decompositions were used to decompose 
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the variance of smoking initiation into genetic and environmental influences common with 
stressful life events and genetic and environmental influences unique to smoking 
initiation. Using this approach, we were also able to test for both quantitative and 
qualitative sex-limitation19 with the following nested models: (1) qualitative for genetic 
factors and quantitative sex differences, (2) qualitative for shared environmental factors 
and quantitative sex differences, (3) quantitative sex differences but not qualitative sex 
differences, and (4) no quantitative and no qualitative sex differences, showed in the 
figures below.  
Figure 5.1a: Quantitative and Qualitative Sex Differences for Genetic Factors: Male 
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Figure 5.1b: Quantitative and Qualitative Sex Differences for Genetic Factors: 
Male and Female Cholesky Paths and Male Specific A Paths 
 
Figure 5.2a: Quantitative and Qualitative Sex Differences for Genetic Factors: 
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Figure 5.2b: Quantitative and Qualitative Sex Differences for Genetic Factors: 
Male and Female Cholesky Paths and Male Specific C Paths 
 
Figure 5.3: Quantitative Sex Differences for Genetic Factors: Male and Female 
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Figure 5.4: Quantitative or Qualitative Sex Differences: One Set of Parameters, 
Same for Males and Females
 
The fit of the nested models was assessed as a function of the change in the value of 
twice the log likelihood of the data, which is distributed as a chi-square statistic with 
degrees of freedom equal to the difference in the number of parameters estimated 
between models. A significant change in Chi Square indicates a significant deterioration 
in model fit. We also used Akaike’s Information Criterion (AIC)20 to select models, such 
that a lower AIC value indicates a better balance between the explanatory power of a 
model and parsimony. We did not test sub models dropping genetic and environmental 
paths in the Cholesky decomposition models to allow for comparability between the 
VTSABD, YAFU, and TSA samples. 
RESULTS 
After testing for quantitative and qualitative sex differences, it was determined that the 
homogeneity model, reflecting neither quantitative nor qualitative sex differences, fit the 
data best for the VTSABD, YAFU, and TSA samples (see Figure 5.4). Thus, no sex 
specific A or C factors significantly contributed to the covariance between stressful life 
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equated to be the same in each final model. In the VTSABD, common genetic (2%) and 
common shared environmental (30%) influences between stressful life events and 
smoking initiation contributed to the variance in smoking initiation, while common non-
shared environmental influences did not. Genetic (30%), shared environmental (21%) and 
unshared environmental (17%) influences unique to smoking initiation also contributed to 
the variance in smoking initiation. 
Figure 5.5: Model of Best Fit and Proportions of Variance (VTSABD) 
 
Meanwhile, in the YAFU, common genetic (9%), shared environmental (3%), and non-
shared environmental (1%) contributed to the variance in smoking initiation at median 
age of 21 years. Genetic (69%) and non-shared environmental (18%) influences unique 





Figure 5.6: Model of Best Fit and Proportions of Variance (YAFU) 
 
Finally, in the TSA, common genetic (16%) and common shared environmental (13%) 
influences contributed to the variance in smoking initiation at median age of 25 years. 
Genetic (45%) and non-shared environmental (26%) influences unique to smoking 
initiation contributed to the variance in smoking initiation.   





Although many studies have examined the relationship between stressful life events and 
tobacco use, none have investigated this relationship using a genetically informed 
sample. To our knowledge, this is the only study that includes stressful life events and 
smoking initiation. In conducting these analyses, we sought to address three major 
questions: (1) Is there evidence of a shared genetic and/or environmental liability for the 
association between SLEs and SI, (2) Does the structure of genetic and environmental 
influences on these traits differ by sex, and (3) Does this structure differ in early 
adolescence and young adulthood? 
Findings from our study suggest that there is evidence of shared genetic and 
environmental liability for the association between SLEs and smoking initiation and that 
this structure differs in early adolescence and young adulthood. Moreover, the structure 
of genetic and environmental influences on these traits does not seem to differ by sex.  
This suggests that the same genes and environments are influencing both stressful life 
events and smoking initiation in males and females, which differs from previous 
population based studies that have found stronger associations between specific stressful 
life events and smoking initiation among females relative to males. These findings may 
differ because this study aggregated the effects of multiple stressful life events and tested 
the association between the ordinal measure of stressful life events, rather than testing 
the association with each specific stressful life event.  
We also find that most of the variance in smoking initiation is accounted for by genetic 
and environmental influences unique to smoking initiation. However, genetic and 
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environmental influences common to stressful life events and smoking initiation do 
contribute to the covariance between stressful life events and smoking initiation. While 
common shared environmental influences contribute more to the variance in smoking 
initiation during late adolescence (i.e. VTSABD), common genetic influences contribute 
more to the variance in smoking initiation in young adulthood (i.e. YAFU & TSA). In other 
words, underlying factors influencing stressful life events and smoking initiation are 
different for adolescent and young adult twins, such that stressful life events and smoking 
initiation is influenced by the same, shared environmental factors in young adolescents 
and by the same, genetic risk factors in young adulthood. This could suggest that once 
an individual is exposed to the effects of stressful life events, genetic factors come into 
play, and only individuals with a certain set of genes will initiate tobacco use.  
Some shared environmental factors that might be involved in the association between 
stressful life events and smoking initiation have been identified in previous studies4,7–
9,namely the influence of peers and family. Peer influence is one of the most important 
determinants of smoking initiation and it is possible that the same peers experiencing 
stressful life events are involved with the initiation of smoking. Meanwhile, the influence 
of family members can be seen as both an environmental factor and influenced by genetic 
factors. For example, parents at high genetic risk for stressful life events may be more 
likely to show negative parenting behaviors, including substance use, and then transmit 
their genetic predisposition for substance use to their children. 
Like other studies, this study is not without its limitations. Firstly, the analytic sample 
included only Caucasians from the Mid-Atlantic region of the United States. This limits the 
generalizability of the findings and future studies need to be conducted to confirm whether 
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the same relationships exist in other population samples. Furthermore, the measures of 
smoking initiation used in the current study were based upon self-report and no secondary 
validation measures were used. Although assurances that answers would be kept 
confidential were given to respondents during administration of surveys to prevent bias 
[and have shown to be effective in studies conducted in the United States21], desirability 
bias could have affected the way in which respondents answered questions regarding 
their tobacco use. To protect against this bias, future studies may consider validation of 
smoking behavior measures using biomarkers, such as cotinine. Similarly, different 
measures for stressful life events were used at each of the survey time points. To 
overcome this obstacle, we tried to harmonize the measures through the inclusion of 
related items for stressful life event measures (i.e. including measures on familial conflict, 
divorce/separation, and death/loss). 
Despite these limitations, the study yields novel information in so much that it suggests 
that stressful life events and smoking initiation are associated among Caucasian 
adolescents and that both genetic and environmental factors play a role in the covariation 
between these traits. Future research should consider how these genetic and 
environmental factors influence the covariation between stressful life events and other 
tobacco use phenotypes, such as smoking progression and nicotine dependence. 
CONCLUSION 
This study suggests that stressful life events and smoking initiation are associated due to 
a common set of environmental factors during young adolescence and common set of 
genetic factors during young adulthood. Prevention and intervention programs for 
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smoking initiation should look towards targeting stressful life events, potentially through 
the implementation of coping strategies with stress and incorporate environmental 




CHAPTER 6:  
PREVALENCE AND CORRELATES OF NICOTINE DELIVERY SYSTEMS AMONG 
YOUNG ADULTS IN UNIVERSITY SETTING 
 
Elizabeth K. Do; Megan E. Cooke; Elizabeth C. Prom-Wormley; Danielle M. Dick; 
Kenneth S. Kendler; Hermine H. Maes 
 
INTRODUCTION  
Tobacco use is the leading preventable cause of morbidity and mortality in the United 
States and worldwide1. Among users, it can lead to several adverse outcomes, including 
nicotine dependence, cancer, and lung disease in later life. Each of these adverse 
outcomes comes with an associated cost, such as lost productivity and wages due to 
hospitalization or premature death. This is a key point to consider, especially when 
thinking about the tobacco use behaviors of young adults. Given the broader range of 
tobacco products available on the market, the tobacco use behaviors of young adults may 
be considerably higher than what has been detected by previous studies limited to the 
use of cigarettes2,3. As with cigarette smoking, the use of alternative nicotine delivery 
systems is associated with serious health problems, such as cardiac, pulmonary and 
reproductive conditions4. Further, their use may hinder efforts to reduce population-level 
tobacco use and risk for nicotine dependence. This is especially problematic, given the 
escalating trend for dual (e.g. using cigarettes and an alternative tobacco product) and 
polytobacco use (e.g. using three or more tobacco products)5,6. According to the Tobacco 
Use Supplements to the Current Population Survey, administered by the U.S. Census 
Bureau, alternative tobacco use occurs more often in combination with cigarette smoking 
than in isolation, as demonstrated by 51.3% of college students aged 18-24 years 
reporting concurrent use2,7. Concurrent use has the potential to increase exposure to 
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nicotine and risk for adverse health effects8 and nicotine dependence9. Concurrent users 
also tend to ingest more nicotine daily and are less likely to stop using tobacco, relative 
to individuals who use only one tobacco product7,10. 
Despite public health efforts to decrease its prevalence, tobacco use remains common, 
especially among young adults. Young adulthood is a critical time during which individuals 
are exploring and/or solidifying their tobacco use patterns. Currently, the prevalence of 
occasional use among college students is higher compared to other adult users of 
tobacco11. Since currently available cessation services are not ideally suited for 
occasional users of tobacco12,13, a better understanding the factors contributing to the 
patterns and nuances of tobacco use among college students could aid the design of 
better prevention and interventions for young adults. Most studies focus on cigarette use, 
which has declined from 45.5% in 1965 to 24.4% in 2005, and leveled out to about 20% 
within the United States. Within the past couple of years, the use of alternative tobacco 
products (e.g. smokeless tobacco, cigars, waterpipe/hookah, and e-cigarettes) has been 
increasing, particularly among adolescents and young adults. 
Factors affecting tobacco use across various age groups include parental autonomy 
granting, parental involvement, and the experience of stressful life events. Higher levels 
of autonomy granting are related to lower levels of drug use14, while associations between 
parental involvement and smoking suggest that young adults whose parents spend more 
time with them and communicate with them more frequently are less likely to use 
tobacco15. Meanwhile, studies identify tobacco use as a potential mechanism by which 
individuals cope with (anticipated) stress16. Higher levels of life stress are associated with 
risk of cigarette smoking initiation within adolescents17 and retrospective accounts of life 
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experiences demonstrate that smokers often report more stressful life events, relative to 
non-smokers18–20. Studies of both adolescents and college students demonstrate that 
increased involvement with smoking is found among those experiencing negative affect, 
often because of stress21. However, it is unclear whether these factors are associated 
with other nicotine delivery use in young adults as well.  
This study evaluates the patterns of use across nicotine delivery systems among young 
adults in a sample of college students attending an urban four-year university. 
Specifically, we want to determine: (1) age of first use for each tobacco product or nicotine 
delivery system, (2) the prevalence of lifetime and current use and whether this differs by 
sex or race/ethnicity, and (3) the degree to which use of these products are associated 
with environmental factors, such as parental environment as well as with experiencing 
stressful life events. 
MATERIALS AND METHODS 
Sample. Data were collected as a part of Spit for Science, an effort being led by 
researchers at a large, diverse, public urban university in the Mid-Atlantic region, to 
understand how genetic and environmental factors come together to contribute to the 
development of problems associated with the use of substances and emotional health. 
Incoming freshman (≥18 years) were invited to participate in the longitudinal cohort study, 
which involves multiple waves of survey data collection, including: two collection periods 
during the freshman year (fall and spring) and spring follow-ups conducted annually 




The study is ongoing, and the results from this study reflect the data available for cohorts 
one through four from Fall 2012 to Spring 201522. Each cohort is followed across time, 
from freshman year when they are enrolled into the study. All information collected was 
managed using an electronic data capture tool hosted at the university called Research 
Electronic Data Capture (REDCap)23. Currently, four cohorts have enrolled in the study: 
2707 enrolled in Fall 2011, 2481 enrolled in Fall 2012, 2391 enrolled in Fall 2013, and 
2310 enrolled in Fall 2014 (Total N = 9,889). DNA collection is also a part of the study 
protocol, but not involved in the present analyses. The university Institutional Review 
Board (IRB) approved all Spit for Science protocols.   
Measures. Demographic characteristics include race/ethnicity, sex, and age. 
Race/ethnicity was collected, since the prevalence of tobacco use in young adulthood is 
expected to differ across race/ethnicity groups. Participants were asked to select from 
“American Indian/Alaska Native”, “Asian”, “Black/African American”, “Hispanic/Latino”, 
“More than one race”, “Native Hawaiian/Other Pacific Islander”, “Unknown”, “White”, or “I 
choose not to answer” to answer the question: “Which one of these groups’ best describes 
you?” The types of tobacco products and nicotine delivery systems used are also 
expected to differ by sex, of which participants could select: “male”, “female”, or “I choose 
not to answer.” The age of respondents ranged from 18 to 35 years, with the mean age 
of respondents being 19.6 years. 
Lifetime and recent use of cigarettes, smokeless tobacco (chaw/dip/snus), cigars 
(including little cigars and cigarillos), hookah, and e-cigarettes were treated as binary 
variables (i.e. yes = 1; no = 0). 
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Age of onset of tobacco use was measured using: “How old were you when you smoked 
a cigarette or used tobacco for the first time (including just one or two puffs)?” This 
variable was coded as an ordinal variable, with those who had not initiated smoking coded 
as zero, those who had initiated after age 18 as 1, gradually increasing to those who 
initiated prior to age 12 (2: 15-18 years, 3: 12-14 years, 4: <12 years). For cohort 4, 
measures for tobacco product-specific age of onset were available, asking “How old were 
you when you [smoked a cigarette/used smokeless tobacco/ smoked cigars, little cigars, 
cigarillos/ smoked hookah/ used an e-cigarette] for the first time?” Participants responded 
to this question by inputting their age in years in a free response. Responses that were 
missing for the age of onset of tobacco use were substituted by measures for tobacco 
product-specific age of onset. 
Exposure to stressful life events prior to university enrollment were calculated as a sum 
score from five yes/no items. The items asked specifically whether before the past 12 
months, the following events happened to the participant: natural disaster (flood, 
hurricane, tornado, earthquake, fire or explosion), physical assault (being attacked, hit, 
slapped, kicked, beaten up, shot, or stabbed), sexual assault (rape, attempted rape, made 
to perform any type of sexual act through force or threat of harm), other unwanted or 
uncomfortable sexual experience, transportation accident (car accident, boat accident, 
train wreck, plane crash). Greater values indicate higher levels of stressful life events 
experienced prior to university and all responses were included in analyses. 
Parental involvement was measured using three items: “My parents helped me with 
schoolwork if there was something I didn’t understand”, “My parents knew who my friends 
were”, and “My parents spent time just talking with me” from the Steinberg Parental Style 
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Scale. Each of these items were reverse-coded and then summed. Greater values 
indicate higher levels of involvement. Only responses where participants answered at 
least 50% of the items were included in analyses. 
Parental autonomy granting was measured using three items: “My parents said I should 
give in on arguments rather than making people angry”, “My parents told me that their 
ideas were correct and I should not question them”, and “My parents acted cold and 
unfriendly if I did something they didn’t like” from the Steinberg Parental Style Scale. 
Greater values indicate lower levels of autonomy granting. Only responses where 
participants answered at least 50% of the items were included in analyses. 
Statistical Analysis. Frequencies of the relevant variables were described with 
percentages, while Chi-square tests and independent sample t-tests were used to assess 
the relationship between age of onset of tobacco use and demographic characteristics, 
stressful life events experienced prior to attending university, parental involvement, and 
parental autonomy granting. Tetrachoric and polychoric correlations were used to 
examine specific and overall tobacco product use by parental environment and stressful 
life events experienced prior to attending university. Multivariate logistic regression 
models were fitted to examine the associations between tobacco use (lifetime and recent 
use) and stressful life events experienced prior to attending university, parental 
involvement, and parental autonomy granting. Analyses were performed using SAS 9.3 






Descriptive characteristics of the sample. The total analytic sample included 9,889 
individuals. Females made up 61.5% (N = 6060) of the sample. Approximately half 
(50.1%; N = 4881) identified as White, 19.2% (N = 1873) identified as Black/African-
American, 16.6% (N = 1614) identified as Asian, 6.3% (N = 617) identified as more than 
one race, 6.1% (N = 594) identified as Hispanic/Latino, 0.7% (N = 67) identified as Native 
Hawaiian/Other Pacific Islander, 0.5% (N = 51) identified as American Indian/Alaska 
Native, and 0.4% (N = 39) identified as unknown race.  
Age of Onset of Tobacco Use. Over half (68.4%) of students have initiated any tobacco 
use. Of those who had initiated, 18.4% did not report an age of onset, while more than 
40% had initiated by age 18. Of those that initiated by 18, most students started using 
tobacco products between ages 15 to 18 years (25.6%). On average, the age of onset for 
smokeless tobacco was 15.82 years, followed by cigarettes at 15.96 years, cigars and 
hookah at 16.15 and 16.18 years, followed by e-cigarettes at 17.26 years (Table 6.1).  
Table 6.1 Tobacco Use – Age of Initiation 
 
Note: Average age of tobacco use initiation was 15 years (SD = 1.2 years) 
 
Overall Tobacco Use  N %  
Did Not Initiate 3091 31.26  
Initiated, but did not report age of initiation 1815 18.35  
> 18 years 1109 11.21  
15 – 18 years 2531 25.59  
12-14 years 1094 11.06  
< 12 years 249 2.52  
By Tobacco Product  N Mean SD 
Cigarettes  662 15.96 2.65 
Smokeless 185 15.82 3.43 
Cigars 640 16.15 3.14 
Hookah 918 16.18 3.81 
E-Cigarettes 591 17.26 1.84 
105 
 
Changes in the prevalence of lifetime tobacco use. Figure 6.1 shows the prevalence 
in lifetime use of tobacco by nicotine delivery system (e.g. cigarettes, snus, cigars, 
hookah, and e-cigarettes), separated by sex and time in college by cohort. Generally, the 
lifetime use of tobacco products increased as the time enrolled in college increased for 
both males and females. On average, 30% of females and 40% of males had ever used 
cigarettes; less than 10% of females and 20% had ever used snus; and 50 % of males 
and females had ever used hookah in their lifetime, by their freshman year of college. 
While the percentages endorsing lifetime use of cigars, and hookah remained consistent 
from freshman year to senior year, the endorsement of lifetime use of cigarettes increased 
across all cohorts. Interestingly, the lifetime use of snus and e-cigarettes differed by 
cohort; however, this might be a function of availability and when this item was measured 
in the survey. Figure 6.2 demonstrates this point by displaying the prevalence of lifetime 
tobacco use by nicotine delivery system, as a function calendar time, separated by sex. 
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Figure 6.1: Prevalence of Lifetime Tobacco Use by Nicotine Delivery System, Sex, and Time in College – Separated by Cohort 
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Tobacco use prevalence and differences by sex and race/ethnicity. Aggregated 
measures of lifetime tobacco use from Table 6.2 demonstrates that the lifetime 
prevalence of tobacco use was highest for hookah (49.6%), followed by cigarettes 
(49.2%), cigars (34.9%), e-cigarettes (25.5%), and smokeless tobacco (15.1%). Overall, 
a higher percentage of males reported using tobacco, relative to females, across each 
tobacco product. The largest difference between the percentages of males vs. percentage 
of females using a tobacco product was found for smokeless tobacco, where 27.8% of 
males and 7.2% of females endorsed ever using smokeless tobacco (Χ2 = 767.46, df = 1, 
p-value <0.0001) (Table 6.2). The prevalence of lifetime use of tobacco products differed 
by race/ethnicity (Table 6.3).  
The tobacco product with the highest prevalence for recent use was cigarettes (48.1%), 
followed by e-cigarettes (27.6%), hookah (24.3%), smokeless tobacco (18.6%), and 
cigars (18/3%). Looking at recent tobacco use by sex, we found that a significantly higher 
percentage of males used tobacco products, relative to females across all tobacco 
products. More than 40% of students have indicated that they used tobacco products in 
the past 30 days, at the time of their most recent follow-up survey (Table 6.2). The 
prevalence of recent use of tobacco products was similar across race/ethnicity, for 
hookah/waterpipe and e-cigarettes (Table 6.3). 
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* skip pattern – if indicated no lifetime use, then skipped question 
  
  
 Male  Female Total  Χdf=1value, p-value 
Lifetime Tobacco Use  n/total n (%)  n/total n (%)  n/total n (%)  
Overall Tobacco Use 2705/3793 (71.3) 4036/6060 (66.6) 6741/9853 (68.4) 23.99, <0.0001* 
Cigarettes 2113/3793 (55.7) 2731/6060 (45.1) 4844/9853 (49.2) 105.71, <0.0001* 
Smokeless  1054/3793 (27.8)      438/6060 (7.2) 1492/9853 (15.1) 767.46, <0.0001* 
Cigars 1645/3793 (43.4)    1795/6060 (29.6) 3440/9853 (34.9) 194.06, <0.0001* 
Hookah 1895/3793 (50.0) 2995/6060 (49.4) 4890/9853 (49.6)          0.27, 0.6033 
E-Cigarettes 1199/3793 (31.6) 1312/6060 (21.7) 2511/9853 (25.5) 121.88, <0.0001** 
Recent Tobacco Use n/total n (%) n/total n (%) n/total n (%)  
Overall Tobacco Use 1880/3520 (53.4) 2164/5599 (38.7) 4044/9119 (44.4) 190.76, <0.0001* 
Cigarettes* 1167/2139 (54.6) 1195/2758 (43.3) 2362/4897 (48.2) 60.84, <0.0001* 
Smokeless* 334/1289 (25.9) 86/958 (9.0) 420/2247 (18.7) 103.70, <0.0001* 
Cigars 874/3346 (26.1) 679/5148 (13.2) 1553/8494 (18.3) 226.96, <0.0001* 
Hookah 993/3411 (29.1) 1165/5455 (21.4) 2158/8866 (24.3) 68.54, <0.0001* 
E-Cigarettes* 419/1203 (34.8) 301/1419 (21.2) 720/2622 (27.5) 60.61, <0.0001* 
110 
 
Table 6.3: Lifetime and Recent Tobacco Use by Race/Ethnicity 
  
 
1=White/Caucasian; 2 = Black/African American; 3 = Asian; 4 = Hispanic/Latino; 5 = More than one race; 6 = Native Hawaiian/Other 
Pacific Islander; 7 = American Indian/Alaska Native 
* skip pattern – if indicated no lifetime use, then skipped question (explains why so many missing) 
 
 
More than 40% of students have used two or more tobacco products within their lifetime. 
Among recent tobacco users, 49.4% used only one tobacco product, 14.3% used two 
tobacco products, 3.3% used three tobacco products, and 0.8% used four or more 
tobacco products concurrently. Among those who only used one tobacco product, hookah 
use was the most popular (44.4%), followed by cigarettes (22.3%), and cigars (22.0%). A 
combination of cigarettes, hookah, cigars, and e-cigarettes was common among those 
who reported using two products or more concurrently.  
 1 2 3 4 5 6 7 Total Χdf=7 
value, p-
value 
Lifetime Tobacco Use 
Any Tobacco Use 
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In the total sample, 15.5% had ever smoked ≥100 cigarettes in their lifetime. Relative to 
females, more males reported smoking at least 100 cigarettes or more in their lifetime 
(21.6% of males vs. 11.7% of females; Χ2 = 202.1, df = 2, p-value <0.001). Differences in 
the reported prevalence of lifetime smoking of 100 or more cigarettes were also found 
across race/ethnicity (Χ2 = 605.7, df = 14, p-value <0.001). Compared to 
White/Caucasians, fewer Blacks/African Americans, Asians, and Hispanics/Latinos 
reported smoking ≥100 cigarettes in their lifetime.    
Of the full sample, 4.9% (N = 487) met criteria for nicotine dependence, when using a cut-
off score of four for the Fagerström Test for Nicotine Dependence. Males were more likely 
to meet criteria for nicotine dependence, relative to females (7.4% vs. 3.4% respectively; 
Χ2 = 83.3, df = 1, p-value <0.0001). 
Lifetime tobacco use, parental involvement, and autonomy granting. Parental 
involvement was negatively correlated with the use of each tobacco product, while 
parental autonomy granting was positively correlated with the use of any tobacco product, 
cigarettes, smokeless tobacco, hookah, and e-cigarettes.  
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Table 6.4: Lifetime and Recent Tobacco Use Correlations 
 
 
Boldface indicates significance at p-value ≤0.05. 
 
 







Any Stressful Life 
Event 
Lifetime Tobacco Use 
Any Tobacco -0.023 (-0.054, 0.007) 0.058 (0.029, 0.088) -0.016 (-0.090, 0.059) 0.197 (0.114, 0.280) 0.177 (0.063, 0.290) 0.185 (0.095, 0.275) 0.076 (0.001, 0.152) 0.038 (-0.041, 0.116) 
Cigarettes -0.049 (-0.078, -0.020) 0.049 (0.021, 0.078) -0.031 (-0.102, 0.040) 0.284 (0.208, 0.359) 0.264 (0.162, 0.368) 0.257 (0.175, 0.339) 0.096 (0.024, 0.167) 0.069 (-0.006, 0.144) 
Smokeless -0.065 (-0.101, -0.030) 0.044 (0.009, 0.055) -0.030 (-0.115, 0.056) 0.241 (0.152, 0.330) 0.007 (-0.121, 0.135) 0.057 (-0.045, 0.159) 0.101 (0.015, 0.187) 0.062 (-0.029, 0.153) 
Cigars -0.033 (-0.063, -0.003) 0.029 (-0.001, 0.059) 0.044 (-0.030, 0.118) 0.203 (0.123, 0.282) 0.138 (0.031,0.245) 0.146 (0.060, 0.232) 0.070 (-0.005, 0.144) 0.086 (0.008, 0.164) 
Hookah -0.031 (-0.060, -0.001) 0.058 (0.030, 0.087) -0.028 (-0.100, 0.042) 0.082 (0.002, 0.161) 0.126 (0.020, 0.231) 0.126 (0.041, 0.210) 0.010 (-0.062, 0.082) 0.00 (-0.075, 0.075) 
E-Cigarettes -0.042 (-0.076, -0.009) 0.062 (0.030, 0.095) -0.016 (-0.093, 0.061) 0.146 (0.063, 0.230) 0.251 (0.146, 0.366) 0.203 (0.116, 0.291) 0.022 (-0.055, 0.100) 0.027 (-0.055, 0.108) 
Recent Tobacco Use 
Any 
Tobacco -0.053 (-0.082, -0.023) 0.064 (0.035, 0.093) -0.21 (-0.095, 0.053) 0.225 (0.145, 0.304) 0.168 (0.060, 0.275) 0.173 (0.087, 0.260) 0.064 (-0.010, 0.139) 0.052 (-0.026, 0.131) 
Cigarettes -0.048 (-0.088, -0.007) 0.029 (-0.011, 0.069) -0.026 (-0.126, 0.073) 0.226 (0.124, 0.328) 0.165 (0.032, 0.299) 0.119 (0.007, 0.231) 0.038 (-0.061, 0.139) 0.056 (-0.051, 0.162) 
Smokeless -0.043 ( -0.113, 0.026) -0.007 (-0.075, 0.061) -0.132 (-0.294, 0.029) -0.003 (-0.176, 0.169) -0.072 (-0.321, 0.176) -0.06 (-0.53, 0.133) -0.098 (-0.262, 0.066) -0.069 (-0.242, 0.134) 
Cigars -0.061 (-0.096, -0.026) 0.041 (0.006, 0.076) 0.010 (-0.080, 0.099) 0.242 (0.150, 0.334) 0.148 (0.014, 0.269) 0.048 (-0.058, 0.154) 0.054 (-0.036, 0.144) 0.076 (-0.020, 0.171) 
Hookah -0.061 (-0.093, -0.028) 0.072 (0.041, 0.104) 0.031 (-0.052, 0.113) 0.115 (0.025, 0.205) 0.002 (-0.121, 0.125) 0.046 (-0.053, 0.144)   0.020 (-0.063, 0.104) -0.009 (-0.097, 0.078) 
E-Cigarettes -0.058 (0.126, 0.009) -0.007 (-0.074, 0.059) -0.004 (-0.150, 0.143) 0.069 (-0.087, 0.224) -0.044 (-0.126, 0.038) -0.063 (-0.226, 0.101) 0.047 (-0.099, 0.195) -0.012 (-0.168, 0.145) 
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Significant correlations were small in effect (Table 6.4). For example, negative 
correlations between parental involvement and lifetime use of tobacco products ranged 
from -0.065 (95%CI: -0.101, -0.030) to -0.031 (95% CI: -0.060, -0.001). Meanwhile, 
parental autonomy granting was statistically, positively correlated with the lifetime use of 
any tobacco product, cigarettes, smokeless tobacco, hookah, and e-cigarettes. These 
significant, positive correlations ranged from 0.044 (95% CI: 0.021, 0.078) to 0.062 (95% 
CI: 0.030, 0.95). 
Lifetime tobacco use, physical and sexual assault. The experience of natural disaster 
was not significantly correlated with the use of any tobacco product (Table 6.4). However, 
the experience of physical assault, sexual assault, other unwanted sexual experiences or 
transportation/accident was significantly, positively associated with the lifetime use of 
tobacco products, except for the association between: sexual assault and other unwanted 
sexual experiences and smokeless tobacco use, and transportation/accident and lifetime 
cigar, hookah, and e-cigarette use. On average, these correlations ranged from 0.082 
(95% CI: 0.002, 0.161) to 0.264 (95% CI: 0.162, 0.368). 
Recent tobacco use, parental involvement and autonomy granting. Correlations 
between parental environment and recent tobacco use followed a similar pattern to those 
found between parental environment and lifetime tobacco use, such that significant 
correlations between parental involvement and recent tobacco use were negative and 
significant correlations between parental autonomy granting and recent tobacco use were 
positive. Significant negative correlations were found between parental involvement and 
the recent use of any tobacco product, cigarettes, cigars, and hookah, which ranged from 
-0.068 (95% CI: -0.082, -0.023) to -0.048 (95% CI: -0.083, -0.007). Significant positive 
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correlations were found between parental autonomy granting and the recent use of any 
tobacco product, cigars, and hookah, which ranged from 0.041 (95% CI: 0.006, 0.078) to 
0.084 (95% CI: 0.036, 0.093). 
Recent tobacco use, physical assault and sexual assault. The experience of physical 
assault, sexual assault, and other unwanted sexual experiences was correlated with the 
recent use of any tobacco product, and cigarette use. The experience of physical assault 
was also correlated with the recent use of cigars and hookah, while the experience of 
sexual assault was correlated with the recent use of cigars. However, the significant 
correlations were slightly weaker, relative to lifetime measures of tobacco use, ranging 
from 0.116 (95%CI: 0.025, 0.206) to 0.242 (95% CI: 0.170, 0.334). 
DISCUSSION 
Despite public health successes in reducing the consumption of cigarettes, the increasing 
popularity of alternative tobacco products poses new challenges. More than 40% of 
students reported tobacco use in the past 30 days at the time of their most recent follow-
up survey. This is important since studies demonstrate that alternative tobacco products 
contribute to negative outcomes, similar to the use of cigarettes. For example, smokeless 
tobacco is addictive and its use has been associated with an increased risk of cancer; 
myocardial infarction and stroke; oral disease; and reproductive problems24. Hookah, or 
waterpipe, tobacco smoking has also been previously associated with higher odds of lung 
cancer, respiratory illness, low birth weight, and periodontal disease25. Cigar smoke 
contains higher concentrations of toxic and carcinogenic compounds relative to 
cigarettes; does not reduce the risk of nicotine addiction, and is known to cause cancers 
of the lung and upper aero digestive tract26. Additionally, individuals who use alternative 
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tobacco products may face the same challenges in quitting and experiencing negative 
tobacco-related health consequences in their futures, as those who only smoke 
cigarettes. Furthermore, concurrent use of tobacco products and cigarettes may make it 
more difficult to quit tobacco use overall24.  
It remains unclear whether alternative forms of tobacco use may serve as an initial 
pathway to nicotine addiction, with or without the use of cigarettes27. From pairwise 
comparisons of reported age of onset, it seems to be the case that cigarette use precedes 
the use of other tobacco products, such as cigars, smokeless tobacco, hookah, and e-
cigarettes. However, a sizeable number of individuals reported using these substances 
within at least the same year. Cigar use appears to precede the use of smokeless 
tobacco, while smokeless tobacco use appears to precede or occur around the same time 
as first use of hookah or e-cigarettes. The timing of onset of the initiation of cigars, 
hookah, and e-cigarette use was more difficult to discern. In part, this could be attributed 
to the growing availability of these substances since students enrolled in S4S. 
Differences by sex and race/ethnicity across lifetime and recent tobacco vary by tobacco 
product. In general, men had higher prevalence of tobacco use than women28. This 
finding is similar to another study that found that men used smokeless tobacco products 
and snus significantly more frequently than women24. Underlying causes for differences 
in tobacco product use across race/ethnicity are complex and multifactorial. It is possible 
that differences among certain racial/ethnic groups are related to cultural factors, such as 
social disapproval of smoking, particularly among women29. This could signal underlying 
cultural norms related to the use of specific tobacco products, as well as change in 
availability of tobacco products.  
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Parental environment prior to university enrollment has a small, but significant influence 
on tobacco use. In part, this could be attributed to the fact that as adolescents grow into 
young adults, protective parental influences become less important in adolescents’ use 
of tobacco. This finding is consistent with findings from twin and epidemiological studies, 
which suggest that parental environment plays a smaller role in young adulthood. One 
study suggested that parental influences of connectedness and punishment for smoking 
remains important until mid-adolescence and parental monitoring continues to be 
important in protecting against smoking at age 1630. Our study suggests that parental 
involvement may be protective against both lifetime and recent tobacco use, while 
parental autonomy granting is positively associated with lifetime and recent tobacco use. 
This is aligned with another study by the same research group that found that a higher 
levels of family involvement is protective against recent smoking31. 
Experience of stressful life events prior to university might have lasting effects on tobacco 
use. Prior research suggests that stressful life events are associated with smoking and 
that stressful life events might have a differential effect on smoking among women versus 
men32. In this study, moderate correlations were found between experience of stressful 
life events prior to university and tobacco use, with the strongest correlations found 
between the experience of physical abuse and sexual abuse and tobacco use. It is 
possible that tobacco use functions as a coping behavior for these stressors, as previous 
observational studies have demonstrated that the experience of acute stressful events 
are associated with higher smoking prevalence. However, tobacco use is an ineffective 
stress-reducing strategy and perpetuates a stress response in users, which can also 
result in diminished self-regulation to control the urge to use. Experimental studies 
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demonstrate that induced stress reduces an individual’s ability to resist tobacco use and 
increases tobacco use intensity and reward33.  
There are, however, a few limitations to note. We are unable to infer causality, despite 
trying to limit the exposure time for the experience of stressful life events and parental 
environment to prior to enrollment at university, due to the use of correlations in this study. 
Another potential limitation could be recall bias, since students are asked to 
retrospectively report their parental environment and stressful life events. Recall of 
information is solely dependent upon memory, which can be imperfect and potentially 
unreliable. Additionally, since the university has a diverse population of students, the 
findings from this study might not be representative of all universities of its size, or of all 
young adults outside of the college setting.  
Despite these limitations, this study contributes to the existing literature by demonstrating 
that tobacco use was prevalent among college students and that tobacco use was not 
limited to the use of cigarettes. The use of smokeless tobacco, hookah, and e-cigarettes 
was also common. The use of tobacco products was correlated with other environmental 
factors, such as parental involvement and parental autonomy granting, physical assault, 
and sexual assault experienced prior to enrollment at university. Our study also 
demonstrated that these associations may persist over time. Given these potentially long-
standing effects, it may be useful to view university enrollment as an opportunity for 
potential intervention or prevention of tobacco use as a coping mechanism for these 
stressful life events34.  Furthermore, the endorsement of lifetime use of tobacco products 
and nicotine delivery systems increased across freshman to senior year, suggesting that 
college is a time when many individuals are trying a range of tobacco products and 
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nicotine delivery systems. This is important since the use of tobacco products put 
individuals at risk of developing nicotine dependence and lead to many negative health 
risks. There are few regulations associated with the marketing, sale and use of emerging 
tobacco products that can encourage young adults to start using tobacco products, if they 
have not by the time they start college35. Thus, further research on the prevalence, 
correlates, and risk factors for the use of alternative tobacco products is needed, 
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BACKGROUND 
It has been suggested that initial experiences during first exposure to tobacco may be 
indicative of individuals’ sensitivity to nicotine1 and vulnerability to nicotine dependence2. 
However, whether innate sensitivity to nicotine dependence either enhances or inhibits 
the likelihood of established patterns in smoking behavior remains an area of debate3. 
Both adverse experiences, such as coughing, dizziness, and nausea, and positive 
experiences such as relaxation or experiencing a pleasurable rush or buzz can result from 
experimentation with tobacco products containing nicotine4. Generally, positive effects 
have been found to have a stronger association with smoking behavior1,5. Though, 
unpleasant reactions due to symptoms of dizziness or nausea during the initial experience 
of tobacco use are not necessarily protective against subsequent smoking5–7. Thus, a 
clearer understanding of the factors influencing initial experiences with tobacco use and 
of how these initial experiences affect subsequent use of tobacco products and the 
development of nicotine dependence is needed5. 
Many factors are likely to influence initial experiences with tobacco use. One such factor 
is the age of onset of tobacco use. One study found that pleasurable sensations upon 
initial exposure to tobacco use were significantly linked to the age at first cigarette, 
whereby the earlier the first tobacco use occurred, the higher the probability of pleasant 
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feelings during initial smoking. The same study reports a trend towards experiencing 
higher relaxation in those with an earlier age at first cigarette, and no relation between 
the age at first cigarette and experience of unpleasant sensations. In this study conducted 
by Buchmann et al. (2011), an earlier age at first cigarette is also associated with a greater 
likelihood of becoming a regular smoker by age 228. 
Since previous studies have primarily focused on initial experiences with cigarette use, 
the present study seeks to contribute to the literature by determining: (1) the prevalence 
of initial experiences with tobacco, recent tobacco use, and nicotine dependence in two 
different samples: the Spit for Science9 and the Virginia Twin Studies of Adolescent 
Behavioral Development10, (2) whether or not initial experiences with tobacco use differ 
according to tobacco product used, (3) whether there is an association between initial 
experiences with tobacco use and recent tobacco use, or nicotine dependence, and (4) 
whether these associations differ by sex. 
MATERIALS AND METHODS 
Samples  
Spit for Science. Data were collected from Spit for Science, a research study examining 
how genetic and environmental factors come together to contribute to the development 
of problems associated with the use of alcohol, the use of other substances, and 
emotional health. Incoming freshman, 18 years of age and older, were invited to 
participate in the study which included an electronic survey designed to collect broad-
based information about substance use and mental health outcomes. Additionally, the 
study design involves multiple waves of data collection, including: two collection periods 
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during the freshman year occurring upon arrival on campus in the fall and again during 
the middle of the spring semester. Further waves of data were collected annually during 
the spring semester. Data collection for this study is ongoing, and results from this study 
reflect a subset of the total Spit for Science sample who answered questions about initial 
experiences with tobacco use, current tobacco use, and completed the Fagerström Test 
for Nicotine Dependence (FTND).  
For the purposes of this study, those who did not provide information on initial experiences 
with tobacco were excluded from analyses. Due to small sample size, individuals who 
reported their self-identified race category as: Native Hawaiian or Other Pacific Islander 
and American Indian or Alaskan Native were excluded (n=67 & 51 respectively). Thus, 
data was available for 2,081 individuals. All survey information collected was managed 
using an electronic data capture tool hosted at Virginia Commonwealth University called 
Research Electronic Data Capture (REDCap). REDCap is a secure, web-based 
application designed to support data capture for research studies11. Participants were 
given a $10 incentive for their participation in each of the surveys. DNA collection is also 
a part of the study protocol, but not used in the present analysis. The VCU Institutional 
Review Board (IRB) approved all S4S protocols.   
Virginia Twin Studies of Adolescent Behavioral Development (VTSABD). The VTSABD is 
a cohort-longitudinal epidemiological study that uses the genetic twin design to study the 
development and maintenance of child psychiatric disorders12. It is comprised of three 
studies: the Virginia Twin Study of Adolescent Behavior Development, the Young Adult 
Follow-Up, and the Transitions to Substance Abuse follow-up. It is the first population-
based, multi-wave, cohort-sequential twin study of adolescent psychopathology and its 
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risk factors. Included within this study are Caucasian families of male and female 
monozygotic and dizygotic twins and their parents to assess the role of genes and the 
environment in developmental trajectories of behavior from childhood to young adulthood. 
The sample was ascertained through Virginia schools and assessment of the children 
involved semi-structured and face-to-face interviews with both twins and both parents 
using the Child and Adolescent Psychiatric Assessment (CAPA). Self-report 
questionnaires were also completed by parents, children, and teachers13.  
Measures 
Demographic characteristics. Within the Spit for Science study, participants were asked 
to select from “American Indian/Alaska Native”, “Asian”, “Black/African American”, 
“Hispanic/Latino”, “More than one race”, “Native Hawaiian/Other Pacific Islander”, 
“Unknown”, “White”, or “I choose not to answer” to answer the question: “Which one of 
these groups’ best describes you?” For sex, participants could select: “male”, “female”, or 
“I choose not to answer”.  Participants in VTSABD were predominantly White. 
Age of onset of tobacco use. Within Spit for Science, age of onset was measured using 
the following question: “How old were you when you smoked a cigarette or used tobacco 
for the first time (including just one or two puffs)?” This variable was coded as an ordinal 
variable, with those who had not initiated smoking coded as 0, those who had initiated 
after age 18 as 1, gradually increasing to those who initiated prior to age 12 (2: 15-18 
years, 3: 12-14 years, 4: <12 years). For cohort 4 of Spit for Science, measures for 
tobacco product-specific age of onset were available, asking “How old were you when 
you [smoked a cigarette/used smokeless tobacco/ smoked cigars, little cigars, cigarillos/ 
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smoked hookah/ used an e-cigarette] for the first time?” Participants responded to this 
question by inputting their age in years in a free response. Age of onset was coded 
similarly for responses from the VTSABD. 
Initial sensitivity to tobacco products. Initial sensitivity was measured by asking eight 
questions about the sensations experienced when the participant first used a specified 
tobacco product. Each question was worded “how much [insert sensation here] … did 
you feel?” with potential responses being: none, slight, moderate, or intense. The eight 
questions asked about feeling pleasant sensations, unpleasant sensations, nausea, 
relaxation, dizziness, pleasurable rush or buzz, coughing, and difficulty inhaling. These 
measures were the same in Spit for Science and the VTSABD. 
Recent use of tobacco products. For the Spit for Science sample, recent use of tobacco 
products (e.g. use of tobacco products in the last 30 days) was treated as binary variables, 
similarly coded to lifetime use of tobacco products. Measures for recent use of cigarettes, 
smokeless tobacco, cigars, hookah, and e-cigarettes included the following, respectively: 
“How frequently did you smoke cigarettes in the past 30 days?”, “How frequently did you 
use a smokeless tobacco product (dip/chaw/snus) in the last 30 days?”, “During the last 
30 days, on how many days have you smoked cigars, little cigars, or cigarillos?”, “During 
the last 30 days, on how many days have you smoked a hookah?”, and “During the last 
30 days, on how many days did you use e-cigarettes?” For each of these measures, if 
the participant indicated ‘I choose not to answer’, the answer was coded as missing. If 
the participant indicated that he/she had not used the tobacco product, the answer was 
coded as 0 (no); otherwise, if the participant had indicated that he/she had used the 
tobacco product at least once, the answer was coded as 1 (yes). An aggregate measure 
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of recent use of tobacco products was also calculated by summing across each of the 
recent use measures of tobacco products, with 0 coded as no, and 1 or greater coded as 
yes. A similar approach was taken for VTSABD data, which focused on cigarette use. 
Nicotine Dependence (ND). Nicotine dependence was measured using the Fagerström 
Test for Nicotine Dependence. A threshold of ≥4 was used to determine whether an 
individual met criteria for ND. 
Statistical Analysis 
Polychoric correlations were computed to examine the relationship between initial 
experiences with tobacco and recent tobacco use and nicotine dependence. Multivariate 
analyses relied on multiple regressions to determine whether sex was an important 
contributor to the association between initial experiences with tobacco use, recent 
tobacco use and nicotine dependence, taking into account the covariates of age of onset, 
race/ethnicity, first tobacco product used, and any significant interaction effects into account. 
RESULTS 
Descriptive Statistics 
Responses regarding initial experiences with tobacco products were only available for a 
subset of participants from cohorts 2 (n=645), 3 (n=650), and 4 (n=786) in Spit for 
Science. The remaining analytic sample (n=2,081) was predominantly female (n=1388; 
66.7%) and nearly half identified as White/Caucasian (n=978; 47.6%), as shown in Table 
7.1. The age at first tobacco use varied by tobacco product; average age of first use was 
15.6 years (SD:2.8) for cigarettes, 15.2 years (SD:4.1) for smokeless tobacco, 16.0 years 
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(SD:2.9) for cigars, 16.8 years (SD:1.8) for hookah, and 17.1 years (SD:1.9) for e-
cigarettes. On average, most participants in the study indicate cigarettes as the product 
that they first used (44.0%), followed by hookah (34.3%), cigars (14.6%), e-cigarettes 
(3.8%), smokeless tobacco (2.5%), and other tobacco product (0.9%).  
Findings from the VTSABD are similar to S4S in that most the sample was female 
(59.2%), White/Caucasian (98.8%), and most tobacco users had initiated use by age 18. 
Table 7.1: Prevalence of recent tobacco use and nicotine dependence 
 S4S 
(n = 2081) 
VTSABD 
 (n = 850) 
 N % N % 
Sex     
Male 692 33.3 343 40.8 
Female 1388 66.7 497 59.2 
Race/Ethnicity     
White/Caucasian 978 47.6 840 98.8 
Black/African American 443 21.6   
Asian 337 16.4   
Hispanic/Latino 148 7.2   
More than one race 147 7.2   
Unknown   10 1.2 
Cohort     
Fall 2012 645 31.0   
Fall 2013 650 31.2   
Fall 2014 786 37.7   
Age of Initiation (Any Tobacco use)     
Did not Initiate 6 0.3 9 1.1 
>18 years 289 13.9 138 16.2 
15-18 years 929 44.6 396 46.6 
12-14 years 325 15.6 229 26.9 
<12 years 90 4.3 78 9.2 
Initiated but did not report age 442 21.2   
 Mean SD   
Age of Initiation (Specific Tobacco Use)     
Cigarettes (S4S n = 494) 15.97 2.39   
Smokeless, Snus, Dip, Chaw (S4S n = 133) 15.98  2.84   
Cigar (S4S n = 496) 16.34 2.56   
Hookah (S4S n = 685) 16.58 2.84   
E-cigarettes (S4S n = 449) 17.32 1.43   
Recent Tobacco Use N % N % 
Any tobacco product (S4S n = 2081) 984 47.3 300 35.3 
Cigarettes (S4S n = 1383) 544 39.3   
Smokeless (S4S n = 398) 398 24.6   
Cigar (S4S n = 1829) 330 18.0   
Hookah (S4S n = 1991) 422 21.2   




The highest proportion of students, who indicated that they used tobacco in the last 30 
days at the most recent survey of Spit for Science, reported using cigarettes (39.3%), 
followed by smokeless tobacco (24.6%), e-cigarettes (23.5%), hookah (21.2%), and 
cigars (18.0%), as shown by Table 7.1. When comparing recent tobacco use across 
males and females, significant differences were found for cigarette, cigar, and e-cigarette 
use, such that males were more likely to endorse the recent use of all tobacco products 
relative to females within S4S. No significant sex differences were found for current use 
of cigarettes within the VTSABD. A little less than 7% of the total sample met criteria for 
nicotine dependence in S4S and 35.3% of the VTSABD sample. Significant differences 
in meeting criteria for nicotine dependence were found between males and females, such 
that a larger proportion of males met criteria for nicotine dependence, relative to females 
(10.4% vs. 5.2% in S4S; 42.5% vs. 31.6% in VTSABD), as shown in Table 7.2.  
Table 7.2: Sex Differences in Endorsement of Recent Tobacco Use and Nicotine Dependence 
 Males Females Chi-Square, df, p-value 
Recent Tobacco Use (S4S) N % N %  
Any tobacco product (n = 2079) 407 58.9 576 41.5 56.0, 1, <0.0001* 
Cigarettes (n = 1382) 251 47.5 293 34.3 23.9, 1, <0.0001* 
Smokeless (n = 398) 70 27.2 28 19.9 2.7, 1, 0.1022 
Cigar (n = 1828) 153 24.0 177 14.9 23.5, 1, <0.0001* 
Hookah (n = 1990) 171 26.1 251 18.8 14.0, 1, 0.0002* 
E-cigarette (n = 1148) 154 32.6 115 17.0 37.3, 1, <0.001* 
Current Use (VTSABD; n=839) 128 37.4 168 33.8 1.2, 1, 0.2804 
 Fagerström Test for Nicotine Dependence 
FTND ≥4 (S4S; n = 1923) 66 10.4 66 5.2 18.7, 1, <0.0001* 




 Fagerström Test for Nicotine Dependence 
 (S4S n=1924; range=0-10) 
0.70 1.50 2.2 2.2 
 N %   
Meets criteria for nicotine dependence 132 6.9 181 21.0 
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Initial experiences by age of onset 
Within the S4S sample, age of onset of tobacco use was associated with stronger initial 
responses to tobacco across positive experiences (e.g. pleasurable buzz, pleasant 
sensation, relaxation), negative experiences (e.g. unpleasant sensation, dizziness, 
nausea), and difficulties with breathing (e.g. difficulty inhaling, coughing), even after 
adjusting for race/ethnicity and sex.  More specifically, age of onset was associated with: 
relaxation (beta = 0.066, p-value = 0.040), pleasurable rush or buzz (beta = 0.107, p-
value = 0.0011), unpleasant sensation (beta = 0.062, p-value = 0.0482), nausea (beta = 
0.149, p-value <0.0001), dizziness (beta = 0.140, p-value <0.0001), and difficulty inhaling 
(beta = 0.074, p-value <0.0001).  
Age of onset of tobacco use was also associated with stronger initial responses to tobacco 
within the VTSABD sample.  Corresponding numbers were: pleasurable rush or buzz 
(beta = 0.098, p-value = 0.0167), unpleasant sensation (beta = 0.092, p-value = 0.0313), 
nausea (beta = 0.187, p-value <0.0001), dizziness (beta = 0.193, p-value <0.0001), 
coughing (beta = 0.159, p-value = 0.0002), and difficulty inhaling (beta = 0.16, p-value = 
0.0003).  
Factor structure of initial experiences with tobacco use 
An exploratory factor analysis was performed on the eight items measuring initial 
sensitivity to tobacco products and eigenvalues showed that two factors could be 
selected. According to Kaiser’s criteria, only factors with eigenvalues equal to or greater 
than 1 should be selected for factor analysis. The two-factor model using varimax rotation 
showed that the first factor was related to positive experiences during initial tobacco use 
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(e.g. pleasant sensation, relaxation, pleasurable rush or buzz), the second factor was 
related to negative experiences during initial tobacco use (e.g. unpleasant sensation, 
nausea, dizziness, coughing, and difficulties inhaling). Interestingly, the item measuring 
dizziness cross-loaded onto positive experiences, though not as highly as it did on 
negative experiences. This implies that many users rated lesser amounts of dizziness as 
a positive experience. This factor structure was the same across S4S and the VTSABD 
samples, and was used to create factor scores for use in linear regressions testing 
whether initial positive or negative experiences with tobacco use are predictive of recent 
tobacco use and/or nicotine dependence – as described later in this manuscript.  
Table 7.3:  Varimax Rotated Factor Patterns for Initial Experiences with Tobacco Use 
 SPIT FOR SCIENCE VTSABD 
Initial 
Experiences Factor 1 Factor 2 Communality Factor 1 Factor 2 Communality 
Pleasant 
Sensations 0.873 0.065 0.766 0.761 -0.135 0.597 
Relaxation 0.851 0.038 0.725 0.646 -0.118 0.432 
Pleasurable Rush 
or Buzz 0.870 0.148 0.778 0.821 0.001 0.674 
Unpleasant 
Sensation 0.038 0.730 0.534 -0.212 0.639 0.453 
Dizziness 0.413 0.600 0.530 0.396 0.443 0.352 
Nausea 0.189 0.693 0.516 0.067 0.610 0.376 
Coughing -0.007 0.622 0.387 -0.051 0.640 0.412 
Difficulty Inhaling 0.012 0.658 0.434 -0.139 0.550 0.321 
Variance 
Explained 2.451 2.220  1.899 1.720  
 
Initial experiences with tobacco by sex  
Initial experiences with tobacco use differed by sex, as depicted by Table 7.4. However, 
significant differences in initial experiences with tobacco use by sex were not the same 
across samples. Whereas there were sex differences across all initial experiences, apart 
from difficulty inhaling in S4S, sex differences were only detected across the initial 
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experiences of: pleasurable rush or buzz, unpleasant sensations, and difficulty inhaling 
in VTSABD.  
Associations between initial experiences and recent tobacco use 
Significant correlations were found between initial experiences with tobacco and recent 
tobacco use, as depicted in Table 7.5. Initial positive experiences (pleasant sensations, 
relaxation, and pleasurable rush or buzz) were moderately correlated with recent use of 
all tobacco products. Smaller but significant correlations were observed between nausea 
and/or dizziness and the recent use of most tobacco products.  The strongest correlations 
with negative initial experiences were with the recent use of smokeless tobacco products. 
The largest correlations were found between positive initial experiences with tobacco use 
and recent use of cigarettes. 
Associations between initial experiences and nicotine dependence 
The initial experiences of pleasant sensations, relaxation, pleasurable rush or buzz, 
nausea, coughing, dizziness, and difficulty inhaling were positively and significantly 
correlated with meeting criteria for nicotine dependence within the S4S sample. These 
correlations ranged in value from 0.11 (95% CI: 0.01, 0.10) to 0.38 (95% CI: 0.29, 0.46). 
The highest significant correlation was found between experiencing a pleasurable rush or 
buzz and meeting criteria for nicotine dependence, as depicted in Table 7.5. Within the 
VTSABD, only initial experiences of relaxation and pleasurable rush or buzz were 
positively and significantly correlated with meeting criteria for nicotine dependence. The 
correlations were lower, relative to the S4S sample, ranging from 0.15 (95% CI: 0.02, 
0.27) to 0.16 (95% CI: 0.04, 0.21). 
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Table 7.4: Sex Differences in Initial Experiences with Tobacco Use in S4S and VTSABD 
 S4S VTSABD Full Males Females  Full Males Females  
POSITIVE EXPERIENCES 









Sensations       
24.9, 3, 
<0.0001*       
6.7, 3, 
0.0804 
None 939 45.8 270 39.8 669 48.8  400 47.3 145 42.4 249 50.5  
Slight 543 26.5 175 25.8 367 26.8  232 27.5 96 29.1 132 26.8  
Moderate 448 21.9 187 27.6 261 19.1  160 18.9 77 22.5 83 16.8  
Severe 119 5.8 46 6.8 73 5.3  53 6.3 24 7.0 29 5.9  
Relaxation       30.6, 3, <0.0001*       
7.4, 3, 
0.0603 
None 877 42.6 245 36.0 632 45.9  458 54.7 170 50.2 281 57.6  
Slight 557 27.1 178 26.2 378 27.5  200 23.9 85 25.1 114 23.4  
Moderate 469 22.8 199 29.3 270 19.6  146 17.4 72 21.2 72 14.8  




      51.5, 3, <0.0001*       
11.2, 3, 
0.0106* 
None 972 47.3 256 37.6 716 52.2  337 40.2 118 34.5 213 43.7  
Slight 504 24.5 170 25.0 333 24.3  232 27.7 92 26.9 137 28.1  
Moderate 387 18.8 171 25.1 216 15.7  190 22.7 94 27.5 96 19.7  
Severe 192 9.3 84 12.3 108 7.9  80 9.5 38 11.1 41 8.4  
NEGATIVE EXPERIENCES 
Dizziness       26.0, 3, <0.001*       
4.0, 3, 
0.2622 
None 1080 52.4 316 46.2 763 55.5  283 33.8 107 31.5 172 35.3  
Slight 502 24.4 165 24.1 337 24.5  214 25.6 84 24.7 128 26.3  
Moderate 331 16.1 140 20.5 191 13.9  220 26.3 91 26.8 126 25.9  
Severe 147 7.1 63 9.2 84 6.1  120 14.3 58 17.1 61 12.5  
Unpleasant 
Sensations       
24.4, 3, 
<0.0001*       
10.6, 3, 
0.0144* 
None 1061 51.8 303 44.6 757 55.4  171 20.2 68 19.8 102 20.7  
Slight 494 24.1 184 27.1 310 22.7  202 23.9 101 29.5 99 20.1  
Moderate 369 18.0 152 22.4 217 15.9  283 33.5 108 31.5 172 34.9  
Severe 124 6.1 41 6.0 83 6.1  190 22.5 66 19.2 120 24.3  
Nausea       29.1, 3, <0.0001*       
0.2, 3, 
0.9728 
None 1288 62.7 375 54.8 912 66.5  411 49.2 169 49.7 236 48.6  
Slight 377 18.3 153 22.4 224 16.3  179 21.4 71 20.9 108 22.2  
Moderate 277 13.5 117 17.1 160 11.7  160 19.1 66 19.4 93 19.1  
Severe 114 5.5 39 5.7 75 5.5  86 10.3 34 10.0 49 10.1  
Coughing       10.9, 3, 0.0120*       
7.1, 3, 
0.0685 
None 761 36.9 257 37.6 503 36.5  172 20.8 74 22.0 96 20.0  
Slight 715 34.6 250 36.6 465 33.7  294 35.6 133 39.6 158 32.9  
Moderate 408 19.8 137 20.0 271 19.7  193 23.4 73 21.7 118 24.5  
Severe 180 8.7 40 5.9 140 10.2  167 20.2 56 16.7 109 22.7  
Difficulty 
Inhaling       
3.9, 3, 
0.2694       
15.1, 3, 
0.0017* 
None 1147 55.8 385 56.5 761 55.5  209 25.2 106 31.6 101 21.0  
Slight 506 24.6 168 24.7 338 24.6  221 26.7 81 24.1 136 28.2  
Moderate 295 14.4 102 15.0 193 14.1  238 28.7 98 29.2 138 28.6  




 Table 7.5. Correlations Between Initial Experiences, Recent Tobacco Use, and Nicotine Dependence 
 Boldface indicates significant correlation. 
 
Sex differences in correlations between initial experiences with tobacco and recent 
tobacco use and/or nicotine dependence 
Within the S4S sample, significant correlations were found between positive experiences 
and recent use of cigarettes in both sexes; cigars and e-cigarette use in males; hookah 
use in females; and, nicotine dependence in both sexes, but more strongly in females. 
Meanwhile, significant correlations were found between negative initial experiences with 
tobacco use and recent use of smokeless tobacco and between difficulty breathing during 
initial experience with tobacco use and recent use of smokeless tobacco, in females. 
Significant correlations between dizziness and recent cigarette use and nicotine 
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Significant sex differences in the correlations between initial experiences and recent 
tobacco use and/or nicotine dependence were also found within the VTSABD sample. 
Specifically, the correlation was higher among males than females for the association 
between the initial experiences of pleasant sensations (0.47 in males, 0.31 in females, z-
statistic = 2.68, p=0.004) and dizziness (0.38 in males, 0.24 in females, z-statistic = 2.19, 
p=0.014) and recent cigarette use. Correlations were higher among females than males 
for the association between: the initial experiences of relaxation (0.04 in males, 0.23 in 
females, z-statistic = -2.11, p=0.017) and of coughing and current cigarette use (-0.14 in 
males, 0.01 in females, z-statistic = 2.11, p=0.017).  
Predictors of tobacco use and nicotine dependence 
Across both samples, positive initial experiences predicted both recent tobacco use and 
meeting criteria for nicotine dependence, after adjusting for sex and age of initiation (and 
race/ethnicity and first tobacco product used within the S4S sample). The direction of 
these effects was the same, such that higher levels of positive initial experiences 
predicted both recent tobacco use and meeting criteria for nicotine dependence. Having 
negative initial experiences with tobacco use was also predictive of meeting criteria for 
nicotine dependence within the S4S sample, but not in the VTSABD. Sex was also found 
to be a predictor of meeting criteria for nicotine dependence, such that being female 
reduced the likelihood of meeting criteria for nicotine dependence (as demonstrated by 
the negative direction of the effect). The magnitude of the sex effect was similar across 
samples (e.g. beta = -0.22 in S4S and -0.28 in VTSABD). Age of initiation also had a 
significant effect on meeting criteria for nicotine dependence, such that earlier ages of 
initiation were predictive of meeting criteria for nicotine dependence. 
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Table 7.6a: Predictors of Recent Tobacco Use and Nicotine Dependence in Spit for Science 
 
Table 7.6b: Predictors of Recent Tobacco Use and Nicotine Dependence in VTSABD 
 
Discussion 
The current study examined associations between initial experiences with tobacco use 
and recent tobacco use and nicotine dependence. We estimated the factor structure of 
initial experiences with tobacco products, concluding that the best fitting model was one 
with two factors: positive experiences (e.g. pleasant sensation, relaxation, and 
pleasurable rush/buzz), negative experiences (e.g. unpleasant sensation, nausea, 
dizziness, coughing, and difficulties inhaling). This factor structure was similar to that 
 
 
Recent Tobacco Use (Any) Meets Criteria for 
Nicotine Dependence 
(FTND≥4) 
Beta SE p-value Beta SE p-value 
Intercept -2.06 85.23 0.9807 -2.81 0.29 <0.0001* 
Positive Initial Experience 0.71 0.06 <0.0001* 0.57 0.11 <0.0001* 
Negative Initial Experience 0.06 0.06 0.3069 0.24 0.11 0.0290* 
Race – More than one race vs. White/Caucasian 0.05 0.17 0.7721 -0.48 0.43 0.2686 
Race – Asian vs. White/Caucasian 0.13 0.13 0.3105 0.38 0.26 0.1427 
Race – Hispanic/Latino vs. White/Caucasian -0.22 0.17 0.1928 -0.22 0.40 0.5825 
Race – Black/AA vs. White/Caucasian 0.07 0.13 0.5775 0.07 0.30 0.8085 
Sex – Female vs. Male -0.19 0.06 0.0019* -0.22 0.11 0.0470* 
Age of Initiation – Did not initiate vs <12 years -10.05 340.9 0.9765 NA NA NA 
Age of Initiation - >18 years vs <12 years 2.21 85.2 0.9793 -0.84 0.28 0.0026* 
Age of Initiation 15-17 years vs <12 years 2.50 85.2 0.9766 -0.43 0.18 0.0156* 
Age of Initiation – 12 -14 years vs <12 years 2.78 85.2 0.9740 0.42 0.19 0.0252* 
First Product Used – Other vs Cigarettes 0.84 0.71 0.2388 1.30 0.74 0.0793 
First Product Used – E-cigarettes vs Cigarettes -0.12 0.28 0.6759 -0.11 0.57 0.8405 
First Product Used – Hookah vs Cigarettes -0.45 0.19 0.0167* -0.13 0.32 0.6980 
First Product Used – Cigars vs Cigarettes -0.21 0.21 0.3075 -0.02 0.32 0.9578 
First Product Used – Smokeless vs Cigarettes 0.13 0.15 0.7013 -1.23 0.65 0.0605 
 
 
Recent Tobacco Use (Any) Meets Criteria for 
Nicotine Dependence 
(FTND≥4) 
Beta SE p-value Beta SE p-value 
Intercept -0.74 0.10 <0.0001* -0.07 0.14 <0.0001* 
Positive Initial Experience 0.74 0.10 <0.0001* 0.34 0.12 0.0044* 
Negative Initial Experience -0.17 0.10 0.0867 0.12 0.13 0.3225 
Sex – Female vs. Male -0.02 0.08 0.7897 -0.28 0.10 0.0074* 
Age of Initiation - >18 years vs <12 years -0.89 0.20 <0.0001* -0.58 0.28 0.0416* 
Age of Initiation 15-17 years vs <12 years -0.01 0.13 0.9279 -0.20 0.17 0.2273 
Age of Initiation – 12 -14 years vs <12 years 0.22 0.15 0.1339 0.31 0.18 0.0864 
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found from a construct validity analysis conducted using confirmatory factor analysis by 
Rodriguez and Audrain-McGovern (2004), which identified two factors: pleasant (e.g. 
pleasant, relaxation, and rush or buzz) and unpleasant (e.g. unpleasant, coughing, 
difficulty inhaling, and nausea). The ‘pleasant’ factor overlaps with our ‘positive 
experiences’ factor and the ‘unpleasant’ factor overlaps with our ‘negative experiences’ 
factor14. Another study investigating the factor structure of early smoking experiences 
conducted by Baggio et al. (2013) tested associations with smoking behavior in two and 
three-factor models15. Similar to the current study and the study conducted by Rodriguez 
and Audrain-McGovern14, this study identified a positive experiences factor (e.g. like the 
experience and felt relaxed) and negative experiences factor (e.g. did not feel very well, 
headache, stomach upset, heart pounding, nauseous, dizzy/lightheaded, coughed, and 
irritation eyes, bad taste) in the two-factor model. In the three-factor model proposed by 
Baggio et al. (2013) negative experiences were split into negative experiences of 
dizziness (e.g. did not feel very well, headache, stomach upset, heart pounding, 
nauseous, dizzy/lightheaded) and negative experiences of irritation (e.g. coughed, 
irritation eyes, bad taste)15. Differences in the factor structure between the current study 
and that conducted by Baggio et al. (2013) may be attributed to the use of different 
measures of initial experiences with tobacco use, limited to cigarette smoking, and the 
age of participants. 
In the current study, we found that earlier age of onset of tobacco use was associated 
with stronger initial responses to tobacco across both positive and negative experiences. 
Given that Buchmann et al. (2011) also finds that the age of first cigarette use and 
pleasure experienced from cigarette use predicts smoking at age 228, it seems that the 
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age of onset of tobacco use and initial experiences with tobacco use should be considered 
in tobacco use interventions. In a study by Klein et al. (2013), 50.7% of study participants 
indicated that their experience with smoking was more negative than they expected, 
30.2% indicated that the experience was about the same as they expected, and 19.1% 
indicated it was more positive than expected, demonstrating the variability in the 
immediate reaction to tobacco use. In the same study, 77.9% of participants remember 
the first cigarette making them feel calm and relaxed, 66.9% remember becoming dizzy, 
52.1% remember coughing extensively, and 16.1% decided to continue smoking because 
they thought their subsequent experiences would be better than the first – suggesting that 
there is a small window of opportunity to intervene on the subsequent patterns of tobacco 
use following initial experience16.  
Like other studies, the current study found that regular use of tobacco products was 
related to initial experiences with tobacco use. Both negative and positive experiences 
seemed to have effects on regular use of tobacco products, which supports findings from 
previous studies2,7,17. Initial experiences during first tobacco use are believed to reflect 
the physiological and pharmacological effects of nicotine, as well an individual’s sensitivity 
to and tolerance for nicotine. Generally, those who become regular users experience 
greater positive and negative reactions to nicotine compared to nonsmokers, while 
positive experiences may play a stronger role than unpleasant experiences in the 
transition to regular use18. This is important given the significant correlations found 
between initial experiences with tobacco and recent tobacco use in the current study – 
particularly stronger correlations found between positive experiences and recent use of 
cigarettes, cigars, hookah, and e-cigarettes (though the effect was not large). It has been 
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suggested elsewhere that social perceptions surrounding tobacco use may play a larger 
role in normalizing opinions regarding patterns of tobacco use, which could lead some 
individuals to be less resistant to experiment with tobacco16. Unfortunately, these findings 
do little to address the debate regarding whether positive reinforcement is sufficient to 
establish a trajectory towards nicotine dependence, or if negative reinforcement must 
come into play before an individual is past a ‘point of improbable return’19.  
Initial sensitivity to nicotine, as measured by initial experiences with tobacco use, is only 
one factor associated with nicotine dependence explored in multiple studies, including the 
current study. The development of nicotine dependence symptoms is complex and can 
vary in timing of onset, level of escalation, duration, and remission of symptoms20. From 
the literature, those who progress to regular tobacco use may be sensitive to the 
rewarding effects of nicotine, as evidenced by the strong correlations between positive 
symptoms and different measures of continued use of tobacco. However, few studies 
have investigated how initial experiences might differ by tobacco product18. The current 
study finds that initial experiences do differ by the first tobacco product used. Another 
study examining the initial experiences with e-cigarette use found that few current e-
cigarette users/triers had a negative first experience and that positive perceptions about 
first experiences were higher among current e-cigarette users when compared to former 
users19. Given the perception that e-cigarettes could be useful in cigarette cessation and 
the generally positive first experiences that users have with e-cigarette use, we must 
wonder what the downstream effects of nicotine from e-cigarettes might be on nicotine 
dependence. This is an especially important point to consider given the recent increase 
137 
 
in alternative tobacco use among youth; though, more research is needed to make more 
definitive conclusions.  
Since data for the current study was collected using self-report measures of initial 
experiences with first use of tobacco products, it may be affected by recall bias – 
especially if recollection of initial experiences is influenced by current or continuous use. 
Previous studies have demonstrated that current smokers have a generally more positive 
recollection of their first tobacco use than former smokers1,7,21. Additionally, since we only 
had information on initial experiences for three of the four cohorts, it is unclear how 
missing data impacts the results. However, the findings of the current study are consistent 
with prior research and contribute to the literature through its assessment of multiple 
tobacco products. Even more importantly, our findings highlight the need for more 
expansive research on initial experiences with tobacco and alternative tobacco products. 
Unmeasured behavioral, social, and environmental factors may play a role in shaping 
initial reactions to nicotine and the subsequent adoption of regular use of tobacco22. 
Social influences of peers and family may have an effect on initial experiences with 
tobacco use17, as individuals with higher levels of exposure to smoking from peers and 
family members are more likely to report positive symptoms of initial smoking 
experience22. Exposure to smoking from peers and family members has also been found 
to be associated with individual reports of feeling: dizzy, relaxed, good, and high upon 
initial use of tobacco. Thus, initial experiences by individuals with greater exposure to 
smoking may be influenced by socially mediated expectancies, derived from the 
experience of others23.  
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Alternatively, frequent or prolonged exposure to nicotine absorbed from environmental 
tobacco smoke may alter neurophysiology in the brain, which may be reflected by altered 
responses to nicotine among non-smokers24. Whereas a study conducted by Kozlowski 
& Harford (1976) found that non-smokers who were tempted to smoke were more likely 
than current smokers to report discomfort from smoking, possibly due to their physical 
reaction to cigarettes, which could discourage future use25. A study by Pomerleau et al. 
(1993) found that the initial sensitivity to noxious effects of smoking also reflects sensitivity 
to the reinforcing effects which may encourage future smoking2. Marked individual 
differences in the response to drugs, such as nicotine, may be attributed to both heritable 
contributions and unique environmental experiences26.  
Yet, few studies have investigated these genetic differences contributing to initial 
experiences with nicotine. One study by Sherva et al. (2008) finds an association between 
genetic variant CHRNA5 and enhanced pleasurable responses to initial cigarette use 
among regular users27. Another study links a person’s initial experience with smoking and 
their current smoking status with variation in a gene that encodes a nicotine receptor in 
the brain28. Adolescents with higher exposure to maternal smoking report lower number 
of unpleasant symptoms during initial smoking29. Genetic variation in two candidate genes 
has been previously associated with initial responses to nicotine. Individuals with the G-
variant of OPRM1 A118G SNP are more likely to report liking of initial smoking, though 
findings are inconsistent30. Adolescents homozygous for the C-variant D4D2 Taq1A 
polymorphism report a lower number of unpleasant symptoms during initial smoking, 
indicating lower sensitivity to nicotine31. Those homozygous for the T-variant shows 
stronger perceptions of nicotine effects, indicating higher nicotine sensitivity among T-
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allele carriers and may be associated with reduced feelings for reward due to reduced 
receptor availability24,32.  
Conclusion 
We have demonstrated that current users of tobacco may be sensitive to the rewarding 
effects of nicotine. Additionally, initial reactions to tobacco differed by tobacco type, as 
well as by sex. Age of onset, sex, and positive initial experiences predicted both recent 
use and meeting criteria for nicotine dependence. Negative initial experiences played less 
of a role in meeting criteria for nicotine dependence. Thus, further research is needed to 
identify genetic and biological pathways influencing initial experiences with nicotine, and 
the social contexts that influence initial experiences with tobacco use, in efforts to 






SEX DIFFERENCES IN FAGERSTRÖM TEST FOR NICOTINE DEPENDENCE ITEMS 
 
Elizabeth K. Do; Danielle M. Dick; Kenneth S. Kendler; Hermine H. Maes 
 
INTRODUCTION 
The Fagerström Test for Nicotine Dependence (FTND), comprised of four dichotomous 
and two multi-response items1, is the most commonly used measure of nicotine 
dependence. It is calculated by adding together scores for the six items, and has a range 
of 0 to 10. A score of four or greater is indicative of nicotine dependence. Using a sum 
score typically assumes a unidimensional trait. However, factor analyses of FTND items 
have yielded inconsistent results: while some studies indicate that the measure is 
comprised of only one factor, others have identified two. Single-factor model specification 
implies a simple linear combination of all FTND items, while two-factor model 
specifications propose “smoking pattern” and “morning smoking” factors2. Previous 
studies also suggest that the psychometric properties of these items may differ by sex 
and race/ethnicity. Psychometric studies of the FTND are necessary to gain greater 
insight into the structure of the test and the assessed dimensions3. The current study was 
conducted to compare sex differences in the response to FTND items within African and 
White/Caucasian Americans and evaluate the factor structure of FTND across these 
groups. 
METHODS 
Study Sample. The study sample was obtained through Spit for Science, a longitudinal 
study of college students’ behavioral and emotional health.  To be included in this study, 
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participants had to have reported ever using tobacco in their lifetime, provide responses 
to the Fagerström Test for Nicotine Dependence, and self-report either “Black/African 
American” or “White/Caucasian’ when asked about which race/ethnicity group best 
describes them. Of the 9889 participants of the Spit for Science study, 6907 individuals 
met study criteria.  
Measures. Tobacco use was measured across the following tobacco products: cigarettes, 
cigarillo’s/small cigars, smokeless tobacco (dip/chaw), hookah/waterpipe, and electronic 
cigarettes. Items of the FTND were adjusted accordingly and include four dichotomous 
and two multi-response items – we will use the abbreviations in square brackets: (1) How 
soon after you woke up did you smoke your first cigarette/use tobacco? [wake] (2) Did 
you find it difficult to refrain from smoking/using tobacco in places where it is forbidden 
(e.g. in church, at the library, in cinema, etc.)? [refrain] (3) Which cigarette/dip/chaw would 
you hate most to give up? [giveup] (4) How many cigarettes/smokeless tobacco products 
per day did you smoke/use? [cpd] (5) Did you smoke/use tobacco more frequently during 
the first hours after waking than during the rest of the day? [morning] and (6) Did you 
smoke/use tobacco if you were so ill that you were in bed most of the day? [whenill]. 
Responses to the wake question included: >60 minutes, 31-30 minutes, 6-30 minutes, 
and ≤5 minutes. Responses to the refrain, morning and whenill questions were no or yes. 
Responses to the giveup question 3 was the first one or any other. Responses to the cpd 
question included: <10 cigarettes, 11-20 cigarettes, 21-30 cigarettes, or >31 cigarettes. 
Since these measures were collected from the start of freshman year for all cohorts, a 
maximum reported FTND score was calculated across all waves for each participant. The 
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items from this maximum reported FTND score were included in this study, and used for 
statistical analyses.  
Statistical Analyses. Since we were interested in determining whether males and females 
were statistically different in how they responded to each of the items of the FTND, chi-
square tests were conducted. Scree plots, incremental variance accounted for, and 
interpretability were used to determine the factor structure. Exploratory factor analyses 
(EFA) were conducted separately by race/ethnicity and sex (e.g. African American males 
(AAM), African American females (AAF), White/Caucasian males (WCM), and 
White/Caucasian females (WCF)). Promax rotation was selected based upon findings 
from prior studies conducted on the FTND, suggesting the presence of correlated 
factors1. Exploratory factor analyses were performed to determine the structure of 
confirmatory factor analyses. Criteria for acceptable model fit included non-significant 
model chi-square, comparative fit index (CFI) ≥ 0.9, and a root-mean-square error of 
approximation (RMSEA) ≤ 0.08. Coding and chi-square tests were conducted using SAS 
9.4 (SAS Institute: Cary, NC). Exploratory factor analyses were conducted using the 
psych and GPArotation packages, and the fa () command in R. Confirmatory factor 
analyses were conducted using MPlus (Muthen & Muthen). 
RESULTS 
Descriptive characteristics. Of the study sample of 6907 individuals (1873 African 
American or AA, and 4881 White/Caucasian American or WCA), 2539 (540 AA; 1999 
WCA) were male and 4197 (1332 AA; 2865 WCA) were female. 
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Statistical differences in FTND item response by sex, separated by race/ethnicity group. 
Within African Americans, differences in response rates by sex were found for all items, 
except for three of the binary items: two related to morning smoking and one to smoking 
when ill. Within White/Caucasian Americans, differences in response rates by sex were 
found for all items, except for the cigarettes per day item.  
Exploratory factor analysis. Consistent with prior studies of the factor structure of the 
FTND, a principal component analysis with promax rotation was conducted. The criterion 
for item inclusion was a factor loading of 0.30 or more4. Items with loadings on other 
factors were interpreted as belonging to the factor on which they had the highest loading. 
Scree plots demonstrated that a two-factor solution fit the data best across each of the 
four groups and accounted for 100% of the variance for each group. However, the factor 
loadings across groups differed.  
Factor loadings (F1 and F2), communalities (H2), and uniqueness (U2) for each group 
are shown in the table below. Extracted communalities ranged from 0.12 to 0.77 and 
factor correlations ranged from 0.58 to 0.68 across all groups. Lowest communalities 
were observed for the giveup item in AA, and the morning item in WCA. The factor 
structure was similar across AA males, WCA males and females. This factor structure 
was such that the wake, refrain, cpd and whenill items loaded on factor 1 and the giveup 
and morning items loaded on factor 2, with factor loadings of 0.30 or greater.  Factor 1 
can be interpreted as a ‘smoking pattern’ factor, while factor 2 reflected a ‘morning 
smoking’ factor. Results within AA females were rather different with a separate factor 




Table 8.1. Factor structure of FTND Items by Race/Ethnicity Group 








ITEM F1 F2 H2 U2 F1 F2 H2 U2 F1 F2 H2 U2 F1 F2 H2 U2 
WAKE 0.00 0.43 0.18 0.82 0.43 0.14 0.28 0.72 0.44 0.17 0.32 0.68 0.46 0.12 0.29 0.71 
REFRAIN 0.97 -0.16 0.77 0.23 0.61 0.22 0.58 0.42 0.62 0.00 0.38 0.62 0.53 0.07 0.33 0.67 
GIVE UP 0.14 0.24 0.12 0.88 -0.08 0.47 0.19 0.81 -0.01 0.87 0.75 0.25 -0.12 0.86 0.61 0.39 
CPD 0.09 0.62 0.40 0.53 0.63 -0.02 0.39 0.62 0.57 0.01 0.33 0.67 0.64 -0.13 0.32 0.68 
MORNING -0.14 0.82 0.54 0.46 0.09 0.56 0.38 0.62 0.00 0.52 0.27 0.73 0.23 0.33 0.26 0.74 
WHENILL 0.59 0.13 0.47 0.53 0.97 -0.22 0.74 0.26 0.74 -0.07 0.49 0.51 0.71 0.03 0.54 0.46 
Values are highlighted in yellow to indicate what factors items are loading on that are higher than 0.30. 
Confirmatory Factor Analysis. CFA was conducted separately for sex and race/ethnicity, 
with two-correlated factors (e.g. “smoking patterns” and “morning smoking”, respectively). 
The wake, refrain, cpd and whenill items loaded on factor 1 (“smoking patterns”) and the 
giveup and morning items loaded on factor 2 (“morning smoking”). The results for CFA 
analyses, using unstandardized estimates, are displayed in the table below.  
Table 8.2. Results from Confirmatory Factor Analyses 
 AAF AAM WCF WCM 
Fit indices     
Model X2 (df) 13.116 (8) 5.973 (8) 13.390 (8) 8.465 (8) 
p-value 0.1079 0.6503 0.0991 0.3894 
CFI ≥ 0.9 0.985 1.000 0.997 1.000 
RMSEA ≤ 0.08 0.053 0.000 0.028 0.009 
F1 Loadings: Smoking Patterns      
wake 1.000 1.000 1.000 1.000 
refrain 1.356 1.321 1.017 1.088 
cpd 1.265 1.111 0.982 0.954 
whenill 1.388 1.304 1.104 1.299 
F2 Loadings:  Morning Smoking     
giveup 1.000 1.000 1.000 1.000 
morning 1.416 1.952 0.686 1.008 
Correlation between F1 & F2 0.361 0.230 0.600 0.434 
Item R2     
wake 0.411 0.496 0.588 0.480 
refrain 0.756 0.865 0.609 0.568 
giveup 0.299 0.239 0.517 0.613 
cpd 0.657 0.611 0.568 0.437 
morning  0.599 0.910 0.508 0.622 
whenill 0.792 0.843 0.718 0.810 
Mean variance explained 0.586 0.659 0.5982 0.588 




Results from these analyses indicated that each of these models fitted the data well, 
apparent from the non-significant chi-square model fit statistics. Based on the cut-off 
criteria for relatively good fit (CFI ≥ 0.9, RMSEA ≤ 0.08), the comparison of measures of 
approximate fit also supported conclusions based on chi-square tests of relative fit. Thus, 
a correlated, two-factor model fitted the data across each of these groups. 
However, we also saw that the correlation between the two factors was different across 
each of the four groups, such that the correlations were lower within Black/African 
American females and males (0.361 and 0.230), when compared to White/Caucasian 
females and males (0.60 and 0.434, respectively). 
DISCUSSION 
This study employed EFA to determine the factor structure of FTND, and then used CFA 
to test model fit for a two correlated factors model. The results confirmed that the factor 
structure of FTND was not one-dimensional. Within this sample of college students, the 
first factor was characterized by the wake, refrain, cpd and whenill items and the second 
factor was characterized by the giveup and morning items. Across each group, the 
correlations between the factors ranged from 0.23 to 0.60, with the highest correlation 
found within WCA females. The correlated two-factor model suggested by the exploratory 
factor analyses and tested with confirmatory factor analyses was like one conducted 
within young smokers entering US Air Force Basic Military Training2 and another sample 
of smokers enrolled in a Veteran’s Affairs Medical Center Smoking Cessation Clinic5.  
Despite the consistency of our findings with these studies, the factor structure we found 
using our college age sample was different than what is found in studies of older adult 
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smokers. These studies still demonstrate two correlated factors, but items differentially 
load on the factors3,6,7. Specifically, in one study of patients admitted for pre-surgical 
assessments, the first factor is still characterized by morning smoking (refrain & giveup 
items), while the second factor assesses the degree of urgency to restore nicotine levels 
to a given threshold after nighttime abstinence (cpd, morning and whenill items), and the 
wake item permitted to load on both factors6. 
The difference in factor structure across these samples might be attributed to the age of 
the samples being assessed. The samples that demonstrate similar factor structures to 
the current study are younger. Older adults have a longer period during which they might 
be exposed to nicotine, and so the effects of nicotine on dependence symptoms might be 
different relative to younger samples who have been exposed for less time. In other 
words, FTND items may perform differently when used with younger, less addicted 
smokers relative to more mature smokers being assessed in cessation clinics.  
In addition to providing another younger sample to test psychometric properties of FTND 
items, this study contributes to the literature by examining factor structure across sex and 
racial/ethnic groups. Chi-square tests indicated that differences existed across FTND 
items by sex. Results from the CFA conducted in this study demonstrated that a 
correlated, two-factor structure fit the data for African American and White/Caucasian 
males and females – suggesting that the factor structure of FTND items was not 
necessarily different by race/ethnicity, even though it did differ by sex. However, EFA 
suggested that the factor structure of FTND items may be different for African American 
females, relative to the other groups in this sample, even though a correlated, two-factor 
model fit the data for all groups. If the factor structure of FTND items were different for 
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African American females, relative to the other groups in this sample, it would mean that 
the constructs being measured within the FTND are biased, and scores from the FTND 
would interpreted differently for this group8. Thus, this factor structure needs to be tested 
in other samples, to determine its validity.  
Other racial/ethnic groups were available for analyses, but not assessed in this study due 
to concerns over sample size. It has been suggested elsewhere that necessary sample 
sizes for factor analyses are dependent upon: the range of communalities, number of 
factors, and number of indicators. This sample had low communalities (e.g. 
communalities under 0.5) and two factors, including a factor which was weakly 
determined by two items. To achieve good recovery of population factors, it is suggested 
that sample sizes over 500 are needed9. Thus, larger samples are needed to assess 
whether the findings of this study generalize to other groups of young adults, who self-
identify with other race/ethnicity groups not described in the current study. 
Finally, other studies identifying a two-factor structure to the FTND have raised concerns 
that simplistic scoring of the six items of the FTND might not reflect the subtle differences 
between individual dependence profiles – especially if study participants score higher on 
one dimension and lower on the other. Using a single total score of the items – which 
would suggest that there is one underlying factor of nicotine dependence, as some other 
studies have found - produces an ‘average’ of dimension-specific scores. However, a 
single total score of the items may lack the ‘sensitivity’ to identify differences in 
dependence profiles, which could limit the potential for tailoring interventions6. Thus, more 
research needs to be conducted to determine whether using factor scores derived from 
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a correlated, two-factor model or the more traditional single total score of FTND derived 
from a one-factor model is the best approach moving forward.  
CONCLUSIONS 
Sex differences exist in the responses to FTND items, and their psychometric properties. 
Further studies are needed to determine how nicotine dependence measures perform 
across sex, race/ethnicity, and age and to assess whether the factor structure identified 
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INTRODUCTION 
Tobacco use encompasses a range of complex behavioral traits that are influenced, at 
least in part, by genes. Studies of adult twins have been useful in inferring genetic 
influences by comparing phenotypic similarities between monozygotic and dizygotic 
twins, and suggest that genetic factors account for approximately 50% of the variance in 
adult smoking behaviors overall. When looking at tobacco use behaviors separately, the 
estimates for heritability are more wide-ranging. Approximately 60% of the variance in 
smoking initiation is attributed to genetic factors, while genetic factors account for 55-69% 
of the variation for smoking persistence, 40 to 56% in smoking quantity, 60-76% in 
nicotine dependence, and about 50% in smoking cessation1–3. Generally, initiation of use 
is more strongly influenced by environmental factors, whereas progression to higher 
levels of use and dependence is more strongly influenced by genetic factors4. 
Additionally, the heritable components of tobacco use become increasingly expressed 
over the transition from adolescence, when many individuals initiate use, into adulthood5.  
Since each of tobacco use behavior constitutes steps along the trajectory towards 
possible nicotine dependence and problem use, it is important to try and elucidate their 
genetic etiology and answer such questions as: What genes are influencing tobacco use 
behaviors? And are the genes influencing individual tobacco use behaviors separate or 
overlapping? In efforts to answer these questions, many genome-wide association 
studies (GWAS) have been conducted to identify genes underlying susceptibility to 
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tobacco use behaviors (in addition to linkage and candidate gene studies). Yet, only a 
handful of genes, with generally small effects, have been identified. The most robust 
finding from the few genome wide association studies of smoking phenotypes is the 
association between smoking quantity and the nicotinic receptor gene cluster CHRNA5-
A3-B4, located on chromosome 156.  
Most genetic analyses on tobacco use behaviors have been conducted in adults of 
predominantly European descent, and so, less is known regarding the role of genes to 
tobacco behavior in adolescence and young adulthood, and among other populations. 
For this reason, we examine several measures of tobacco use [e.g. initiation, age of 
onset, current use, regular use, cigarettes per day, time to first tobacco use, and the 
Fagerström Test for Nicotine Dependence (FTND)] among a diverse sample of young 
adults attending university to: (1) calculate the heritability of tobacco use behaviors 
among this group, and (2) identify genetic variants contributing to tobacco use behaviors 
during young adulthood. 
SAMPLE AND METHODS 
Study population. Individuals included in this study were participants of Spit for Science 
(‘S4S’), a longitudinal study of college students enrolled in a large, urban university in the 
Mid-Atlantic region of the United States. S4S is aimed at understanding how genes and 
environments impact substance use and mental health outcomes across time in college 
students7. To be eligible to participate in this study, incoming students had to be 18 years 
or older. Freshmen participants completed phenotypic assessments, covering a wide 
range of topics, including tobacco use. Each subsequent spring semester, students were 
invited to complete follow-up assessments. Students who did not participate in the first 
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wave of data collection (including those who turned 18 after the end of the first wave of 
data collection) had the opportunity to enroll in the study the following spring. Data for this 
study was collected and managed using REDCap electronic data capture tools8.  
Those who completed phenotypic assessments were also eligible to provide a DNA 
sample. A total of 9,889 university students have enrolled in S4S, including four cohorts, 
which matriculated from Fall 2011 to Fall 2014. Of those that enrolled into the study, 98% 
provided a DNA sample. Of the entire sample, 6754 indicated that they had ever used 
tobacco in their lifetime. Of those that indicated they had ever used tobacco in their 
lifetime, 5990 had provided DNA passing quality control steps, were and included in the 
current study, which utilizes data released in Spring 2016. The university Institutional 
Review Board approved study protocols and informed consent was obtained from all 
participants prior to participant enrollment into the study. 
Tobacco Use Phenotypes. For the current study, multiple tobacco use behaviors were 
examined, including: ever tobacco use (e.g. indicated they had ever used tobacco in their 
lifetime), age of initiation, current use, regular use (e.g. indicated they had used ≥100 
cigarettes in their lifetime or the equivalent), tobacco use quantity (e.g. cigarettes per 
day), time to first tobacco use after waking, and FTND scores. Ever, current, and regular 
tobacco use were treated as binary phenotypes (ever versus never). Smoking quantity, 
age of tobacco use initiation, and FTND were treated as continuous variables. These 
variables were evaluated among ever users. 
Genotyping, Pre-imputation Quality Control, and Imputation. As reported and described 
in greater detail elsewhere9, 6534 samples passed DNA and initial genotyping quality 
control (QC). Genotyping was performed at Rutgers University Cell and DNA Repository 
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using the Affymetrix BioBank array (653k), which contains both common GWAS 
framework variants (296k) for imputation, and functional variants (357k), including: rare 
high impact exome variants (272k), indels (18k), eQTLs (16k), and miscellaneous (51k). 
Off target variants were identified using SNPolisher. Variants were excluded due to: high 
missingness of SNPs (5%), high missingness of samples (2%), and high missingness in 
post-sample filtering (2%), similar to the Psychiatric Genomics Consortium (PGC)10. Pre-
imputation QC removed 209 samples, which left 6325 samples and 560138 variants for 
imputation. Imputation was conducted using SHAPEIT211 / IMPUTE212 and the 1000 
Genomes Phase 3 reference panel (n=2504).  
Population Stratification. Given the ethnic diversity within this sample, we had to account 
for potential genetic heterogeneity, or when a single phenotype is caused by any one of 
a multiple number of alleles or non-allele mutations, caused by population stratification. 
Population stratification occurs when both the prevalence and allelic frequency 
differences exist within the population sampled for analyses. Such stratification may lead 
to false positive associations of genetic signals, especially when millions of markers are 
tested across the genome.  
Genomic inflation can occur when many markers show allele frequency differences 
between populations and the overall distribution of test statistics is inflated. A 
consequence of genomic inflation can be an increase in false positives. To measure the 
extent of inflation due to population stratification or other potential sources of confounding, 
genomic control (e.g. λ, λ1000) is computed. Genomic control is defined as a the median 
χ2 (1 degree of freedom) association statistic across SNPs divided by its theoretical 
median under the null distribution, with a value of 1 indicative of no stratification and a 
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value of >1 indicative of stratification, family structure, cryptic relatedness, differential 
bias, or potential other confounders. Generally, values <1.05 are considered benign; 
though, it is important to note that inflation in genomic control is proportional to sample 
size13. 
Meanwhile, methods inferring genetic ancestry have been used to correct for potential 
population stratification13.The most common approach to assessing ancestry and 
population structure is to apply principal components analyses (PCA) to genotype data, 
and infer continuous axes of genetic variation. The resulting axes of variation are used to 
reduce the data to a small number of dimensions, or principal components, that describe 
as much variability as possible. These principal components are the top eigenvectors of 
a covariance matrix between samples and are later used in regression analyses as 
covariates14. The goal of using this approach is to maximize power for discovering 
etiologically relevant genetic variants, while minimizing false positive associations due to 
population stratification. 
Ancestry Principal Components. Ancestry principal components (PCs) can be estimated 
either from the sample itself or from external references. Both approaches were taken in 
the current set of analyses. As explained by Webb et al. (2017), 1000 Genomes Project 
(1KGP) phase 3 variants were merged together with post quality control filtered 
genotypes from Spit for Science. Regions with high linkage disequilibrium were excluded, 
and then the common set of variants was pruned (r2<0.1) using PLINK1.9 to yield 109,259 
semi-independent variants for ancestry analyses. EIGENSOFT and smartPCA14,15 were 
used to perform PCA using only the 1KGP phase 3 reference panel to determine SNP 
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weights for each eigenvector. The solution from the PCA was then projected onto the S4S 
data to generate 10 PCs9. 
Genetic Based Population Assignment. Participants were empirically assigned to 1KGP 
based ancestry super-populations [AFR, Africa; AMR, Americas; EAS, East Asia; EUR, 
Europe; and SAS, South Asia]. Using all 10 ancestry PCs, the Mahalanobis distance 
between the S4S sample and 1KGP population without reference population outliers 
(>4SD from population median, n=61) was calculated. Each subject was then assigned 
to the 1KGP population with the minimum Mahalanobis distance and collapsed into their 
respective super-population assignment. This empirically-based ancestry has several 
advantages to self-identified race/ethnicity including the reduction of within group 
variance and the ability to include “Unknown”, “More than one race”, and small groups in 
the analysis without an increase in genomic inflation9. 
Within Group Quality Control. To account for the diversity found in the S4S sample, 
filtering by Hardy-Weinberg Equilibrium (HWE), minor allele frequency (MAF), and 
relatedness were performed within the empirically assigned super populations. Genome-
wide IBD (Π ̂) was calculated using PLINK 1.9. For each group, the mean cross-sample 
Π ̂ was calculated to find samples showing cryptic relatedness to other samples. 194 
samples were excluded (>2.5 standard deviations above the mean) as outliers for 
average relatedness with all other samples. Clusters of probable relatives were defined 
using Π ̂ > 0.1, Z0 >= 0.825, and Z1 < 0.175. The inclusion of Z0/Z1 is important since Π ̂ 
> 0.1 can be due to artifacts where Z2 > 0 is extremely unlikely for cryptic relatives. Then 
the best performing sample for each relative cluster was retained which resulted in an 
additional 180 samples being excluded from the GWAS sample9. 
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Within Ancestry Group PCA. As an added step to adjust for potential fine structure within 
each super population, within ancestry group PCA was conducted. Again, EIGENSOFT 
and smartPCA14,15 were used to perform PCA for each super population found in the Spit 
for Science sample. Additional filtering excluded regions with high linkage disequilibrium 
and PLINK 1.9 was used to prune variants (r2< 0.1, MAF>0.01, HWE>5*10-8). This yielded 
the following number of semi-independent variants: 71,873 (EUR); 137,042 (AFR); 
84,774 (AMR); 62,046 (EAS); and 80,654 (SAS). Ten distinct PCs were generated for 
each super population9.  
Covariates. Within ancestry group PCs and covariates (e.g. sex and age) to include in 
genetic analyses were determined by stepwise linear regression for each tobacco use 
behavior phenotype being analyzed. Non-ancestry covariates of sex and age are kept in 
each model, while ancestry covariates were kept if they were retained in the best fitting 
model per AIC9.  
Genome-wide Complex Trait Analysis. Genome-wide Complex Trait Analysis (GCTA)16 
was used to estimate the proportion of phenotypic variance attributable to non-imputed, 
and directly genotyped, genetic variants [V(G)/V(P) or h2SNP]. Genetic relationship 
matrices, or GRMs, were derived for each ancestry group, as described in a previous 
study9. Within a mixed linear model, GCTA fits the effect of SNPs as random effects, 
includes the effect of sex, age, and significant within ancestry group PCs as fixed effects. 
The variance explained by all SNPs (e.g. the SNP-based heritability) is estimated, with 
heritability calculated separately by ancestry group. An ancestry group-specific minor 
allele frequency (MAF) cut-off of 0.01 was applied, and only unrelated individuals were 
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included in GRMs, resulting in the following sample sizes: N = 1339 (AFR), N = 582 
(AMR), N = 557 (EAS), N = 3018 (EUR) and N=455 (SAS).  
Genome Wide Association Study. Genome wide association studies (GWAS) were 
conducted using SNPTest17, separately for each tobacco use behavior phenotype. Each 
GWAS was conducted separately by ancestry group. Association analyses were 
conducted under an additive model, only including markers with a minimum MAF of 0.005 
and INFO of 0.5. Post-GWAS filtering was performed using ancestry specific HWE and 
sample size based MAFs. Rather than using a fixed MAF threshold for each group, the 
minimum observed minor allele count (MAC) was used, as prior research has shown a 
MAC of ~40 is robust for most association analyses performed in GWAS18. Additionally, 
post-filtered GWAS results were meta-analyzed using METAL19, where sample sizes 
within ancestry groups were ≥400 for each tobacco use behavior phenotype. Meta-
analyses using METAL implements a fixed effect model and inverse variance weighting 
based on sample size. Estimation of genomic inflation (λ and λ1,000) for within super-
population GWAS and meta-analyses was performed in R20. False Discovery Rate (FDR) 
analysis was performed using the “q-value” package (https://github/jdstorey/qvalue) using 
Bioconductor 3.221. Genomic bins were defined for follow-up, starting with all markers 
with a q-value < 0.25. Initially, markers were collapsed into bins if they were within 10kb; 
however, post-hoc inspection showed several adjacent bins <75kb apart which were then 
collapsed into reported bins. The web-based plotting tool, LocusZoom22, was used to 
visually display regional information regarding the strength and extent of the association 
signals relative to genomic position, local linkage disequilibrium, and recombination 
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patterns and positions of genes in the region, was used to inspect genome-wide 
significant SNPs. 
Individual Variant Replication. Summary statistics from GWAS results of the Tobacco and 
Genetics (TAG) Consortium were extracted and compared to the corresponding 
phenotypes found in S4S. Due to differences in allele frequencies across the discovery 
and replication, summary statistics were not available for all markers. Replication was 
attempted for genome-wide significant SNPs found in TAG; however, only results based 
on equivalent phenotypes were examined. Nominal associations were found where p-
value <0.05.  
RESULTS 
Descriptive statistics. Within the genetic sample, the sample was mostly female (61.2%), 
and had indicated that they had used any tobacco product at least once in their lifetime 
(67.9%). Frequencies and percentages for tobacco use behaviors within the entire 
sample and genetic sample only are presented in Table 9.1 below. [Though the 
frequencies and percentages are not shown, cohorts were equally represented.] Sex, 




Table 9.1: Tobacco Use Behaviors of the Spit for Science Sample  
 
Tobacco Use Phenotype ENTIRE SAMPLE N=9889 
GENETIC SAMPLE 
N=5990 
 N % N % 
Ever Tobacco Use 6754 68.3% 4069 67.9% 
Age of Initiation     
     Did not initiate 3091 31.3% 1839 39.0% 
     >= 18 years 1109 11.2% 806 17.1% 
     15-18 years 2531 25.6% 1282 27.2% 
     12-14 years 1094 11.1% 673 14.3% 
     <12 years 249 2.5% 114 2.4% 
Current Use 4049 40.9% 2490 61.3% 
Regular Use     
     Never Used 1909 19.3% 2855 48.3% 
     <100 cigarettes/lifetime 3316 33.5% 2094 35.4% 
     >=100 cigarettes/lifetime 1529 15.5% 959 16.2% 
Regular Use Among Smokers     
     <100 cigarettes/lifetime 5225 52.8% 3110 76.4% 
     >=100 cigarettes/lifetime 1529 15.5% 959 23.6% 
Cigarettes Per Day     
     <10 cigarettes 3220 32.6% 1870 31.4% 
     11-20 cigarettes 375 3.8% 241 4.0% 
     21-30 cigarettes 112 1.1% 67 1.1% 
     >31 cigarettes 69 0.7% 42 0.7% 
Time to First Tobacco Use     
     >60 minutes 3230 32.7% 1915 73.9% 
     31-60 minutes 448 4.5% 267 10.3% 
     6-30 minutes 470 4.8% 296 11.4% 
     Within 5 minutes 200 2.0% 115 4.4% 
 Mean Range Mean Range 
 Fagerström Test for Nicotine Dependence 0.82 0-10 0.84 0-10 
  
GCTA/Heritability estimates. Heritability estimates for each tobacco use behavior were 
calculated using GCTA16, separately by ancestry group, as shown in Table 9.2. The 
heritability of ever tobacco use ranged from 0.00 to 0.28, but was only significant amongst 
those of East Asian (h2 =0.13, p=0.0480) and European ancestry (h2 =0.28, p=0.0133). 
Significant heritability was observed for age of initiation in those of European ancestry (h2 
=0.30, p=0.0288). None of the heritability estimates were significant for current use, 
regular use, and time to first tobacco use after waking across any ancestry group, while 
the heritability of regular use among smokers within those of European ancestry (h2 =0.50, 
p=0.0041), cigarettes per day and FTND scores within the Americas ancestry group 
(CPD: h2 =1.00, p=0.0212; FTND: h2 =1.00, p=0.0211) were statistically significant at a p-
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value of ≤ 0.05. However, after corrections for multiple testing, none of these results were 
significant at the adjusted threshold of p-value ≤ 0.00125 (or p-value ≤0.05/40 tests; 
where 40 tests account for eight phenotypes x five ancestry groups). Additionally, the 
sample sizes for the AMR, EAS, and SAS ancestry groups were smaller than suggested 
for GCTA analyses23; so those results should be interpreted with caution.  






2SNP SE p-value 
Ever Tobacco 
Use 
AFR 1329 0.00 0.26 0.5000 
AMR 577 0.00 0.44 0.5000 
EAS 552 0.13 0.59 0.0480 
EUR 2980 0.28 0.13 0.0133 
SAS 453 0.00 0.71 0.5000 
Age of Initiation 
AFR 897 0.44 0.37 0.1214 
AMR 487 0.00 0.51 0.5000 
EAS 460 0.52 0.72 0.2258 
EUR 2523 0.30 0.16 0.0288 
SAS 334 0.00 0.97 0.5000 
Current Use 
AFR 884 0.00 0.38 0.5000 
AMR 412 0.49 0.56 0.2046 
EAS 297 0.00 1.22 0.5000 
EUR 2172 0.00 0.18 0.5000 
SAS 284 0.99 1.11 0.1027 
Regular Use 
AFR 1329 0.20 0.25 0.2045 
AMR 577 0.13 0.46 0.3949 
EAS 552 0.00 0.61 0.5000 
EUR 2980 0.26 0.13 0.0221 




AFR 886 0.16 0.35 0.3152 
AMR 412 0.40 0.59 0.2728 
EAS 297 0.00 1.18 0.5000 
EUR 2175 0.50 0.18 0.0041 
SAS 285 0.90 1.05 0.1911 
Cigarettes Per 
Day 
AFR 402 0.53 0.61 0.1758 
AMR 224 1.00 1.01 0.0212 
EAS 148 0.00 2.03 0.5000 
EUR 1307 0.06 0.30 0.4181 
SAS 139 0.48 1.86 0.3980 
Time to First 
Tobacco Use 
After Waking 
AFR 471 0.00 0.59 0.5000 
AMR 269 0.13 0.85 0.4450 
EAS 173 0.00 1.82 0.5000 
EUR 1519 0.25 0.25 0.1520 
SAS 157 0.63 1.78 0.3651 
 Fagerström 
Test for 
AFR 670 0.23 0.48 0.3248 
AMR 324 1.00 0.68 0.0021 





EUR 1773 0.31 0.22 0.0832 
SAS 217 1.00 1.40 0.1510 
 
Primary GWAS results. Prior to applying filtering, 17,461,305 markers were available for 
analyses. The number of available markers following the application of filtering and meta-
analyses are shown in Table 9.3, in addition to the sample size, and measures of genomic 
inflation (and 
1000
). To be included in the meta-analyses, sample sizes had to be ≥400 
within a given ancestry group. 
Table 9.3: Sample Sizes, Marker Counts, and Genomic Inflation Estimation 
   
AFR AMR EAS EUR SAS Metal 
Ever Use 
n 1329 577 552 2980 453 >1000 
n 
Markers 14466464 10909721 6835923 10333295 7361150 16638242 
 1.0095 1.0220 1.0238 1.0178 1.0031 1.0034 

1000
 1.0016 1.0037 1.0040 1.0030 1.0005 1.0034 
Age of Initiation 
N 897 487 460 2523  >1000 
n 
Markers 12797220 10213567 6598175 10106533 
 10332814 
 0.9900 0.9617 1.0171 0.9970  1.0150 

1000
 0.9977 0.9912 1.0039 0.9993  1.0000 
Current Use 
N 884 412  2172  >1000 
n 
Markers 12731483 9542115 
 9855533  9941997 
 1.0057 1.0513  1.0020  1.0019 

1000
 1.0016 1.0147  1.0005  1.0000 
Regular Use 
N 1329 577 552 2980 453 >1000 
n 
Markers 14462978 8037689 6833967 10336157 7361674 16941407 
 0.9819 0.9738 0.9943 1.0069 0.9788 0.9934 

1000
 0.9969 0.9956 0.9990 1.0012 0.9964 1.000 
Regular Use Among 
Smokers 
N 886 412  2175  >1000 
n 
Markers 12717222 7339884  9856239  9941327 
 1.0385 1.0073  1.0206  1.0136 

1000
 1.0110 1.0021  1.0059  1.000 
CPD 
N 402   1307  >1000 
n 
Markers 6874724 
  6874724  6861522 
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 0.9982   0.9999  1.0008 

1000
 0.9989   0.9999  1.0000 
TFT 
N 471   1519  >1000 
n 
Markers 4839510 
  4839810  4835232 
 0.9923   1.0047  0.9958 

1000
 0.9933   1.0016  0.9999 
FTND 
N 670   1773  >1000 
n 
Markers 7497960 
  7497960  7486766 
 1.0032   0.9904  1.0014 

1000
 1.0013   0.9960  1.0000 
 
The meta-analyses showed no evidence of genomic inflation, as demonstrated by with 
ߣ ܽ݊݀ ߣଵ଴଴଴s shown in Table 9.3. Analyses were adjusted for sex, age, and significant 
within ancestry group principal components (identified by step-wise linear regression). 
Figure 9.1, depicts the QQ- and Manhattan Plots for each of the tobacco use behaviors. 
Figure 9.1: QQ-Plots and Manhattan Plots for Tobacco Use Behaviors 
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No genome-wide significant SNPs were identified for ever tobacco use, age of initiation, 
regular use, regular use among smokers, TFT and FTND. Significant findings were found 
for current use and cigarettes per day, which are described in further detail below, and 
shown in Table 9.4. Across the measures of current use and cigarettes per day, FDR 
analysis showed 38 markers with q<0.25. Each of these markers are listed in 
Supplementary Tables 9.7a-9.8b, with summary statistics and information on nearby 
genes within 75kb. These 37 markers map to 20 genomic bins, with seven genomic bins 
containing at least one genome-wide significant marker (p-value ≤ 5 x 10-8). Regional 
association plots (Figures 9.2a and 9.2b) are only shown for the genome-wide significant 
SNPs that are found to be located within genes (e.g. rs148027841 and rs9653371).  
Current Use. Three SNPs (rs148027841, rs73111343, rs73111344) were found to be 
associated with current use, at the significance threshold level of p-value < 5 x 10-8. SNP 
rs148027841 is located on chromosome 16 within the protein coding gene RAB11 Family 
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Interacting Protein 3 or (RAB11FIP3) that has a regulatory role in the formation, targeting, 
and fusion of intracellular transport vesicles24. Figure 9.2a depicts the regional association 
plot for RAB11FIP3, and displays other markers that are not in high linkage disequilibrium 
with rs148027841, but have low p-values. rs148027841 is rare (MAF ≤ 0.02) in each of 
the ancestry groups. The direction of the effect was consistent across the African and 
European ancestry groups (e.g. negative), but in the opposite direction across the 
Americas ancestry group (e.g. positive). The strength of the association varied by 
ancestry group (e.g. -0.35 in AFR; 0.13 in AMR; and -1.40 in EUR). The other two 
genome-wide significant SNPs, rs73111343 and rs73111344, are common in each of the 
listed ancestry groups and are in high LD with one another, but are not located within any 
genes.  
Cigarettes Per Day. Six SNPs were found to be associated with cigarettes per day 
(rs9653371, rs34731037, rs71427733, rs75714873, rs41319146, and rs371955890) at 
the genome-wide significance level. rs9653371 mapped onto a gene located on 
chromosome 2 (PID1), and is rare within those of European ancestry (MAF = 0.14) and 
is common within those of African ancestry (MAF = 0.02). Figure 9.2b depicts the regional 
association plot for PID1, which suggests that rs9653371 is a lone SNP, with no linkage 
disequilibrium with other SNPs. The direction of the effect is consistent across these two 
ancestry groups, but the strength of association is greater within those of European 
ancestry, relative to African ancestry. Although SNP rs34731037, located on 
chromosome 13, did not map onto any genes, it is common within those of African and 
European ancestry (MAF = 0.06, 0.07 respectively). The direction of the effect is 
consistent across these two groups, but the strength of association is greater within those 
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of African ancestry relative to those of European ancestry. Genome-wide significant SNPs 
(rs71427733, rs75714873, and rs41319146) located on chromosome 2 were also not 
located within any genes (or nearby any genes within 75kb) and are common within those 
of African and European ancestry (MAF = 0.06 for both ancestry groups). The direction 
of the effect is consistent across the two ancestry groups, but the strength of association 
is greater within the African ancestry group. rs371955890, located on chromosome 9, is 
not located within any genes, but is nearby to AK096159 and LOC100132352. However, 
the direction of the effect is not consistent across African and European ancestry groups, 
and the effect size is greater within the African ancestry group – even though the SNP 


















INFO MAF HWE P-value Beta SE 
Current Use 
rs148027841 (chromosome 16) 
AFR 884 1.7E-06 0.69 0.01 1.00 0.58 -0.35 0.62 
AMR 412 NA 0.79 0.01 1.00 0.85 0.13 0.71 
EUR 2172 1.8E-06 0.75 0.02 1.00 5.5E-09 -1.40 0.24 
Current Use 
rs73111344 (chromosome 4) 
AFR 884 5.1E-06 0.87 0.10 0.85 3.2E-06 0.84 0.19 
AMR 412 4.8E-06 0.92 0.06 0.63 1.0E-04 1.30 0.35 
EUR 2172 3.2E-06 0.91 0.08 1.00 5.5E-09 0.33 0.13 
Current Use 
rs73111343 (chromosome 4) 
AFR 884 5.1E-06 0.87 0.10 0.85 3.2E-06 0.84 0.19 
AMR 412 6.1E-06 0.92 0.06 0.63 1.0E-04 1.30 0.35 
EUR 2172 3.2E-06 0.91 0.08 1.00 5.5E-09 0.33 0.13 
Cigarettes Per 
Day 
rs9653371 (chromosome 2) 
AFR 402 1.1E-05 0.84 0.14 0.84 0.76 0.04 0.11 
EUR 1307 1.1E-06 0.51 0.02 1.00 2.0E-22 3.26 0.20 
Cigarettes Per 
Day 
rs34731037 (chromosome 13) 
AFR 402 1.9E-05 0.53 0.06 1.00 1.9E-27 2.52 0.17 
EUR 1307 1.1E-05 0.67 0.07 0.52 0.02 0.27 0.10 
Cigarettes Per 
Day 
rs71427733 (chromosome 2) 
AFR 402 1.2E-06 0.96 0.06 1.00 4.6E-05 0.64 0.16 
EUR 1307 1.2E-06 0.96 0.06 0.62 1.4E-05 0.36 0.08 
Cigarettes Per 
Day 
rs75714873 (chromosome 2) 
AFR 402 1.2E-06 0.96 0.06 1.00 4.6E-05 0.64 0.16 
EUR 1307 1.2E-06 0.96 0.06 0.62 1.4E-05 0.36 0.08 
Cigarettes Per 
Day 
rs41319146 (chromosome 2) 
AFR 402 3.4E-16 0.95 0.06 1.00 4.7E-05 0.64 0.16 
EUR 1307 7.7E-07 0.96 0.06 0.62 1.4E-05 0.36 0.08 
Cigarettes Per 
Day 
rs371955890 (chromosome 9) 
AFR 402 2.0E-05 0.50 0.05 0.61 6.4E-37 3.00 0.12     














Table 9.5: Individual Variant Replication Summary 
Phenotype SNP CHR BP Alleles 
Tobacco and Genetics Consortium (EUR) Spit for Science (EUR) 
N Coded AF INFO OR SE P N MAF INFO Beta SE P 
CPD 
 
rs1051730 15 76681394 G/A 38,181 0.65 1.00 -1.02 0.09 8.0E-33 1,307 0.33 1.00 0.04 0.04 0.27 
rs16969968 15 76669980 G/A 38,181 0.65 1.00 -1.02 0.09 4.5E-33 1,307 0.33 1.00 0.05 0.04 0.16 
rs1329650 10 93338100 T/G 38,181 0.28 1.00 -0.43 0.09 2.3E-06 1,307 0.27 1.00 -0.07 0.04 0.11 
rs1028936 10 93339777 C/A 37,284 0.18 1.00 -0.55 0.12 1.6E-06 1,307 0.17 0.95 -0.04 0.05 0.49 




rs6265 11 27636492 T/C 74,035 0.21 1.00 -0.06 0.01 1.7E-05 2,980 0.19 1.00 -0.001 0.03 0.97 
rs1013442 11 27535522 T/A 74,035 0.26 1.00 -0.06 0.01 3.4E-05 2,980 0.24 0.99 0.02 0.03 0.57 
rs4923457 11 27605156 T/A 74,035 0.23 1.00 -0.06 0.01 2.1E-05 2,980 0.21 0.99 0.03 0.03 0.27 
rs4923460 11 27613365 T/G 74,035 0.23 1.00 -0.06 0.01 2.2E-05 2,980 0.21 0.99 0.03 0.03 0.27 
rs4074134 11 27603861 T/C 74,035 0.23 1.00 -0.06 0.01 1.9E-05 2,980 0.21 1.00 0.03 0.03 0.27 
rs1304100 11 27528179 G/A 74,035 0.26 1.00 -0.06 0.01 4.9E-05 2,980 0.24 0.99 0.02 0.03 0.53 
rs6484320 11 27659764 T/A 74,035 0.24 1.00 -0.06 0.01 2.0E-05 2,980 0.22 0.97 -0.03 0.03 0.39 








Identification of Novel Genetic Variants and Replication of TAG SNPs in S4S. Despite 
being able to identify nine genome-wide significant SNPs contributing to either current 
use or cigarettes per day in the S4S sample, none have been associated with tobacco 
use behaviors in any previous studies. In attempts to replicate findings for individual 
variants from the TAG Consortium using the S4S dataset, only results based on 
equivalent phenotypes were examined (e.g. markers associated with cigarettes per day 
and regular use (e.g. which is like the current study’s measure of ever use), as shown in 
Table 9.5. None of the individual variants from the TAG Consortium demonstrated 
nominal associations (p-value < 0.05) in S4S.  
DISCUSSION 
Study findings support previous research on complex, polygenic nature of tobacco use 
behaviors, and suggest the need for additional research investigating the role of genes 
contributing to tobacco use behaviors. More specifically, by using a population-based 
study of university students, we found that there are common SNPs contributing to 
tobacco use behaviors. Estimates of SNP-based heritability using GCTA indicate that 
tobacco use behaviors are moderately heritable, but only within those of the European 
ancestry group. Although these estimates are generally lower than those estimated from 
twin studies, they were non-zero and significant those of European ancestry (at least 
before applying multiple testing corrections), indicating that the existing sample sizes 
should be adequate for calculations of SNP-based heritability. The expected range 
heritabilities for smoking phenotypes are between 0.4 and 0.7 - at least according to twin 
and family studies of individuals of European ancestry. However, prior research suggests 
that SNP-based heritabilities using GCTA are typically 50% of that of found within twin 
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studies. For this reason, Table 9.6 shows a range of heritabilities from 0.2 to 0.7. From 
power calculations using the GCTA-GREML Power Calculator, there was sufficient (e.g. 
>80% power) to detect SNP-based heritabilities between 0.5 and 0.7, with sample sizes 
of >1,500 individuals (Supplementary Table 9.6).  
Meanwhile, ancestry groups with smaller sample sizes often yielded nonsignificant 
heritability estimates close to zero. This could mean that either the sample sizes for these 
groups are too small and we do not have enough power to calculate heritability using 
GCTA, or that the phenotypic traits being measured are weakly (or not at all) affected by 
genetic variation within this sample. Since published evidence suggests these tobacco 
use behaviors are similarly heritable across different populations25, it could be that larger 
sample sizes are needed to estimate heritability across South Asian, American, and East 
Asian ancestry groups. What this means is that to get the statistical power needed to 
determine associations between the aggregate effect of genetic variants and tobacco use 
behaviors for the remaining ancestry groups, larger samples may be needed.  
Like other studies, the current study is not without limitations. Firstly, all the tobacco use 
behaviors used within this study (and all the studies included within this dissertation 
thesis) is based upon self-report data. Thus, the findings from this (and subsequently, all 
studies included in this dissertation thesis) are subject to potential reporting bias and does 
not offer the possibility for any external verification (e.g. outsider reporting, or verification 
using biomarkers, such as cotinine levels). To mitigate potential reporting bias, we 
examined tobacco use variables across each wave of individual data and recoded 
variables to maintain consistency.  
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Additionally, the current study was not able to replicate findings from the larger meta-
analyses of tobacco use behavior. Failures to replicate significant GWAS hits from the 
TAG Consortium could be due to many reasons, including: variability in phenotype 
definitions across independent samples, inadequate sample size, false positive results, 
and population-specific effects19, as described in fuller detail on the next page. 
Variability in phenotype definitions can result from differences in measurement protocols 
across studies. The definitions used in the current study are different than definitions used 
in previous studies. For example, within the studies included within larger consortiums, 
“ever use” was defined as having used at least 100 cigarettes in a lifetime, which matches 
more closely with our “regular use” variable. Meanwhile, “ever use” within the context of 
the current study is defined as having used any tobacco product during a lifetime. This 
means that individuals within previous studies will have had more exposure to nicotine, 
relative to individuals within the current study which could influence association findings.  
Another potential contributor to the failure to replicate SNP associations (even when 
comparing similar phenotypes of “regular use” in our study to “ever use” of previous 
studies) is inadequate sample size. Studies finding significant SNP associations with 
tobacco use phenotypes report larger sample sizes than that found in this study. For 
example, the ENGAGE Consortium includes more than 30,000 genotyped participants 
for each of the tobacco-related phenotypes20. Sample size is important because it directly 
impacts power, or the chance of discovering effects. Generally, low-powered studies 
produce more false negatives relative to higher-powered studies and have reduced 
probabilities of observing effects that pass the required threshold of claiming discovery 
(e.g. reaching statistical significance threshold). Additionally, even when true effects are 
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found within low powered studies, it is likely that the estimate of the magnitude of the 
effect is exaggerated21. Potentially, what this means for the current study is that because 
the study was underpowered (as evidenced by a post-hoc power calculation 
demonstrating that we have <80% power to replicate findings from the larger TAG 
Consortium), the sample sizes were not large enough to find any associations across 
certain tobacco use behaviors (e.g. ever tobacco use, age of initiation, regular use, and 
regular use among smokers) and/or the effect of the significant associations found for 
current use, time to first tobacco use after waking, cigarettes per day, and the Fagerström 
Test for Nicotine Dependence may be exaggerated. Alternatively, in the case where effect 
sizes are already small, false positives are likely. To correct for any false positives driven 
by population stratification, we conducted genetic analyses separately by ancestry and 
included principal components as covariates in the models. Furthermore, we calculated 
lambda inflation factors and implemented a false discovery rate correction.     
Despite these precautions, it is also possible that our failure to replicate GWAS hits from 
previous studies is due to population-specific effects, or the possibility that detected 
effects are stronger within a specific sample, rather than the general population. Given 
that most tobacco-related GWAS have been conducted within older adults of European 
ancestry and focused on cigarette use, it is possible that the findings from previously 
conducted genetic studies of tobacco use behaviors are limited to that subset. This study 
diverges from these studies in that it includes younger individuals of varied ancestral 
backgrounds and has a broader definition of tobacco use. Participants were included in 
analyses if they had indicated they had ever used any of the following tobacco products: 
cigarettes, snus, cigars, hookah and e-cigarettes. The reason why these measures were 
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aggregated into the broader umbrella of tobacco, was that the sample sizes across each 
tobacco product, except for cigarettes, were not adequate to conduct separate analyses. 
Perhaps future studies, with larger samples of individuals who use alternative tobacco 
products and electronic nicotine delivery systems, will be able to identify genetic variants 
influencing the use of different tobacco products, or assess whether this is primarily driven 
by the availability of specific products. Although it is possible that the associations found 
within this study might not be generalizable to other genetic studies of tobacco use 
behaviors, a couple of associations not previously reported were found between tobacco 
use behaviors and markers localized within or near genes of possible biological interest. 
However, the robustness of these findings is limited, and require further investigation. 
Finally, given that sample is representative of university students, it is relatively young 
and participant’s behaviors may change with time. This means is that the estimated 
heritability, accounted for by genetic variants may change. Previous studies suggest that 
genetic factors may become more influential as participants mature, so we would expect 
the contribution of genes to increase over time, if we were to follow these individuals as 




Supplementary Table 9.6: Power Calculation Summary 





2 = 0.70 h2 = 0.60 h2 = 0.50 h2 = 0.40 h2 = 0.30 h2 = 0.20 
EVER USE 
ALL 5891 1.000 1.000 1.000 1.000 1.000 0.961 
AFR 1329 0.837 0.713 0.556 0.390 0.243 0.134 
AMR 577 0.248 0.195 0.149 0.113 0.085 0.065 
EAS 552 0.231 0.182 0.141 0.108 0.082 0.064 
EUR 2980 1.000 1.000 0.997 0.965 0.807 0.470 
SAS 453 0.171 0.138 0.111 0.088 0.071 0.060 
AGE OF 
INITIATION 
ALL 4367 1.000 1.000 1.000 1.000 0.986 0.789 
AFR 897 0.510 0.398 0.294 0.206 0.136 0.088 
AMR 487 0.190 0.152 0.120 0.095 0.075 0.061 
EAS 460 0.175 0.141 0.113 0.090 0.072 0.060 
EUR 2523 1.000 0.998 0.979 0.891 0.668 0.358 
CURRENT USE 
ALL 3468 1.000 1.000 1.000 0.992 0.908 0.592 
AFR 884 0.358 0.389 0.287 0.358 0.134 0.087 
AMR 412 0.149 0.122 0.100 0.082 0.068 0.058 
EUR 2172 0.998 0.985 0.930 0.785 0.540 0.279 
REGULAR USE 
ALL 5891 1.000 1.000 1.000 1.000 1.000 0.961 
AFR 1329 0.837 0.713 0.556 0.390 0.243 0.134 
AMR 577 0.248 0.195 0.149 0.113 0.085 0.065 
EAS 552 0.231 0.182 0.141 0.108 0.082 0.064 
EUR 2980 1.000 1.000 0.997 0.965 0.807 0.470 




ALL 3473 1.000 1.000 1.000 0.993 0.909 0.594 
AFR 886 0.501 0.390 0.288 0.202 0.134 0.087 
AMR 412 0.149 0.122 0.100 0.082 0.068 0.058 
EUR 2175 0.998 0.985 0.930 0.786 0.541 0.280 
CPD 
ALL 1709 0.966 0.990 0.771 0.580 0.368 0.191 
AFR 402 0.145 0.119 0.097 0.080 0.067 0.057 
EUR 1307 0.825 0.698 0.543 0.380 0.236 0.131 
TFT 
ALL 1990 0.993 0.965 0.882 0.711 0.471 0.242 
AFR 471 0.181 0.145 0.116 0.092 0.073 0.060 
EUR 1519 0.920 0.822 0.671 0.485 0.302 0.161 
FTND 
ALL 2443 1.000 0.996 0.972 0.871 0.640 0.339 
AFR 670 0.317 0.246 0.185 0.136 0.097 0.071 
EUR 1773 0.975 0.920 0.801 0.611 0.391 0.202 
 Boldface indicates power ≥80%
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Supplementary Table 9.7a: SNPs Contributing to Current Use, Following FDR Correction  
CHR = chromosome; A1 = allele 1; A2 = allele 2; INFO = imputation quality; MAF – minor allele frequency; HWE = Hardy Weinberg Equilibrium; P = p-value; Q_1k = q-value 
 
Supplementary Table 9.7b: Genomic Bins for SNPs Contributing to Current Use, Following FDR Correction 
CHR START BP END BP NSNP P-VALUE Q-VALUE N WITHIN GENES NEARBY GENES (75KB) 
16 542536 542536 1 5.48E-09 0.054365312 2172 RAB11FIP3 C16orf11, LINC00235,MIR3176,MIR5587,NHLRC4,PIGQ,RAB11FIP3,SOLH 
4 27350593 27350679 2 4.41E-08 0.146066436 3468 None None 
4 27368605 27373502 2 7.48E-08 0.185710913 3468 None None 
CHR = chromosome; Start BP = starting base pair; End BP = ending base pair; NSNP = number of SNPs within genomic bin 
 
Supplementary Table 9.8a: SNPs Contributing to Cigarettes Per Day, Following FDR Correction  
   AFRICAN ANCESTRY EUROPEAN ANCESTRY        
SNP CHR BP INFO MAF HWE P INFO MAF HWE P A1 A2 Weight Zscore P Direction q_1k 
rs9653371 2 230003866 0.840 0.142 0.838 7.58E-01 0.506 0.016 1.000 2.00E-22 a c 1709 -8.669 4.36E-18 -- 3.0E-11 
rs34731037 13 98575958 0.537 0.056 1.000 1.85E-27 0.668 0.070 0.516 1.68E-02 t c 1709 7.357 1.89E-13 ++ 6.4E-07 
rs71427733 2 205109090 0.957 0.058 1.000 4.64E-05 0.962 0.061 0.620 1.39E-05 t c 1709 5.776 7.67E-09 ++ 1.1E-02 
rs75714873 2 205109081 0.957 0.058 1.000 4.64E-05 0.962 0.061 0.620 1.39E-05 a g 1709 -5.775 7.68E-09 -- 1.1E-02 
rs41319146 2 205108675 0.953 0.058 1.000 4.69E-05 0.964 0.060 0.620 1.43E-05 t c 1709 -5.768 8.01E-09 -- 1.1E-02 
rs371955890 9 68695692 0.502 0.050 0.613 6.37E-37 0.601 0.113 0.266 5.18E-01 c g 1709 -5.592 2.25E-08 -+ 2.5E-02 
SNP CHR A1 A2 AFRICAN ANCESTRY AMERICAN ANCESTRY EUROPEAN ANCESTRY WEIGHT ZSCORE P DIRECTION Q_1K 
INFO MAF HWE P INFO MAF HWE P INFO MAF HWE P 
rs148027841 16 a g 0.695 0.009 1.000 0.5754 0.795 0.014 1.000 0.852 0.746 0.024 1.000 0.000 2172 5.832 5.48E-09* ??+ 0.054 
rs73111343 4 c g 0.872 0.103 0.855 3.17E-06 0.925 0.059 0.628 0.000 0.909 0.083 0.777 0.023 3468 5.473 4.41E-08* +++ 0.146 
rs73111344 4 a g 0.872 0.103 0.855 3.17E-06 0.925 0.059 0.628 0.000 0.909 0.083 0.777 0.023 3468 5.474 4.41E-08* +++ 0.146 
rs10489015 4 t c 0.887 0.100 0.849 3.68E-06 0.952 0.057 0.623 0.000 0.920 0.082 0.670 0.025 3468 5.379 7.48E-08 +++ 0.186 
rs73111362 4 a t 0.884 0.100 0.851 4.01E-06 0.950 0.057 0.623 0.000 0.917 0.082 0.667 0.032 3468 -5.290 1.22E-07 --- 0.243 
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rs12264038 10 23293025 0.865 0.185 0.505 4.80E-05 0.963 0.064 0.008 8.08E-05 t c 1709 -5.419 5.99E-08 -- 5.0E-02 
rs71427734 2 205114662 1.000 0.057 1.000 1.46E-03 1.000 0.059 1.000 1.03E-05 a g 1709 -5.401 6.61E-08 -- 5.0E-02 
rs16840927 2 205113668 0.992 0.057 1.000 1.48E-03 0.994 0.059 0.618 1.02E-05 a g 1709 -5.400 6.66E-08 -- 5.0E-02 
rs2479719 6 41913081 0.930 0.106 0.786 3.62E-02 0.949 0.016 1.000 7.90E-07 c g 1709 -5.334 9.60E-08 -- 6.2E-02 
rs185526451 2 7039120 0.907 0.081 1.000 1.76E-02 0.887 0.023 0.489 1.99E-06 t g 1709 -5.309 1.10E-07 -- 6.2E-02 
15:28703003 15 28703003 0.525 0.055 1.000 2.18E-29 0.580 0.029 1.000 8.52E-01 a g 1709 -5.295 1.19E-07 -+ 6.2E-02 
rs143847239 15 28703004 0.525 0.055 1.000 2.18E-29 0.580 0.029 1.000 8.52E-01 a c 1709 -5.295 1.19E-07 -+ 6.2E-02 
rs7562403 2 213947476 0.891 0.210 0.880 4.59E-01 0.836 0.028 1.000 2.40E-08 t c 1709 -5.239 1.62E-07 -- 7.6E-02 
rs16944923 15 91383766 0.542 0.055 1.000 1.76E-24 0.595 0.116 0.684 7.59E-01 c g 1709 -5.221 1.78E-07 -- 7.6E-02 
rs10886927 10 123132045 0.985 0.186 0.506 4.83E-02 0.988 0.383 0.725 1.32E-06 t c 1709 -5.187 2.14E-07 -- 7.6E-02 
rs10430703 10 123132206 0.981 0.186 0.506 4.88E-02 0.982 0.383 0.682 1.43E-06 t c 1709 -5.172 2.32E-07 -- 7.6E-02 
rs11199933 10 123130356 0.999 0.189 0.623 4.51E-02 0.999 0.387 0.726 1.80E-06 c g 1709 5.147 2.64E-07 ++ 7.6E-02 
rs1896402 10 123130715 0.999 0.189 0.623 4.51E-02 0.999 0.387 0.726 1.80E-06 t c 1709 -5.147 2.65E-07 -- 7.6E-02 
rs12220114 10 123130495 1.000 0.189 0.517 4.50E-02 1.000 0.387 0.727 1.81E-06 a g 1709 -5.147 2.65E-07 -- 7.6E-02 
rs55823562 10 123130834 0.999 0.189 0.623 4.51E-02 0.998 0.387 0.726 1.81E-06 caata c 1709 5.146 2.66E-07 ++ 7.6E-02 
rs35059288 10 123131428 0.998 0.189 0.517 4.52E-02 0.998 0.387 0.726 1.81E-06 t ta 1709 -5.146 2.67E-07 -- 7.6E-02 
rs10886926 10 123131594 0.996 0.189 0.623 4.52E-02 0.998 0.387 0.683 1.83E-06 t c 1709 -5.144 2.69E-07 -- 7.6E-02 
rs10886925 10 123131571 0.996 0.189 0.623 4.52E-02 0.998 0.387 0.683 1.83E-06 a g 1709 5.144 2.70E-07 ++ 7.6E-02 
rs13128868 4 31329383 0.827 0.188 0.411 1.59E-04 0.937 0.392 0.072 1.72E-04 t g 1709 5.117 3.10E-07 ++ 8.4E-02 
rs10186370 2 1716434 0.935 0.256 0.357 3.47E-02 0.985 0.027 0.062 3.25E-06 a g 1709 5.094 3.50E-07 ++ 9.1E-02 
rs10713378 3 141829796 0.830 0.051 1.000 2.20E-03 0.954 0.151 0.161 4.70E-05 g ga 1709 5.044 4.56E-07 ++ 1.1E-01 
rs10430704 10 123132309 0.958 0.173 0.479 8.55E-02 0.972 0.378 0.480 2.48E-06 a g 1709 4.952 7.33E-07 ++ 1.8E-01 
rs113116955 6 41914195 0.949 0.060 0.145 6.62E-02 0.948 0.016 1.000 3.70E-06 t c 1709 -4.938 7.90E-07 -- 1.8E-01 
rs5809760 14 76944781 0.820 0.304 0.639 3.52E-03 0.935 0.397 0.386 6.50E-05 ctt c 1709 4.908 9.20E-07 ++ 2.1E-01 
rs867188 19 51631165 1.000 0.114 0.456 2.06E-02 1.000 0.303 0.294 1.59E-05 a c 1709 -4.898 9.69E-07 -- 2.1E-01 






Supplementary Table 9.8b: Genomic Bins SNPs Contributing to Cigarettes Per Day, Following FDR Correction  
CHR STARTBP ENDBP NSNP P-VALUE Q-VALUE N WITHIN GENES NEARBY GENES (75KB) 
2 230003866 230003866 1 4.36E-18 2.96E-11 1709 PID1 None 
13 98575958 98575958 1 1.89E-13 6.40E-07 1709 None IPO5 
2 205108675 205114662 5 7.67E-09 0.010864774 1709 None None 
9 68695692 68695692 1 2.25E-08 0.025414477 1709 None AK096159,LOC100132352 
10 23290952 23293025 2 5.99E-08 0.050233272 1709 ARMC3 None 
6 41913081 41914195 2 9.60E-08 0.062015813 1709 CCND3 BYSL, CCND3, MED20, USP49 
2 7039120 7039120 1 1.10E-07 0.062015813 1709 None CMPK2, RNF144A, RNF144A-AS1, RSAD2 
15 28703003 28703004 2 1.19E-07 0.062015813 1709 None DQ578199, DQ578700, DQ588687, DQ599733, GOLGA8F, GOLGA8G, JB175342, MIR4509-1 
2 213947476 213947476 1 1.62E-07 0.076203844 1709 IKZF2 None 
15 91383766 91383766 1 1.78E-07 0.076203844 1709 None BLM, FES, FURIN, MAN2A2 
10 123130356 123132309 10 2.14E-07 0.076203844 1709 None None 
4 31329383 31329383 1 3.10E-07 0.084203692 1709 None None 
2 1716434 1716434 1 3.50E-07 0.091274956 1709 PXDN None 
3 141829796 141829796 1 4.56E-07 0.114536686 1709 TFDP2 GK5, TFDP2 
14 76944781 76944781 1 9.20E-07 0.208066183 1709 ESRRB None 
19 51631165 51631165 1 9.69E-07 0.212190467 1709 SIGLEC9 BC045766, CTU1, KLK13, KLK14, SIGLEC17P, SIGLEC7, SIGLEC9 
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CHAPTER 10:  
POLYGENIC RISK SCORES FOR TOBACCO USE BEHAVIORS: ARE THEY 
PREDICTIVE WITHIN A UNIVERSITY SAMPLE? 
 
Elizabeth K. Do, Jeanne E. Savage, Roseann E. Peterson, Bradley T. Webb, Danielle 
M. Dick, Kenneth S. Kendler, Hermine H. Maes 
 
BACKGROUND 
Previously conducted genome wide association studies identified several regions and 
candidate genes related to smoking behavior1–3. Recently, three large consortia (Oxford-
GlaxoSmithKline, Tobacco and Genetics Consortium, and ENGAGE consortium) 
combined their summary statistics into a single meta-analysis for: smoking initiation, 
quantity, and cessation. This  effort yielded a genome-wide significant association 
between the number of cigarettes per day and a cluster of nicotinic acetylcholine receptor 
genes on chromosome 154–6. Additional genes contributing to tobacco use behaviors 
have been identified, such as the neuronal nicotinic acetylcholine receptor subunit beta-
3 (CHRNB3) and alpha-6 (CHRNA6)7, cytochrome P450, family 2, subfamily A, 
polypeptide 6 (CYP2A6)6,7, and LOC100188945. Each of these genes, which include 
genetic variants that contribute individually small effects, account for a very small 
proportion of the variance within smoking quantity (<2%). 
Polygenic risk scores (PRS) are used8 to summarize the genetic effects among a group 
of genetic variants that do not individually achieve genome-wide significance (p-value ≤ 
5 x 10-8) in large-scale genome wide association studies (GWAS). The effects of single 
nucleotide polymorphisms, or SNPs, are pooled together to represent a measured set of 
variants underlying a trait from GWAS summary statistics9. Traditionally, this is done by 
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abstracting the GWAS results from an initial discovery sample, ranking markers by their 
evidence of association (e.g. p-value), and then analyzing an independent target sample 
by constructing a PRS from the weighted sum of associated alleles using weights from 
the discovery sample within each subject. An association analysis is then conducted 
between a given trait and the constructed PRS. Where there is a statistically significant 
association (p-value ≤ 0.05)  between the PRS and a given trait, the genetic effects found 
within the discovery sample are thought to contribute to the trait within the target sample8. 
Since the development of this method in 2009, which was first successfully implemented 
in a GWAS of schizophrenia10, many other approaches have been developed to account 
for linkage disequilibrium11 and improve resolution and determine the best-fit PRS12. 
PRS have the potential to be useful in increasing understanding and drawing inferences 
about genetic architectures both within and across many complex traits11. Though, within 
existing studies of complex traits, the variance explained by PRS seldom exceeds 2-3%. 
Additionally, while some studies report positive findings, others have been unable to find 
evidence for common genetic risk variation contributing to selected traits. Since the 
accuracy of the prediction score increases with the size of the discovery sample9, it is 
possible that either: previously conducted studies finding null results did not have an 
adequate sample size within the discovery sample, there is a lack of genetic contribution 
to the phenotype of interest, or the genetic structure of the discovery and target samples 
are different11. This is an important point given the current lack of gene identification 
studies in populations of diverse ancestry, genetic architecture of tobacco use behaviors 
not being well described within ancestral groups outside of European ancestry, and 
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evidence that genetic determinants have important implications for addiction within many 
populations across the globe13. 
Despite the large epidemiological literature focused on social determinants of tobacco 
use and growing literature on the genetic epidemiology of tobacco use behaviors 
demonstrating the role that genes and the environment play in the development of 
tobacco-related phenotypes, few studies have examined how genetic variants interact 
with aspects of the environment to produce tobacco use behaviors. As described in a 
recent narrative review of the literature on genes, the environment, and their interaction 
on cigarette use, twin and family studies demonstrate that as individuals move from 
initiation to more established patterns of use, the importance of environmental factors 
decreases while the influence of genes increase. As this occurs, environmental factors 
begin to moderate the influence of genetic susceptibilities, implying gene-environment 
interaction. To date, these studies have included gene-environment interaction between 
either aggregate or individual genetic variants and their interaction with: religiosity, 
parental environment, traumatic events, and neighborhood factors14.  
To build upon this existing literature, we investigate two other aspects of parenting – 
autonomy granting and involvement – and the experience of stressful life events prior to 
university enrollment. In addition to being available for analyses in the current study, the 
parental environment and experience of stressful life events seem to be salient factors 
contributing to the progression and trajectory of tobacco use behaviors in young 
adulthood. Additionally, these analyses expand upon those conducted in previous 
chapters of this dissertation; namely, chapter 5 which describes a twin study of the 
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association between the experience of stressful life events and smoking initiation, and 
chapter 6 which investigates the prevalence and correlates of tobacco use behaviors.  
To summarize, the current study seeks to: (1) generate polygenic risk scores from 
summary statistics from the TAG Consortium, (2) determine whether these polygenic risk 
scores are predictive of tobacco use behaviors within a college-aged sample, and (3) 
assess gene-by-environment interactions between polygenic risk scores, parental 
environment, and stressful life events prior to university enrollment, across individuals of 
European and African ancestry. We hypothesize that the polygenic risk scores will be 
predictive of tobacco use behaviors, and that associations will be higher among those in 
the European ancestry group, relative to the African ancestry group. 
METHODS 
Discovery Sample. Data from the Tobacco and Genetics (TAG) Consortium GWAS 
meta-analyses for smoking behavior, using genotype and smoking data from existing 
GWAS of other traits, was used as the discovery sample. This sample is comprised of 
74,035 individuals from sixteen different studies conducted in the United States and 
Europe. Associations between approximately 2.5 million imputed markers and four 
smoking phenotypes were tested: ever versus never regular smokers, age at onset of 
smoking, cigarettes per day, and smoking cessation. For the purposes for the current 
analyses, one dimension of smoking behavior was included: ever versus never regular 
smokers. For ever versus never regular smokers, regular smokers were defined as those 
who reported having smoked ≥100 cigarettes during their lifetime and never regular 
smokers were defined as those who reported having smoked between 0 and 99 cigarettes 
during their lifetime (n=69,409). Each study conducted uniform cross-sectional analyses 
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using an additive genetic model for each tobacco use phenotype. Linear regression was 
used for quantitative traits, while logistic regression was used for dichotomous traits. 
Although original analyses were run separately for males and females, the TAG 
Consortium did not detect significant interactions by sex and data was analyzed together. 
Age was not included as a covariate in analyses conducted by the TAG Consortium, 
though case-control studies included case/control status as a covariate. 
Target Sample. The target sample consisted of participants from Spit for Science, a 
longitudinal study of college students enrolled in a large, public, urban university in the 
Mid-Atlantic region, as described in previous studies15. This study collects population-
based longitudinal data across five waves of survey data that were collected from 2011 
to 2016. The phenotypes of interest within the target sample are as follows: 
1. Ever Tobacco Use: lifetime measure of using any tobacco product 
2. Age of Initiation: time at which tobacco product use started 
3. Current Use: recent use measure of tobacco use within the past 30 days 
4. Regular Use: endorses smoking at least 100 cigarettes in a lifetime 
5. Cigarettes Per Day: maximum number of cigarettes smoked per day 
6. Time to First Tobacco Use after Waking: amount of time taken between waking 
and using tobacco 
7. Fagerström Test for Nicotine Dependence: standard measure of physical 
dependence on nicotine 
Details regarding genotyping, pre-imputation quality control, imputation, population 
stratification, within ancestry group principal components analyses, and the inclusion of 
covariates can be found in the previous chapter (Chapter 9).  
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Polygenic risk scores. For the present study, polygenic risk scores for tobacco use 
behaviors were identified based on the large meta-analysis of the Tobacco and Genetics 
(TAG) Consortium. The risk alleles from the TAG Consortium measure of “ever vs. never 
regular use” were used as the discovery sample, to calculate polygenic risk scores in the 
Spit for Science sample. PRS were calculated using the methodology described by 
Purcell et al. (2009)10. 
This approach generates scores for individuals based on an allelic scoring system 
involving single nucleotide polymorphisms. The steps involved include performing quality 
control on both samples, filtering on call rate of ≥ 0.9, MAF > 0.01, and the removal of 
strand ambiguous SNPs (which occurs when you are unable to differentiate forward vs. 
backward strands, without information on allele frequency) and mismatched alleles. Prior 
to conducting quality control steps, 17,461,305 SNPs were contained within Spit for 
Science and 2,455,593 SNPs within the TAG Consortium data. Following quality control 
filtering and the removal of ambiguous SNPs, there were 7,653,789 and 2,455,593 SNPs 
retained in S4S and TAG, respectively. Across both samples, there were 1,802,970 
common SNPs, after removing 1,924 mismatched SNPs. Then, LD clumping was 
performed on the remaining list of common SNPs, within the European and African 
ancestry groups. The --clump command considers LD when there are multiple significant 
association p-values within the same region. When performed, clumps are formed around 
central ‘index variants’ which must have p-values no larger than 0.0001 by default. For 
these analyses, the r2 threshold was set to 0.1, the clump kb radius was set to 1000. 
Within the European ancestry group, 9,248 clumps were formed from 81,525 index 
variants and within the African ancestry group, 11,165 clumps were formed from 81,525 
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index variants. After pruning, 9,142 and 11,107 common variants were retained for the 
European and African ancestry groups.  Scores were then created using the --score 
procedure with multiple p-value thresholds, and standardized to have a mean of zero and 
a standard deviation of one.  
Statistical Analyses. Data analysis processes included: calculation of LD statistics, 
matching independent SNPs from the discovery and target samples, and calculation of 
ever regular use-based polygenic risks cores to conduct association analyses and predict 
tobacco use behaviors. Associations between each threshold were tested using 
regression analyses in R, adjusted by sex, age, and significant within ancestry group 
principal components from GWAS analyses conducted in the previous chapter. Where 
polygenic risk scores were predictive of tobacco use behaviors, regression analyses 
including the main effects of the PRS and the environment (e.g. parental involvement, 
parental autonomy granting, experience of stressful life events) and an interaction (e.g. 
PRS x environment), were tested to determine potential gene-by-environment 
interactions, using a significance threshold of p-value ≤ 0.05. 
RESULTS 
Table 9.1 (previous chapter) depicts the distribution of tobacco use variables for the S4S 
target sample, which only included individuals who provided genetic data passing quality 
control (n = 5,950). Information regarding the summary of environmental measures in 
S4S is shown in Table 10.1 on the next page. The information provided in this table is 




Table 10.1: Summary of Environmental Measures in S4S 
 EUR AFR 
Environmental Measures N / Total % N / Total % 
Any Stressful Life Event 372 / 500 74.4 86 / 303 28.3 
Accident  223 / 499 46.7 120 / 302 39.7 
Physical Assault  125 / 500 25.0 65 / 301 21.6 
Sexual Assault  36 / 498 7.2 18 / 299 6.0 
Other Sexual Assault  89 / 496 17.9 41 / 298 13.8 
Natural Disaster 281 / 500 56.2 170 / 302 56.3 
  Mean Range Mean Range 
Parental Autonomy Granting (unstandardized) 6.49 1-12 6.62 1-12 
Parental Involvement (unstandardized) 9.83 1-12 9.47 1-12 
 
Polygenic risk scores (PRS) reflect a combined effect of selected SNPs, based upon five 
different p-value thresholds (p-values = 5x10-8, 5x10-6, 5x10-4, 5x10-2, and 5x102). These 
selected SNPs were used to define large sets of risk alleles in the discovery sample, 
which were then used to generate a PRS for individuals in the independent target sample, 
as shown in Table 10.2. Within this table, we have indicated the total number of SNPs 
from the discovery (TAG Consortium) and target (S4S) samples, as well as the total 
number of common SNPs found across TAG and S4S, for the African (AFR) and 
European (EUR) ancestry groups found in S4S. For each of the p-value thresholds shown 
below, we also show the number of SNPs contributing to the estimated PRS. Generally, 








Table 10.2: P-value Thresholds and Number of SNPs 
 
 
Prior to running regression analyses, we ran correlations between each polygenic risk 
score set and the tobacco use behaviors measured in the target sample. Correlations 
between PRS and tobacco use behaviors were wide ranging for both the European 
ancestry group and for the African ancestry group, as shown in Table 10.3. Within the 
European ancestry group, negative correlations were found between each PRS with: ever 
tobacco use (range: -0.0224 to -0.0451) and age of initiation (range: -0.0255 to -0.0016). 
Alternatively, positive correlations were found between each PRS with: ever tobacco use 
(range: 0.0350 to 0.1014), age of initiation (range: 0.0397 to 0.0881), regular use (range: 
0.0238 to 0.0685), and cigarettes per day (range: 0.1235 to 0.1494) within the African 
ancestry group. Where correlations are negative, it is suggested that polygenic risk scores 
are associated with lower levels of a given tobacco use behavior phenotype (e.g. 
polygenic risk scores were associated with never using tobacco products in a lifetime and 
older age of initiation within those of European ancestry). Meanwhile, positive correlations 
indicate that polygenic risk scores are associated with higher levels of tobacco use 
behavior phenotypes (e.g. polygenic risk scores were associated with having used 
tobacco products in a lifetime, younger age of initiation, having smoked 100 cigarettes in 
a lifetime, and the use of more cigarettes per day within those of African ancestry).  
 n SNPs Ever Use  
All SNPs TAG  2,457,119 
All SNPs S4S 17,461,305 
 AFR EUR 
Total Common SNPS: TAG and S4S 235,306 130,353 
P-value threshold = 5x102 66,282 120,080 
P-value threshold = 5x10-2 7,212 13,051 
P-value threshold = 5x10-4 105 194 
P-value threshold = 5x10-6 37 9 
P-value threshold = 5x10-8 28 6 
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Table 10.3: Correlations between PLINK-based Polygenic Risk Scores and Tobacco Use  
EUROPEAN ANCESTRY GROUP: TAG EVER VS. NEVER REGULAR USE PRS 
P-value 
Threshold EU AO CU RU RUS CPD TFT FTND 
5x102 -0.0451 -0.0016 0.0343 0.0111 0.0241 -0.0698 0.0167 0.0072 
5x10-2 -0.0224 -0.0023 0.0331 -0.0095 0.0042 -0.0159 0.0289 0.0188 
5x10-4 -0.0528 -0.0255 -0.0112 -0.0265 -0.0037 0.0219 0.0444 0.0192 
5x10-6 -0.0374 -0.0102 -0.0133 -0.0224 -0.0154 0.0241 0.0607 0.0308 
5x10-8 -0.0388 -0.0141 -0.0227 -0.0247 -0.0188 0.0299 0.0677 0.0395 
AFRICAN ANCESTRY GROUP: TAG EVER VS. NEVER REGULAR USE PRS 
P-value 
Threshold EU AO CU RU RUS CPD TFT FTND 
5x102 0.1014 0.0881 0.0211 0.0685 -0.0111 0.1235 -0.0142 -0.0727 
5x10-2 0.0350 0.0397 -0.0145 0.0238 -0.0157 0.1327 -0.0316 -0.0453 
5x10-4 0.0464 0.0576 0.0131 0.0422 0.0229 0.1427 -0.0131 0.0031 
5x10-6 0.0408 0.0437 0.0330 0.0287 0.0215 0.1487 0.0035 -0.0001 
5x10-8 0.0420 0.0452 0.0427 0.0303 0.0270 0.1494 0.0093 0.0031 
Note: EU = ever use; AO = age of onset; CU = current use; RU = regular use; RUS = regular use among smokers; 
CPD = cigarettes per day; TFT = time to first tobacco use; FTND = Fagerström Test for Nicotine Dependence 
We used five sets of risk scores with p-value thresholds ranging from 5x10-8 to 5x102 to 
predict ever tobacco use (EU), age of initiation (AO), current use (CU), regular use (RU), 
regular use among smokers (RUS), cigarettes per day (CPD), time to first tobacco use 
after waking (TFT), and the Fagerström Test for Nicotine Dependence (FTND) using 
either logistic regression, where the outcome was binary, or linear regression, where the 
outcome of interest was continuous.  
Polygenic risks scores only significantly predicted: ever tobacco use (using the threshold 
p-value ≤ 5 x 10-4) and time to first tobacco use after waking (using the threshold p-value 
≤ 5 x 10-8) within the European ancestry group (estimates of the effects, z-value, and 
model fit statistics are shown in Supplemental Tables 10.4a-b; information also provided 
in Figure 10.1a-b). Within these models, PRS using the threshold of p-value ≤ 5 x 10-4 
accounted for 8.0% of the variance of ever tobacco use and the PRS using the threshold 
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of p-value ≤ 5 x 10-8 accounted for 8.5% of the variance of time to first tobacco use within 
the European ancestry group. 
Figure 10.1a. PRS using Ever vs. Never Regular Tobacco Use in the Tobacco and Genetics Consortium 
Predicting Tobacco Use Phenotypes in Spit for Science (AFR) 
 
Note: EU = ever use; AO = age of onset; CU = current use; RU = regular use; RUS = regular use among smokers; CPD = cigarettes 
per day; TFT = time to first tobacco use; FTND = Fagerström Test for Nicotine Dependence 
 
Figure 10.1b. PRS using Ever vs. Never Regular Tobacco Use in the Tobacco and Genetics Consortium 
Predicting Tobacco Use Phenotypes in Spit for Science (EUR) 
 
Note: EU = ever use; AO = age of onset; CU = current use; RU = regular use; RUS = regular use among smokers; CPD = cigarettes 
per day; TFT = time to first tobacco use; FTND = Fagerström Test for Nicotine Dependence 
 
Main Effects of Environment. Since PRS were only significant for ever tobacco use and 
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No PRS p=0.50 p=0.05 p=0.0005 p=0.000005 p=0.00000005
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test whether measures of the parental environment and the experience of stressful life 
events prior to university enrollment were significant in predicting those two variables 
within those of European ancestry (see Supplementary Tables 10.5a-b). Parental 
autonomy granting, parental involvement, as well as experiencing an accident, physical 
assault, or other sexual assault prior to university enrollment were predictive of ever 
tobacco use. Meanwhile, parental involvement and the experience of physical assault, 
sexual assault, or other sexual assault prior to enrollment at university predicted time to 
first tobacco use after waking. These variables were used for subsequent analyses to test 
PRS by environment interactions, using p-value thresholds that explain the most variance 
in ever tobacco use (p-value ≤ 5 x 10-4) and time to first tobacco use after waking (p-value 
≤ 5 x 10-8). Data for the main effects of the environment (and subsequent PRS x 
environment interactions) on tobacco use among the African ancestry group are not 
shown, since PRS did not significantly predict tobacco use behaviors within this sample, 
and because we were interested in testing PRS x environment interactions where main 
effects of both PRS and the environmental measures are significant. 
Interaction Effects of the Environment. Main and interaction effects of PRS and 
measures of the parental environment on ever tobacco use and time to first tobacco use 
are shown in Supplementary Tables 10.5a-b, while the main and interaction effects of 
stressful life events experienced prior to university enrollment and ever tobacco use and 
time to first tobacco use are shown in Supplemental Tables 10.6a-10.3b. Only the 
interaction between effect of polygenic risk score (p-value = 5x10-4) and environment was 
significant for the experience of physical assault, predicting ever tobacco use within the 




Tobacco use behaviors are complex traits that are highly polygenic in nature. Many 
genetic variants, each of small effect (e.g. R2 < 0.005) contributing to the development of 
each specific phenotype. Unfortunately, what this means is that it is unlikely that genome 
wide association studies will lead to straightforward results to be replicated in independent 
samples16 at current sample sizes. Results from the TAG Consortium meta-analysis 
demonstrates these difficulties, as even with large sample sizes (greater than 70,000 
individuals) no genome wide significant results were obtained for either smoking initiation 
or age at smoking initiation. Modeling the additive or cumulative effects of associated 
variants works to get around this problem and has the potential to explain a higher 
proportion of variation relative to any single genetic variant17. Thus, in efforts to 
investigate the cumulative effects of associated variants contributing to tobacco use 
behaviors within our sample, we calculated polygenic risk scores derived from the TAG 
Consortium meta-analyses of GWAS results for ever vs. never regular use and conducted 
association analyses to determine whether we could predict: ever tobacco use, age of 
initiation, current use, regular use among smokers, time to first tobacco use, cigarettes 
per day, and the Fagerström Test for Nicotine Dependence.   
The standard PRS approach requires testing over a range of p-value thresholds10, which 
are often chosen arbitrarily. Potential limitations of this approach include the possibility of 
including variants that could be false positives and raw estimates of effect sizes being 
subject to selection bias. One alternative to this approach is to consider linkage 
disequilibrium (LD) among markers, using a reference LD panel. However, potential 
limitations of the approach using LDpred includes the method’s reliance on LD information 
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from a reference panel and potential heterogeneity hindering prediction accuracy11. This 
approach might not be appropriate for the sample described here, since LDpred performs 
best with an LD reference panel of at least 1,000 individuals. Additionally, its flagship 
paper applied LDpred to GWAS summary statistics for large sample sizes ranging from 
27,000 to 86,000 individuals. Our LD reference panel, available from the TAG Consortium 
data, includes a sample of 69,409 and meets these requirements. However, it is possible 
that our power to detect effects is still limited, since our target sample included less than 
10,000 individuals – or more specifically, 3,018 of European ancestry and 1,339 of African 
ancestry for these genetic analyses. Given that our target sample size was small, the 
relatively small number of individuals may have limited power to detect effects across all 
p-value thresholds.  
LDpred might also not perform well with our sample, because of the requirement that the 
target sample needs to have LD patterns like the discovery set. The discovery sample 
from the TAG Consortium is primarily made up of older adults of European ancestry. 
Although one of the subsets of our target sample was comprised of individuals of 
European ancestry, it is possible that our sample has higher levels of admixture which 
could also result in differences in allele frequencies across the discovery and target 
samples. Additionally, our sample is younger relative to the discovery set, which is 
important if some genetic variants do not play a large role until later in life, as 
demonstrated in previously published twin studies18.  
Other potential limitations exist in the interpretation of findings from the current study and 
those employing polygenic risk score methodologies more broadly. Firstly, adequate 
sample size is necessary for score estimates within discovery populations to be precise 
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and optimal p-value thresholds used for selecting score variants, depends on the size of 
the discovery sample. Generally, the variance explained is dependent upon the sample 
size of the discovery set, such that when the sample size is large, the effects detected 
within the GWAS contains less noise, which can lead to more accurate predictions in the 
target sample19. Disparate patterns of LD and differences in marker allele frequencies 
between discovery and target samples are also thought to attenuate effects of PRS 
analyses17. Additionally, population stratification and differential patterns of LD across 
racial and ethnic groups, like those found in the current sample, may bias results within 
genetic association studies20. Since GWAS have traditionally been conducted on 
individuals of European descent, and methods for computing polygenic risk scores are 
dependent upon GWAS, risk alleles identified from these studies may be specific to the 
ancestral group or include tag SNPs not found in other populations21.  
Along those same lines, reported values of R2 might not directly reflect the degree of 
missing heritability, but could perhaps reflect the effect of sampling variation on the 
variance, as explained by estimated scores. Since the effects of individual SNPs are very 
small, they are estimated with a great deal of error. Thus, the prediction of a phenotype 
using estimated SNP effects may suffer from sampling variance with which the effect is 
estimated. Added to this, the measures of tobacco use are crude within the discovery 
sample, and the worse the estimate of the effect size of the variant in the discovery 
sample, the worse the variance will be explained by the predictor in the target/validation 
sample. Nevertheless, the TAG meta-analysis is the largest GWAS meta-analysis for 
tobacco use behavior that exists. The chances of success of polygenic risk score 
analyses are dependent upon the size of the discovery set, so if the sample size is too 
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small (which is still potentially the case with the TAG Consortium data), the risk profiles 
could be based upon random noise and are not expected to explain variance in the target 
set. 
However, what was encouraging about these analyses, was that they provided further 
evidence that different measures of tobacco use behaviors were influenced by 
overlapping genetic factors. Ever tobacco use (EUR: h2 = 0.28, p-value = 0.0133), age of 
initiation (EUR: h2 = 0.30, p-value = 0.0288), and regular use among smokers (EUR: h2 = 
0.18, p-value = 0.0041) yielded significant SNP-based heritability estimates (at least, prior 
to correction for multiple testing) using GCTA within individuals of European ancestry, as 
demonstrated in Chapter 9. PRS derived from TAG Consortium data on ever vs. never 
regular use significantly predicted both ever tobacco use and time to first tobacco use 
within individuals of European ancestry, suggesting that at least some of the SNPs 
influencing ever tobacco use were the same as those influencing the time to first tobacco 
use after waking. And as expected, the amount of variance explained by PRS were lower 
than previously reported heritability estimates from twin studies. 
Adding parental environmental variables (parental autonomy granting and parental 
involvement) and their interactions with polygenic risk scores explained more of the 
variance within the tobacco use behaviors of ever tobacco use and time to first tobacco 
use after waking within those of European ancestry, relative to including polygenic risk 
scores and covariates alone (see Supplementary Tables 10.5a and 10.5b). This suggests 
that the environments provided by parents, as well as the interaction between the parental 
environment and PRS, were significant contributors to the variance in ever tobacco use 
and time to first tobacco use within this population. Although we also could detect 
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significant main effects of stressful life events experienced prior to university enrollment 
on these two measures of tobacco use, none of the interactions between stressful life 
events and PRS were significant.  
PRS did not significantly predict any of the measures of tobacco use behaviors within 
individuals of African ancestry within this study. The lack of predictive power for the PRS 
among individuals of African ancestry might be the result of differences in patterns of LD 
between African and European-ancestry individuals, which has important implications for 
future studies that intend to use cumulative measures of risk to predict a given phenotype, 
especially when many large-scale GWAS derive their discovery datasets from individuals 
of European ancestry. Future studies may require newer methodologies that are able to 
incorporate more accurate measures of LD from the target population, particularly within 
ancestry groups that are ad-mixed16.  
These results must be interpreted in the context of certain limitations. This study does 
provide evidence for a genetic architecture of multiple common variants with small 
individual effect sizes (as evident from 6 SNPs contributing to PRS for time to first tobacco 
use after waking and 194 SNPs contributing to PRS for ever tobacco use, among 
individuals of the European ancestry group) influencing tobacco use behaviors. 
Additionally, this study explored the contribution of genetic risk across a range of tobacco 
use behaviors across both European and African ancestral groups. Using an aggregate 
measure of genetic risk by way of polygenic risk scores, we did not need to require the 
rigorous statistical test corrections that are required for genome wide association studies. 
We were also able to examine specific environmental risk factors, focused on risk prior to 
enrollment in university, and how genetic influences might change as a function of 
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environmental risk. This information is potentially useful for public health interventions, 
since it allows for the identification for potentially modifiable risk factors13. Also, polygenic 
risk scores were based on a large discovery sample – the largest meta-analyses to date 
on tobacco use behaviors – which should add to the accuracy of the polygenic risk scores. 
However, to be sure that these polygenic risk scores are accurate, more studies need to 
be conducted across a variety of different ancestral groups with larger sample sizes - 
especially since it is important to validate the predictive ability of polygenic risk scores for 
tobacco use phenotypes, while also gaining a better understanding of the genetic 
contributions to these behaviors. 
CONCLUSION 
In conclusion, we investigated the genetic architecture of tobacco use behaviors within a 
sample of young adults attending university. We constructed polygenic risk scores that 
predicted ever tobacco use and time to first tobacco use after waking, within individuals 
of European ancestry. As hypothesized, PRS did significantly predict tobacco use 
behaviors, and PRS explained more of the variance in tobacco use behaviors within 
individuals of European ancestry relative to African ancestry. However, PRS only 
predicted ever tobacco use and time to first tobacco use after waking within individuals of 
European ancestry. Limited predictive power of the PRS may be attributed to three key 
issues: differences in phenotype definitions, potential differences in marker allele 
frequencies between the discovery and target samples, and issues related to sample size 
(potentially in both the discovery and target samples) and power.  
Despite these potential limitations, significant additive interactions were observed 
between polygenic risk scores and aspects of individual environments prior to university 
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enrollment – particularly, parental autonomy granting, parental involvement, and the 
experience of an accident, physical, sexual, or other sexual assault prior to university 
enrollment. Thus, this study provides support for further study of polygenic risk scores 
and gene-environment interactions. This study also suggests that the time prior to 
university enrollment may be useful for prevention and intervention strategies. 
Specifically, the findings of this study suggest that interventions should look towards 
parental environment and the experience of stressful life events prior to university 
enrollment to diminishing genetic vulnerability to tobacco use behaviors, such as ever use 
and time to first tobacco use after waking.  
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5 x 10-2 
Estimate (z-value) 
p-value = 




5 x 10-6 
Estimate (z-value) 
p-value = 
5 x 10-8 
Estimate (z-value) 
 
PGRS   0.11 (1.71)  0.02 (0.34)  0.05 (0.84)  0.04 (0.75)  0.04 (0.75)  
Sex -0.41 (-3.24) ** -0.42 (-3.26) . -0.41 (-3.24) ** -0.41 (-3.23) ** -0.41 (-3.24) ** -0.41 (-3.24) ** 
Age 0.12 (2.55) * 0.12 (2.53) * 0.12 (2.54) * 0.12 (2.53) * 0.12 (2.53) * 0.12 (2.53) * 
PC1 7.71 (3.62) *** 5.94 (2.52) * 7.50 (3.39) ** 7.37 (3.40) ** 7.42 (3.43) ** 7.40 (3.41) ** 
PC3 -3.54 (-1.67) . -3.52 (-1.66) . -3.54 (-1.67) . -3.59 (-1.69) . -3.58 (-1.69) . . -3.58 (-1.69)  
PC8 3.06(1.48)  3.16 (1.52)  3.08 (1.49)  3.16 (1.52)  3.16 (1.53)  3.16 (1.52)  
Intercept -1.44 (-1.51)  -1.41 (-1.48)  -1.42 (-1.49)  -1.42 (-1.49)  -1.42 (-1.49)  -1.42 (-1.49)  
Nagelkerke R2 0.034  0.038  0.035  0.035  0.035  0.035  
Change in R2   0.004  0.001  0.001  0.001  0.001  
Chi-Square: 
Deviance, p 











N 1329  1329  1329  1329  1329  1329  










5 x 10-2 
Estimate (z-value) 
p-value = 




5 x 10-6 
Estimate (z-value) 
p-value = 
5 x 10-8 
Estimate (z-value) 
 
PGRS   0.03 (0.63)  0.00 (0.03)  0.02 (0.66)  0.01 (0.42)  0.02 (0.44)  
Sex -0.31 (-4.00) *** -0.31 (-4.00) *** -0.31 (-4.00) *** -0.31 (-3.99) *** -0.31 (-4.00) *** -0.31 (-4.00) *** 
Age 0.08 (2.59) ** 0.08 (2.53) * 0.08 (2.59) ** 0.08 (2.55) * 0.08 (2.57) * 0.08 (2.56) * 
PC1 4.61 (3.62) *** 4.18 (2.88) ** 4.60 (3.43) *** 4.43 (3.39) *** 4.51 (3.46) *** 4.49 (3.44) *** 
PC2 1.83 (1.44) . 1.60 (1.21)  1.83 (1.41)  1.81 (1.42)  1.83 (1.44)  1.82 (1.43)  
PC3 -1.91 (-1.47)  -1.91 (-1.47)  -1.91 (-1.47)  -1.91 (-1.48)  -1.92 (-1.48)  -1.92 (-1.48)  
Intercept -0.12 (-0.21)  -0.09 (-0.15)  -0.12 (-0.20)  -0.10 (-0.17)  -0.10 (-0.18)  -0.11 (-0.18)  
Nagelkerke R2 0.065  0.066  0.065  0.066  0.066  0.066  
Change in R2   0.001  0.000  0.001  0.001  0.001  
Chi-Square: 
Deviance, p 































5 x 10-2 
Estimate (z-value) 
p-value = 
5 x 10-4 
Estimate (z-value) 
p-value = 
5 x 10-6 
Estimate (z-value) 
p-value = 
5 x 10-8 
Estimate (z-value) 
PGRS   0.003 (0.04)  -0.01 (-0.17)  0.03 (0.39)  0.06 (0.70)  0.07 (0.84)  
Sex -0.49 (-2.79) ** -0.49 (-2.79) ** -0.49 (-2.79) ** -0.49 (-2.77) ** -0.49 (-2.77) ** -0.49 (-2.76) ** 
Age -0.30 (-4.61) *** -0.30 (-4.61) *** -0.30 (-4.61) *** -0.30 (-4.62) *** -0.30 (-4.63) *** -0.30 (-4.63) *** 
PC1 4.57 (2.93)  4.51 (1.36)  4.72 (1.53)  4.31 (1.43)  4.13 (1.38)  4.00 (1.33)  
PC2 -5.26 (-1.77) . -5.29 (-1.72) . -5.19 (-1.72) . -5.25 (-1.77) . -5.19 (-1.75) . -5.17 (-1.74) . 
PC7 -5.74 (-2.87) * -5.74 (-2.00) * -5.72 (-2.00) * -5.76 (-2.00) * -5.76 (2.01) * -5.76 (-2.01) * 
Intercept 7.38 (5.54) *** 7.38 (5.54) *** 7.38 (5.53) *** 7.38 (5.54) *** 7.41 (5.55) *** 7.42 (5.55) *** 
Nagelkerke R2 0.076  0.076  0.076  0.076  0.077  0.077  
Change in R2   0.000  0.000  0.000  0.001  0.001  
Chi-Square: 
Deviance, p 






















5 x 10-2 
Estimate (z-value) 
p-value = 
5 x 10-4 
Estimate (z-value) 
p-value = 
5 x 10-6 
Estimate (z-value) 
p-value = 
5 x 10-8 
Estimate (z-value) 
PGRS   0.02 (0.81)  0.00 (0.00)  0.01 (0.60)  0.01 (0.34)  0.01 (0.38)  
Sex -0.20 (-5.50) *** -0.20 (-5.51) *** -0.20 (-5.50) *** -0.20 (-5.50) *** -0.20 (-5.50) *** -0.20 (-5.50) *** 
Age 0.04 (3.22) ** 0.04 (3.18) ** 0.04 (3.20) ** 0.04 (3.20) ** 0.04 (3.21) ** 0.04 (3.21) ** 
PC1 2.27 (3.82) *** 2.02 (3.03) ** 2.27 (3.66) *** 2.20 (3.63) *** 2.23 (3.69) *** 2.22 (3.67) *** 
PC2 -0.38 (-0.65) . -0.51 (-0.84) . -0.38 (-0.64)  -0.39 (-0.66)  -0.38 (-0.65)  -0.38 (-0.65)  
Intercept -0.09 (-0.32)  -0.08 (0.29)  0.10 (0.18)  -0.08 (-0.30)  -0.08 (-0.31)  -0.08 (-0.31)  
Nagelkerke R2 0.048  0.049  0.048  0.049  0.048  0.048  
Change in R2   0.001  0.000  0.001  0.00  0.00  
Chi-Square: 
Deviance, p 






























5 x 10-2 
Estimate (z-value) 
p-value = 
5 x 10-4 
Estimate (z-value) 
p-value = 
5 x 10-6 
Estimate (z-value) 
p-value = 
5 x 10-8 
Estimate (z-value) 
PGRS   -0.11 (-0.82)  -0.06 (-0.50)  0.01 (0.05)  0.004 (0.04)  0.02 (0.13)  
Sex -0.81 (-3.27) ** -0.81 (-3.26) ** -0.81 (-3.26) ** -0.81 (-3.27) ** -0.81 (-3.27) ** -0.81 (-3.27) ** 
Age 0.12 (1.34)  0.12 (1.36)  0.12 (1.37)  0.12 (1.33)  0.12 (1.33)  0.12 (1.32)  
PC1 6.06 (1.50)  7.84 (1.71)  6.63 (1.58)  6.01 (1.45)  6.03 (1.45)  5.94 (1.42)  
PC2 -3.71 (-1.04)  -2.76 (-0.74)  -3.36 (-0.92)  -3.71 (-1.04)  -3.71 (-1.04)  -3.70 (-1.04)  
Intercept 0.83 (1.37) . -3.38 (-1.82) . -3.39 (-1.82) . -3.33 (-1.79) . -3.33 (-1.79) . -3.32 (-1.79) . 
Nagelkerke R2 0.046  0.047  0.047  0.046  0.046  0.046  
Change in R2   0.001  0.001  0.001  0.001  0.001  
Chi-Square: 
Deviance, p 











N 744  744  744  744  744  744  








5 x 10-2 
Estimate (z-value) 
p-value = 
5 x 10-4 
Estimate (z-value) 
p-value = 
5 x 10-6 
Estimate (z-value) 
p-value = 
5 x 10-8 
Estimate (z-value) 
PGRS    0.02 (0.81)  0.04 (1.55)  0.03 (1.37)  0.03 (1.27)  0.03 (1.23)  
Sex -0.14 (-2.70) ** -0.14 (-2.73) ** -0.15 (-2.78) ** -0.14 (-2.71) ** -0.14 (-2.73) ** -0.14 (-2.73) ** 
Age 0.00 (0.01)  -0.00 (-0.02)  -0.001 (-0.09)  -0.00 (-0.03)  -0.00 (-0.04)  -0.00 (0.03)  
PC1 1.64 (2.05) * 1.27 (1.37)  1.26 (1.51)  1.35 (1.64)  1.39 (1.69) . 1.38 (1.66) * 
PC2 -1.87 (-2.29) .* -1.87 (-2.29) .* -2.06 (-2.49) .* -1.87 (-2.29) .* -1.84 (-2.25) .* -1.84 (-2.25) .* 
PC7 -2.20 (-2.48) * -2.03 (-2.41) * -2.30 (-2.59) * -2.28 (-2.57) * -2.26 (-2.55) * -2.26 (-2.54) * 
Intercept 1.38 (3.58) *** -2.24 (-2.52) *** 1.42 (3.68) *** 1.38 (3.61) *** 1.39 (3.63) *** 1.39 (3.62) *** 
Nagelkerke R2 0.065  0.067  0.071  0.070  0.070  0.069  
Change in R2   0.001  0.005  0.004  0.004  0.003  
Chi-Square: 
Deviance, p 











N 369  369  369  369  369  369  
203 
 








5 x 10-2 
Estimate (z-value) 
p-value = 
5 x 10-4 
Estimate (z-value) 
p-value = 
5 x 10-6 
Estimate (z-value) 
p-value = 
5 x 10-8 
Estimate (z-value) 
PGRS    -0.01 (-0.24)  -0.004 (-0.12)  -0.004 (-0.13)  -0.002 (-0.07)  -0.0002 (-0.01)  
Sex -0.29 (-3.72) *** -0.29 (-3.69) *** -0.29 (-3.70) *** -0.29 (-3.71) *** -0.29 (-3.71) *** -0.29 (-3.71) ** 
Age -0.00 (-0.01)  -0.00 (-0.00)  -0.00 (-0.01)  -0.00 (-0.01)  -0.00 (-0.01)  -0.00 (-0.01) *** 
PC1 0.68 (0.56)  0.85 (0.61)  0.73 (0.57)  0.72 (0.58)  0.70 (0.56)  0.68 (0.54)  
PC2 -2.53 (-2.18) * -2.46 (-2.03) * -2.51 (-2.12) * -2.54 (-2.18) * -2.54 (-2.18) * -2.54 (-2.17) . 
PC3 2.24 (1.69) . 2.26 (1.70) . 2.25 (1.70) . 2.24 (1.70) . 2.25 (1.69) . 2.24 (1.69) * 
PC5 -2.07 (-1.47)  -2.05 (-1.46)  -2.05 (-1.45)  -2.05 (-1.45)  -2.06 (-1.46)  -2.07 (-1.46)  
PC7 -2.54 (-1.93) . -2.52 (-1.91) . -2.53 (-1.92) . -2.53 (-1.92) . -2.54 (-1.93) . -2.54 (-1.93)  
Intercept 0.83 (1.37)  0.82 (1.35)  0.82 (1.35)  0.83 (1.36)  0.83 (1.37)  0.83 (1.36)  
Nagelkerke R2 0.083  0.083  0.083  0.083  0.083  0.083  
Change in R2   0.000  0.000  0.000  0.000  0.000  
Chi-Square: 
Deviance, p 
   












N 427  427  427  427  427  742  








5 x 10-2 
Estimate (z-value) 
p-value = 
5 x 10-4 
Estimate (z-value) 
p-value = 
5 x 10-6 
Estimate (z-value) 
p-value = 
5 x 10-8 
Estimate (z-value) 
PGRS   -0.10 (-1.02)  -0.03 (-0.33)  0.0008 (0.01)  -0.01 (-0.10)  -0.005 (-0.06)  
Sex 0.004 (0.02)  0.01 (0.07)  0.01 (0.04)  0.004 (0.02)  0.005 (0.03)  0.005 (0.02)  
Age 0.19 (2.71) ** 0.19 (2.70) ** 0.19 (2.71) ** 0.19 (2.70) ** 0.19 (2.71) ** 0.19 (2.71) ** 
PC1 0.40 (0.13)  2.02 (0.58)  0.70 (0.22)  0.39 (0.12)  0.47 (0.15)  0.44 (0.14)  
PC2 -6.78 (-2.24) .* -5.93 (-1.89) . -6.59 (-2.15) .* -6.78 (-2.24) .* -6.78 (-2.24) .* -6.78 (-2.24) .* 
PC3 5.17 (1.63)  5.29 (1.67) . 5.23 (1.65)  5.17 (1.63)  5.19 (1.63)  5.19 (1.63)  
PC7 -4.80 (-1.51)  -4.64 (-1.45)  -4.76 (-1.49)  -4.81 (-1.50)  -4.79 (-1.50)  -4.80 (-1.50)  
Intercept -2.67 (-1.81) . -2.66 (-1.81)  -2.68 (-1.82) . -2.67 (-1.81) . -2.67 (-1.81) . -2.67 (-1.81) . 
Nagelkerke R2 0.149  0.156  0.150  0.149  0.149  0.149  
Change in R2   0.007  0.001  0.000  0.000  0.000  
Chi-Square: 
Deviance, p 











N 527  527  527  527  527  527  
204 
 













5 x 10-2 
Estimate (z-value) 
p-value = 
5 x 10-4 
Estimate (z-value) 
p-value = 
5 x 10-6 
Estimate (z-value) 
p-value = 
5 x 10-8 
Estimate (z-value) 
PGRS   0.0002 (0.01)  -0.04 (-0.91)  -0.09 (-2.31) * -0.07 (-1.70) . -0.06 (-1.60)  
Sex -0.47 (-5.71) *** -0.47 (-5.71) *** -0.47 (-5.71) *** -0.47 (-5.70) *** -0.47 (-5.71) *** -0.47 (-5.70) *** 
Age 0.12 (3.50) *** 0.12 (3.50) *** 0.12 (3.49) *** 0.12 (3.59) *** 0.12 (3.54) *** 0.12 (3.54) *** 
PC1 -0.94 (-0.42)  -0.94 (-0.41)  -0.64 (-0.28)  -0.71 (-0.32)  -0.90 (-0.40)  -0.86 (-0.39)  
PC2 -2.17 (-0.97)  -2.17 (-0.97)  -2.14 (-0.95)  -2.00 (-0.89)  -2.06 (-0.92)  -2.06 (-0.92)  
PC5 -4.57 (-2.01) * -4.58 (-2.01) * -4.58 (-2.01) * -4.45 (-1.94) * -4.48 (-1.96) * -4.48 (-1.96) * 
Intercept -0.77 (-1.14)  -0.77 (-1.14)  -0.77 (-1.13)  -0.84 (-1.23)  -0.80 (-1.18)  -0.80 (-1.18)  
Nagelkerke R2 0.023  0.023  0.024  0.025  0.025  0.025  
Change in R2   0.000  0.001  0.002  0.002  0.002  
Chi-Square: 
Deviance, p 















N 2980  2980  2980  2980  2980  2980  










5 x 10-2 
Estimate (z-value) 
p-value = 
5 x 10-4 
Estimate (z-value) 
p-value = 
5 x 10-6 
Estimate (z-value) 
p-value = 
5 x 10-8 
Estimate (z-value) 
PGRS   0.002 (0.08)  -0.002 (-0.08)  -0.02 (-1.22)  -0.01 (-0.51)  -0.01 (-0.61)  
Sex -0.24 (-5.14) *** -0.24 (-5.14) *** -0.24 (-5.14) *** -0.24 (-5.12) *** -0.24 (-5.13) *** -0.24 (-5.13) *** 
Age 0.06 (3.47) *** 0.06 (3.47) *** 0.06 (3.47) *** 0.07 (3.51) *** 0.06 (3.48) *** 0.06 (3.48) *** 
PC1 0.78 (0.60)  0.75 (0.56)  0.79 (0.61)  0.84 (0.65)  0.78 (0.61)  0.79 (0.61)  
PC2 -2.13 (-1.68) . -2.13 (-1.69) . -2.13 (-1.68) . -2.07 (-1.64) . -2.11 (-1.67) . -2.10 (-1.66) . 
PC5 -2.07 (-1.63)  -2.07 (-1.63)  -2.07 (-1.63)  -2.01 (-1.58)  -2.05 (-1.60)  -2.04 (-1.61)  
Intercept 0.47 (1.26)  0.47 (1.26)  0.47 (1.26)  0.45 (1.20)  0.47 (1.24)  0.46 (1.24)  
Nagelkerke R2 0.029  0.029  0.029  0.030  0.029  0.029  
Change in R2   0.000  0.000  0.001  0.000  0.000  
Chi-Square: 
Deviance, p 































5 x 10-2 
Estimate (z-value) 
p-value = 
5 x 10-4 
Estimate (z-value) 
p-value = 
5 x 10-6 
Estimate (z-value) 
p-value = 
5 x 10-8 
Estimate (z-value) 
PGRS   0.06 (1.24)  0.04 (0.81)  -0.02 (-0.35)  -0.03 (-0.60)  -0.04 (-0.83)  
Sex -0.54 (-5.46) *** -0.54 (-5.44) *** -0.54 (-5.43) *** -0.54 (-5.46) *** -0.54 (-5.46) *** -0.54 (-5.46) *** 
Age -0.30 (-7.51) *** -0.29 (-7.45) *** -0.29 (-7.47) *** -0.29 (-7.50) *** -0.29 (-7.50) *** -0.29 (-7.50) *** 
PC1 -6.17 (-2.18) * -7.08 (-2.42) * -6.52 (-2.28) * -6.12 (-2.16) * -6.15 (-2.17) * -6.10 (-2.16) * 
PC2 -1.21(-0.45)  -1.32 (-0.48)  -1.29 (-0.47)  -1.19 (-0.44)  -1.17 (-0.43)  -1.14 (-0.42)  
PC6 5.18 (1.88) . 4.99 (1.80) . 5.06 (1.82) . 5.21 (1.89) . 5.21 (1.88) . 5.23 (1.89) . 
Intercept 7.45 (9.31) *** 7.41 (9.24) *** 7.43 (9.26) *** 7.45 (9.30) *** 7.45 (9.30) *** 7.45 (9.30) *** 
Nagelkerke R2 0.070  0.071  0.070  0.070  0.070  0.070  
Change in R2   0.001  0.000  0.000   0.000  0.000  
Chi-Square: 
Deviance, p 






















5 x 10-2 
Estimate (z-value) 
p-value = 
5 x 10-4 
Estimate (z-value) 
p-value = 
5 x 10-6 
Estimate (z-value) 
p-value = 
5 x 10-8 
Estimate (z-value) 
PGRS   0.003 (0.21)  -0.01 (-0.75)  -0.02 (-1.72)  -0.02 (-1.43)  -0.02 (-1.46)  
Sex -0.17 (-6.05) *** -0.17 (-6.05) *** -0.17 (-6.05) *** -0.17 (-6.04) *** -0.17 (-6.04) *** -0.17 (-6.04) *** 
Age 0.08 (6.76) *** 0.08 (6.76) *** 0.08 (6.76) *** 0.08 (6.82) *** 0.08 (6.80) *** 0.08 (6.79) *** 
PC1 0.99 (1.29)  0.94 (1.19)  1.07 (1.38)  1.04 (1.36)  1.00 (1.30)  1.01 (1.32)  
PC2 -0.71 (-0.92)  -0.71 (-0.92)  -0.70 (-0.91)  -0.67 (-0.86)  -0.68 (-0.88)  -0.68 (-0.88)  
PC6 1.40 (1.82) . 1.39 (1.81) . 1.41 (1.84) . 1.42 (1.85) . 1.42 (1.84) . 1.42 (1.84) . 
Intercept -0.40 (-1.77) . -0.41 (-1.78) . -0.40 (-1.77) . -0.42 (-1.83) . -0.41 (-1.81) . -0.41 (-1.80) . 
Nagelkerke R2 0.037  0.037  0.037  0.038  0.038  0.038  
Change in R2   0.000  0.000  0.001  0.001  0.001  
Chi-Square: 
Deviance, p 





























5 x 10-2 
Estimate (z-value) 
p-value = 
5 x 10-4 
Estimate (z-value) 
p-value = 
5 x 10-6 
Estimate (z-value) 
p-value = 
5 x 10-8 
Estimate (z-value) 
PGRS    -0.03 (-1.51)  -0.01 (-0.46)  0.01 (0.39)  0.01 (0.31)  0.01 (0.37)  
Sex -0.14 (-4.38) *** -0.15 (-4.37) *** -0.15 (-4.39) *** -0.15 (-4.38) *** -0.14 (-4.38) *** -0.15 (-4.38) *** 
Age 0.04 (3.33) *** 0.04 (3.24) *** 0.04 (3.30) *** 0.04 (3.33) *** 0.04 (3.33) *** 0.04 (3.33) *** 
PC1 -1.78 (-1.76) . -1.40 (-1.35) . -1.07 (-1.66) . -1.81 (-1.79) . -1.79 (-1.77) . -1.80 (-1.78) . 
PC2 -0.08 (-0.08)  -0.03 (-0.03)  -0.06 (-0.07)  -0.09 (-0.10)  -0.09 (-0.10)  -0.09 (-0.11)  
Intercept 0.64 (2.48) * 0.66 (2.56) * 0.64 (2.50) * 0.64 (2.48) * 0.64 (2.48) * 0.64 (2.48) * 
Nagelkerke R2 0.031  0.033  0.031  0.031  0.031  0.031  
Change in R2   0.000  0.000  0.000  0.000  0.000  
Chi-Square: 
Deviance, p 























5 x 10-2 
Estimate (z-value) 
p-value = 
5 x 10-4 
Estimate (z-value) 
p-value = 
5 x 10-6 
Estimate (z-value) 
p-value = 
5 x 10-8 
Estimate (z-value) 
PGRS   0.02 (0.45)  -0.01 (-0.22)  -0.02 (-0.51)  -0.04 (-0.87)  -0.02 (-0.95)  
Sex -0.41 (-4.35) *** -0.41 (-4.34) *** -0.41 (-4.36) *** -0.41 (-4.35) *** -0.41 (-4.36) *** -0.41 (-4.36) *** 
Age 0.18 (4.85) *** 0.18 (4.86) *** 0.18 (4.84) *** 0.18 (4.86) *** 0.18 (4.86) *** 0.18 (4.86) *** 
PC1 3.09 (1.17)  2.77 (1.02)  3.17 (1.18)  3.14 (1.19)  3.10 (1.17)  3.13 (1.19)  
PC2 -2.66 (-1.04)  -2.69 (-1.05)  -2.65 (-1.04)  -2.63 (-1.03)  -2.60 (-1.01)  -2.59 (-1.04)  
PC6 6.97 (2.65) ** 6.90 (2.62) ** 6.99 (2.65) ** 7.00 (2.66) ** 7.00 (2.66) ** 7.00 (2.67) ** 
Intercept -3.68 (-4.84) *** -3.71 (-4.87) *** -3.68 (-4.83) *** -3.69 (-4.86) *** -3.69 (-4.85) *** -3.69 (-4.85) *** 
Nagelkerke R2 0.033  0.034  0.034  0.034  0.034  0.034  
Change in R2   0.001  0.001  0.001  0.001  0.001  
Chi-Square: 
Deviance, p 























5 x 10-2 
Estimate (z-value) 
p-value = 
5 x 10-4 
Estimate (z-value) 
p-value = 
5 x 10-6 
Estimate (z-value) 
p-value = 
5 x 10-8 
Estimate (z-value) 
PGRS   0.03 (0.61)  0.06 (1.15)  0.08 (1.39)  0.09 (1.72) . 0.10 (1.92) . 
Sex -0.33 (-2.97) ** -0.32 (-2.96) ** -0.32 (-2.91) ** -0.32 (-2.95) ** -0.32 (-2.93) ** -0.32 (-2.93) ** 
Age 0.22 (5.26) *** 0.22 (5.28) *** 0.22 (5.31) ** 0.22 (5.24) *** 0.22 (5.25) *** 0.22 (5.25) *** 
PC1 -1.68 (-0.54)  -2.18 (-0.68)  -2.26 (-0.72)  -1.90 (-0.62)  -1.76 (-0.57)  -1.84 (-0.60)  
PC2 4.04 (1.40)  3.99 (1.37)  3.93 (1.36)  3.91 (1.35)  3.90 (1.34)  3.88 (1.34)  
PC5 -7.61 (-2.62) ** -7.66 (-2.63) ** -7.67 (-2.64) ** -7.70 (-2.65) ** -7.70 (-2.65) ** -7.71 (-2.65) ** 
Intercept -2.51 (-2.92) ** -2.55 (-2.95) ** -2.56 (-2.98) ** -2.50 (-2.91) ** -2.51 (-2.92) ** -2.51 (-2.92) ** 
Nagelkerke R2 0.134  0.135  0.137  0.138  0.141  0.142  
Change in R2   0.001  0.003  0.004  0.007  0.008  
Chi-Square: 
Deviance, p 














N 1690  1690  1690  1690  1690  1690  








5 x 10-2 
Estimate (z-value) 
p-value = 
5 x 10-4 
Estimate (z-value) 
p-value = 
5 x 10-6 
Estimate (z-value) 
p-value = 
5 x 10-8 
Estimate (z-value) 
PGRS    0.03 (1.13)  0.03 (1.24)  0.03 (1.46)  0.04 (1.77) . 0.05 (2.02) * 
Sex -0.20 (-4.44) *** -0.20 (-4.44) *** -0.20 (-4.40) *** -0.20 (-4.44) *** -0.20 (-4.44) *** -0.20 (-4.44) *** 
Age 0.05 (3.01) ** 0.05 (3.08) ** 0.05 (3.09) ** 0.05 (3.00) ** 0.05 (3.01) ** 0.05 (3.01) ** 
PC1 -0.78 (-0.61)  -1.20 (-0.90)  -1.10 (-0.83)  -0.88 (-0.69)  -0.83 (-0.65)  -0.87 (-0.68)  
PC2 -0.03 (-0.03)  -0.10 (-0.81)  -0.09 (-0.07)  -0.11 (-0.10)  -0.14 (-0.12)  -0.16 (-0.13)  
PC5 1.89 (1.60)  1.86 (1.57)  1.87 (1.58)  1.86 (1.57)  1.86 (1.57)  1.86 (1.58)  
PC7 1.96 (1.64)  1.97 (1.65)  1.93 (1.62)  1.97 (1.65)  2.00 (1.67)  1.98 (1.66)  
Intercept -0.22 (-0.62)  -0.24 (-0.69)  -0.24 (-0.70)  -0.21 (-0.61)  -0.21 (-0.62)  -0.22 (-0.62)  
Nagelkerke R2 0.032  0.033  0.033  0.033  0.034  0.035  
Change in R2   0.001  0.001  0.001  0.002  0.003  
Chi-Square: 
Deviance, p 














N 1476  1476  1476  1476  1476  1476  
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Supplementary Table 10.5a: Main and Interaction Effects of PLINK-based PRS and Parental Environment 















Autonomy Granting Main 






Main and Interaction 
Effects with PGRS 
Estimate (z-value) 
PGRS (p-value = 5 x 10-4)   -0.09 (-2.33) * -0.10 (-2.41) * 
Parental Environment (PE)   0.17 (4.19) *** -0.09 (-2.14) * 
PGRS x PE   0.06 (1.42)  0.01 (0.33)  
Sex -0.46 (-5.53) *** -0.45 (-5.35) *** -0.45 (-5.37) *** 
Age 0.11 (3.31) *** 0.12 (3.41) * 0.12 (3.40) *** 
PC1 -0.85 (-0.37)  -0.08 (-0.03) *** -0.47 (-0.21)  
PC2 -2.10 (-0.93)  -1.34 (-0.59)  -1.87 (-0.83)  
PC5 -4.63 (-2.01) * -4.52 (-1.95) . -4.46 (-1.93) . 
Intercept -0.67 (-0.99)  -1.27 (-1.32)  -0.76 (-1.11)  
Nagelkerke R2 0.022  0.035  0.027  
Change in R2   0.013  0.005  
Chi-Square: Deviance, p   26.234 (0.000008) *** 10.575 (0.01) * 
N 2940   2940  2940  
 











Main Effect Only 
Estimate (z-value) 
Parental Environment (PE)   0.18 (4.24) *** -0.09 (-2.15) * 
Sex -0.46 (-5.53) *** -0.45 (-5.37) *** -0.45 (-5.37) *** 
Age 0.11 (3.31) *** 0.11 (3.27) ** 0.11 (3.31) *** 
PC1 -0.85 (-0.37)  -0.48 (-0.21)  -0.70 (-0.31)  
PC2 -2.10 (-0.93)  -1.53 (-0.68) . -2.04 (-0.91)  
PC5 -4.63 (-2.01) * -4.65 (-2.00)  -4.60 (2.00) * 
Intercept -0.67 (-0.99)  -0.69 (-0.98)  -0.70 (-1.02)  
Nagelkerke R2 0.022  0.032  0.024  
Change in R2   0.010  0.002  
Chi-Square: Deviance, p   18.2980 (0.00005) *** 4.7177 (0.03) * 
N 2940  2940  2940  
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Supplementary Table 10.5b: Main and Interaction Effects of PLINK-based PRS and Parental Environment 
















Autonomy Granting Main 






Main and Interaction 
Effects with PGRS 
Estimate (z-value) 
PGRS (p-value = 5 x 10-8)   0.04 (1.95) . 0.05 (2.14) * 
Parental Environment (PE)   0.07 (3.20) ** -0.11 (-5.09) *** 
PGRS x PE   0.01 (0.33)  0.01 (0.46)  
Sex -0.19 (-4.28) *** -0.18 (-4.08) *** -0.19 (-4.23) *** 
Age 0.05 (2.97) ** 0.05 (2.92) ** 0.05 (3.14) ** 
PC1 -0.86 (-0.66)  -0.83 (-0.64)  -0.95 (-0.74)  
PC2 -0.17 (-0.14)  -0.02 (-0.01)  -0.18 (-0.15)  
PC5 1.86 (1.57)  1.81 (1.53)  1.93 (1.63)  
PC7 1.83 (1.57)  1.88 (1.58)  1.91 (1.61)  
Intercept -0.21 (-0.62)  -0.21 (-0.62)  -0.28 (-0.80)  
Nagelkerke R2 0.030  0.039  0.058  
Change in R2   0.009  0.028  




21.6880 (0.000001)  
*** 
N 1455  1455  1455  
 












Main Effect Only 
Estimate (z-value) 
Parental Environment (PE)   0.07 (3.18) ** -0.11 (-5.06) *** 
Sex -0.19 (-4.28) *** -0.18 (-4.09) *** -0.19 (-4.23) *** 
Age 0.05 (2.97) ** 0.05 (2.91) ** 0.05 (3.14) ** 
PC1 -0.86 (-0.66)  -0.74 (-0.57)  -0.85 (-0.66) *** 
PC2 -0.17 (-0.14)  0.11 (0.09)  -0.06 (-0.05)  
PC5 1.86 (1.57)  1.84 (1.56)  1.93 (1.64)  
PC7 1.83 (1.57)  1.85 (1.55)  1.87 (1.58)  
Intercept -0.21 (-0.62)  -1.27 (-1.32)  -0.28 (-0.80)  
Nagelkerke R2 0.030  0.040  0.054  
Change in R2    0.001  0.024  








N 1455  1455  1455  
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Supplementary Table 10.6a: Main Effects of Stressful Life Events on Measures of Ever Tobacco Use and Time to First Tobacco Use After Waking within 
European Ancestry Group within Spit for Science 
  



















Environment   0.09 (0.78)  0.46 (3.81) *** 0.84 (4.49) *** 0.63 (4.78) *** 0.08 (0.70)  
Sex -0.28 (-2.45) * -0.28 (-2.50) * -0.26 (-2.30) * -0.40 (-3.56) *** -0.43 (-3.77) *** -0.27 (-2.42) * 
Age 0.08 (2.27) * 0.08 (2.25) * 0.09 (2.46) * 0.09 (2.45) * 0.09 (2.48) * 0.08 (2.31) * 
PC1 -5.87 (-1.90) . -6.00 (-1.93) . -6.36 (-2.11) * -5.54 (-1.86) . -7.92 (-2.65) ** -6.08 (-1.95) . 
PC2 2.51 (0.96)  2.38 (0.90)  2.34 (0.92)  1.79 (0.71)  1.30 (0.52)  2.73 (1.03)  
PC5 -1.37 (-0.42)  -1.22 (-0.37)  0.38 (0.12)  -1.15 (-0.36)  -1.02 (-0.33)  -1.10 (-0.33)  
PC7 -1.48 (-0.47)  -1.64 (-0.52)  -1.51 (-0.50)  -1.67 (-0.55)  -1.72 (-0.58)  -1.46 (-0.46)  
Intercept -0.65 (-0.86) . -0.67 (-0.89)  -0.92 (-1.25)  -0.61 (-0.85)  -0.66 (-0.92)  -0.74 (-0.96)  
Nagelkerke R2 0.097  0.100  0.172  0.199  0.211  0.099  
Change in R2   0.003  0.075  0.102  0.114  0.002  
Chi-Square: 
Deviance, p 


















N 230  230  230  230  230  230  

















Environment   0.57 (2.65) ** 0.90 (3.17) ** 0.96 (1.89) . 0.69 (2.24) * 0.01 (0.03)  
Sex -0.50 (-2.35) * -0.52 (-2.41) * -0.46 (-2.11) * -0.57 (-2.67) ** -0.61 (-2.78) ** -0.50 (-2.35) * 
Age 0.15 (1.64)  0.17 (1.74) . 0.18 (1.82) . 0.16 (1.69) . 0.15 (1.54)  0.15 (1.63)  
PC1 -2.72 (-0.53)  -3.79 (-0.73)  -3.29 (-0.64)  -2.64 (-0.51)  -3.83 (-0.74)  -2.73 (-0.53)  
PC2 3.31 (0.73)  2.96 (0.65)  3.17 (0.69)  2.99 (0.66)  3.22 (0.71)  3.31 (0.73)  
PC5 2.23 (0.36)  3.57 (0.58)  3.90 (0.61)  2.54 (0.41)  2.42 (0.39)  2.24 (0.36)  
Intercept -1.21 (-0.64)  -1.69 (-0.88)  -1.93 (-1.00)  -1.31 (-0.69)  -0.99 (-0.53)  -1.21 (-0.64) . 
Nagelkerke R2 0.027  0.048  0.060  0.040  0.043  0.027  
Change in R2   0.021  0.033  0.013  0.016  0.000  
Chi-Square: 
Deviance, p 



















N 495  495  495  495  495  495  
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Supplementary Table 10.6b: Main and Interaction Effects of PGRS and Stressful Life Events on Ever Tobacco Use and Time to First Tobacco Use After 
Waking within European Ancestry Group within Spit for Science 










Main and Interaction Effects 
Estimate (z-value) 
Other Sexual Assault Main 
and Interaction Effects 
Estimate (z-value) 
PGRS (p-value = 5 x 10-8)   0.04 (0.56)   0.07 (1.14)  0.03 (0.48)  
Environment   0.47 (3.85) *** 0.90 (4.84) *** 0.60 (4.42) *** 
PGRS x Environment   0.17 (1.48)  0.30 (1.91) . 0.10 (0.87)  
Sex -0.28 (-2.45) * -0.24 (-2.13) * -0.39 (-3.46) *** -0.40 (-3.54) *** 
Age 0.08 (2.27) * 0.08 (2.23) * 0.08 (2.37) * 0.08 (2.34) * 
PC1 -5.87 (-1.90) . -6.44 (-2.15) * -6.01 (-2.04) * -7.98 (-2.66) ** 
PC2 2.51 (0.96)  2.06 (0.81)  1.12 (0.45)  1.09 (0.43)  
PC5 -1.37 (-0.42)  0.99 (0.31)  -1.40 (-0.45)  -0.84 (-0.27)  
PC7 -1.48 (-0.47)  -1.19 (-0.39)  -1.80 (-0.60)  -1.42 (-0.47)  
Intercept -0.65 (-0.86) . -0.77 (-1.06)  -0.56 (-0.79)  -0.59 (-0.82)  
Nagelkerke R2 0.097  0.200  0.237  0.220  
Change in R2   0.103  0.140  0.123  












N 230  230  230  230  









Main and Interaction Effects 
Estimate (z-value) 
Other Sexual Assault Main 
and Interaction Effects 
Estimate (z-value) 
PGRS (p-value = 5 x 10-4)   -0.39 (-2.66) ** -0.40 (-3.06) ** -0.29 (-2.31) * 
Environment   0.53 (2.44) * 0.94 (3.22) ** 0.78 (2.41) * 
PGRS x Environment    1.29 (1.27)  0.58 (1.99) * -0.13 (-0.41)  
Sex -0.50 (-2.35) * -0.51 (-2.35) * -0.45 (-2.06) * -0.61 (-2.76) ** 
Age 0.15 (1.64)  0.18 (1.86) . 0.20 (2.01) * 0.17 (1.73)  
PC1 -2.72 (-0.53)  -3.49 (-0.66)  -2.56 (-0.48)  -3.71 (-0.71)  
PC2 3.31 (0.73)  4.69 (1.02)  5.14 (1.11)  5.06 (1.10)  
PC5 2.23 (0.36)  2.57 (0.41)  4.71 (0.72)  1.92 (0.31)  
Intercept -1.21 (-0.64)  -1.92 (-0.99)  -2.37 (-1.20)  -1.42 (-0.74)  
Nagelkerke R2 0.027  0.068  0.089  0.064  
Change in R2   0.021  0.033  0.016  












N 495  495  495  495  
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CHAPTER 11:  
A MOVING TARGET: THE EMERGENCE OF NICOTINE DELIVERY SYSTEMS AND 
ITS POTENTIAL PUBLIC HEALTH IMPACTS 
Elizabeth K. Do 
Tobacco use remains the leading cause of preventable morbidity and mortality within the 
United States, accounting for over 400,000 deaths per year1. Despite an overall decrease 
in the use of cigarettes, increases in the use of cigars, e-cigarettes, and hookah/waterpipe 
among adolescents and young adults have been reported2,3. It has also been suggested 
that the overall increase in use of electronic cigarettes and hookah between 2011 and 
2014 has offset the overall decrease in more traditional tobacco products, like cigarettes 
and cigars4. Additionally, the use of alternative tobacco products and nicotine delivery 
systems are evolving rapidly. Estimates from a national survey conducted in 2014 
demonstrate that: one in four current cigarette smokers use alternative tobacco products 
and nicotine delivery systems, and almost one-third of current users of alternative tobacco 
products are ex-smokers and never smokers5. To some extent, this growth in the 
availability and use of products is driven by market forces: the tobacco industry and 
financial markets are capitalizing on this period of tobacco product innovation and 
transformation6,7.The potential impact of these products on public health is faced with 
uncertainty, though a report by the 2014 Surgeon General suggests that additional 
“endgame strategies” are needed to reduce the projected and sustained pattern of 
tobacco-related morbidity and mortality1. This is especially important, given that other 
tobacco products and nicotine delivery also have negative health consequences, despite 
most tobacco-related morbidity and mortality being attributed to the use of cigarettes. It 
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is plausible that the severity of negative consequences may vary across products; but, 
overemphasizing this point may counter public health efforts to reduce harm.  
Categories of Alternative Tobacco Products and Nicotine Delivery Systems 
Alternative tobacco products include two types of products: smoked and smokeless. 
Smoked products include cigars, cigarillos, and hookah/waterpipe, while smokeless 
products refer to chewing tobacco, snuff (smokeless tobacco), chaw, and dip. Like these 
alternative tobacco products, electronic nicotine delivery systems (ENDS) – such as 
electronic cigarettes, or e-cigarettes – are highly available in the US market and are being 
promoted as potentially less harmful alternatives to cigarettes. They are also being 
marketed as products to be used as substitutes for cigarette smoking. However, these 
products occur more often in combination with the use of cigarettes, rather than in 
isolation. Multiple studies of tobacco use have reported concurrent use of tobacco 
products among college students8 – a population that is prone to experimentation and is 
actively developing patterns of tobacco use behaviors that could affect their risk for 
tobacco-related morbidity and mortality. Studies demonstrate that concurrent users of 
tobacco products and nicotine delivery systems experience higher intermediate levels of 
mortality, tend to ingest more nicotine daily, and have more difficulty when trying to stop 
the use of tobacco9,10.  
Why Alternative Tobacco Products/ Nicotine Delivery Systems are Growing in 
Popularity 
Despite the harms involved with any tobacco use, alternative tobacco products and 
electronic nicotine delivery systems are growing in popularity – especially among 
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adolescents and young adults. The growing popularity of these products is attributed to 
multiple factors, though the most common explanations are: the widespread availability, 
lax regulation, targeted advertising, and perceptions that these products are safer, relative 
to cigarettes.  
Widespread availability of alternative tobacco products. As new tobacco products 
are being developed, the availability of alternative tobacco products and nicotine delivery 
systems will grow over time11. By January 2014, there were more than 460 brands and 
7760 unique flavors of electronic nicotine delivery systems available for purchase 
online12. Reviews of tobacco industry documents demonstrate that tobacco companies 
are using flavoring to make tobacco products more palatable and attractive to new users 
of tobacco products13. The widespread availability of alternative tobacco products may be 
driven by the changing preferences that exist among current and former users of tobacco 
products, who are either looking for a product to use instead of or in addition to 
cigarettes14. 
Targeted advertising. Tobacco product marketing has emphasized the point that 
alternative tobacco products may facilitate reduction or cessation of cigarette use15. 
Meanwhile, some advertisements use messages that position alternative tobacco 
products as a modern substitute to be used in places where smoking is banned or made 
inconvenient by smoking bans15,16. Given the declining cigarette consumption, major US 
tobacco companies have tried to maintain their profits through the marketing (and 
development) of alternative tobacco products and nicotine delivery systems17,18. Much of 
the current research has focused on how tobacco companies have focused on the 
increased use among youth, who are more price sensitive and interested in tobacco-
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masking flavors relative to older adults14. Manufacturers of alternative tobacco products 
and electronic nicotine delivery systems have utilized lax regulation over the marketing of 
alternative tobacco products to their advantage in that they have aggressively marketed 
products to youth through product flavoring, promotional materials, and the distribution of 
free samples19.   
Lax regulation. The FDA currently holds immediate authority over cigarettes, smokeless 
tobacco products, and roll-your-own tobacco. As of October 2015, the Food and Drug 
Administration lacks the authority to regulate novel tobacco products, such as electronic 
vapor products marketed for non-therapeutic purposes20, even though the FDA can 
promulgate regulations extending regulatory authority over all other products meeting the 
definition of tobacco product under the Family Smoking Prevention and Tobacco Control 
Act (FSPTCA)21. The FSPTCA was originally enacted in 2009, and provided the FDA with 
the power to regulate the manufacture, sale, marketing and distribution of tobacco 
products. Under the FSPTCA, the FDA has the power to restrict marketing and sales of 
tobacco products to youth, mandate reporting of ingredients and additives, ban cigarette 
flavorings, and review manufacturers’ claims to lower-risk19. In 2016, the FDA finalized a 
rule (also referred to as the “Deeming Rule”) extending the agency’s authority to regulate 
electronic cigarettes and related vapor products as tobacco products. This rule, makes it 
illegal for any e-cigarettes, e-liquids, and other tobacco products without FDA approval to 
remain on the market and takes effect on August 8, 2018. What this means is that 
manufacturers must submit a package of research required by the FDA prior to this date, 
to be considered for approval to stay on the market22.     
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Perception that products are safer relative to cigarettes. Research has suggested 
that marketing focused on potential-harm reduction aspects of alternative tobacco 
products may cause tobacco users to reject or ignore health messages regarding the 
potential dangers of these products23. There is also a common belief among users of 
tobacco products that the government evaluates most tobacco products for safety. This 
is problematic in that the belief that the government evaluates certain products for safety 
(when many tobacco products are unregulated by the government) may contribute to 
continued use24. It becomes even more problematic when we consider that polytobacco 
users report the least perceived dangers of various tobacco products25, despite 
heightened risk for escalated use and addiction among individuals who use more than 
one tobacco product concurrently. Polytobacco users may view alternative tobacco 
products as less dangerous, perhaps because they see alternative tobacco products as 
an effective means for cessation, or as an acceptable substitute when smoking is publicly 
prohibited26.  
Who Uses Alternative Tobacco Products and Nicotine Delivery Systems?  
Some research has been done to identify which individuals are at higher risk of using 
alternative tobacco products and nicotine delivery systems. Generally, individuals with 
peers or family members supporting tobacco use, who hold favorable beliefs about 
smoking, are younger in age and male are at higher risk of using alternative tobacco 
products. Some recent studies suggest that the uptake of certain alternative tobacco 
products may differ by race/ethnicity, but the evidence is mixed. Whereas some studies 
have indicated that individuals who self-identify as White endorse using alternative 
tobacco products relative to other race/ethnicities27, others have demonstrated that the 
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prevalence is higher among those who self-identify as Black28. Furthermore, those who 
are never smokers are at highest risk of using alternative tobacco products, relative to 
former, non-daily smokers and non-smokers. The reason for this might be that young 
adults who use alternative tobacco products might not (want to) perceive themselves to 
be smokers28. Rather, initial users of alternative tobacco products and electronic nicotine 
delivery systems may self-identify as non-users who are experimenting, or only users 
within social settings. Data from focus groups conducted to assess themes related to e-
cigarette experimentation and discontinuation support this viewpoint by showing that the 
top reasons for experimenting with or initiating the use of electronic nicotine delivery 
systems were curiosity, appealing flavors, and peer influences29. Since almost a third of 
current users report that they are nonsmokers, the use of alternative tobacco products 
and electronic nicotine delivery systems are contributing to nicotine addiction and 
renormalizing tobacco use30,31. The extent to which alternative tobacco products and 
electronic nicotine delivery systems are contributing to nicotine addiction and tobacco-
related morbidity and mortality is not yet clear, though there is evidence demonstrating 
that concurrent use of tobacco products may sustain nicotine dependence and potentially 
postpone cessation32. More studies need to be conducted to quantify the risks involved 
with using alternative tobacco products and electronic nicotine delivery systems. 
Future Directions of Research 
The main challenge to public health regarding tobacco control is how to address the 
growing use of alternative tobacco products and nicotine delivery systems and balance 
public health messaging about the use of these products. It remains unclear whether 
these alternative tobacco products and nicotine delivery systems will be replacing 
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traditional tobacco products without expanding patterns of nicotine use among 
adolescents and young adults – the main target of tobacco company advertising and 
public health harm reduction and prevention efforts. As information is collected regarding 
how much and how these products are being used, the availability and marketing of these 
products will continue to grow and change with user preferences5 – especially since 
young adulthood is an ideal period during which tobacco use can be introduced and 
solidified33.  
One area of research that needs more attention is the relationship between the use of 
alternative tobacco products and electronic nicotine delivery systems, and traditional 
cigarette use. Alternative tobacco products might serve as gateway products for 
adolescents, leading to the use of other tobacco products – including cigarettes. A study 
conducted by Soneji et al. (2015), demonstrates this by providing data from a national 
survey of young adults aged 15-23 years, showing that baseline water pipe tobacco and 
snus use were associated with increased interim cigarette initiation, current cigarette 
smoking, and high-intensity cigarette use after a 2-year follow-up period34. Added to this, 
half of adolescent tobacco users within the US are dual or poly-tobacco users35. Yet, their 
tobacco use trajectories remain poorly characterized. We know from other studies, that 
several young adults have used multiple tobacco products in their lifetime, and are current 
dual and poly-tobacco users36. More work needs to be done to better understand the 
increasing complexity of tobacco use among adolescents and young adults to promote 
effective public health planning and to ensure that the regulation of alternative tobacco 
products (or potential lack thereof) does not undermine current anti-tobacco regulatory 
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efforts19 which have predominantly been focused on consumption changes, successful 
quitting, as well as attitude and belief changes among current users37.  
To reduce and/or prevent the use of alternative tobacco products, more data needs to be 
collected on the use of all tobacco products as they are being developed, rather than just 
focusing on cigarettes38. It also seems to be the case that a two-pronged approach needs 
to be taken in the research field: one focused on how to alter existing social norms 
regarding tobacco use that may be undermining current tobacco control efforts, and one 
focused on the reduction of harm of products that are currently and/or will be made 
available in the future. Much of this research will be driven by changes in consumer-driven 
preferences already being studied by tobacco companies, who pay close attention to how 
products are being used and adapted39.  
Thus, in addition to determining the prevalence of use of different tobacco products, better 
characterization of tobacco products in terms of composition and toxicity should be 
undertaken to inform regulators to develop guidelines for safety and focus should be 
placed on minimizing risks associated with tobacco products and nicotine delivery 
systems12. It is also important to determine what the overall morbidity and mortality 
contributions of different tobacco products are, relative to cigarettes and in combination 
with cigarette use – given that concurrent tobacco use of multiple products is increasingly 
common, especially among adolescents and young adults who are the moving targets of 





CHAPTER 12:  
PLANS FOR A PILOT RANDOMIZED CONTROL TRIAL OF AN INTERNET-BASED 
EDUCATIONAL INTERVENTION FOR THE REDUCTION OF TOBACCO USE (AND 
NICOTINE DEPENDENCE)  
 
Elizabeth K. Do, Juan Lu, and Hermine H. Maes 
INTRODUCTION 
Tobacco use results in $130 billion annually in direct adult medical care costs. It is 
projected that 5.6 million of Americans under the age of 18 years will die prematurely from 
tobacco-related illnesses. Thus, developing methods to reduce tobacco use among 
individuals is necessary1. However, before this is possible, a better understanding of the 
etiology of tobacco use and nicotine dependence is required and examining risk factors 
for tobacco use behaviors may be useful for the identification of potential areas of 
intervention and prevention.  
Tobacco use behaviors involve the interplay of genetic and environmental factors. Adding 
to this complexity, the influence of genes and the environment seems to change over the 
life course. Twin studies of adult samples show that genetic and shared environmental 
influences contribute significantly to the liability of tobacco initiation, regular use, and 
nicotine dependence2–4, with significant overlap in the genetic and/or environmental risk 
factors at each stage5. Adolescent studies suggest that the impact of the shared 
environment is more pronounced during mid-adolescence when many initiate use, but the 
influence of genes - though present to some degree early on - comes to play a larger role 
by late adolescence, when the etiological structure of tobacco use resembles that of 
adults5–7, such that initiation is explained by genetic, shared, and unique environmental 
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factors in early adolescence and genetic and unique environmental factors in young 
adulthood8. 
Despite the growing evidence that genetic factors play an important role in tobacco use, 
genome wide association studies (GWAS) have only identified a few genes associated 
with smoking quantity and nicotine dependence so far. Identification and exploration of 
genetic loci influencing smoking behavior have primarily been conducted in adults and in 
populations of European ancestry9. The most robust finding to emerge from GWAS 
studies of smoking behavior is the association between genetic variant rs16969968, 
located within the α5-α3-β4 nicotinic receptor gene cluster on chromosome 15, and 
smoking quantity10–13. A study of African Americans confirmed this region as an important 
susceptibility locus for smoking quantity in men and women. There is also a reported 
association between rs1051730 and nicotine dependence (and two tobacco-related 
diseases, lung cancer and peripheral arterial disease)13. Yet, larger studies are needed 
to validate other suggestive loci not reaching genome-wide significance9.  
Consortia-based GWAS meta-analyses of individuals of European ancestry with sample 
sizes approaching 10,000 individuals have identified several novel genomic regions 
associated with a range of smoking phenotypes. A nonsynonymous SNP (rs6265) located 
on the brain-derived neurotrophic factor (BDNF) gene on chromosome 11 has been 
associated with smoking initiation, while a gene variant on chromosome 9 near the 
dopamine beta hydroxylase (DBH) gene was associated with smoking cessation12,14. Two 
nicotinic receptor sub-unit genes (CHRNB3/CHRNA6) on chromosome 8 and CYP2A6 
on chromosome 19 have also been associated with smoking quantity12. However, the 
proportion of phenotypic variance explained by rs16969968-rs1051730 SNPs is less than 
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1%15. A recent genome-wide meta-analysis of an objective marker of smoking has 
observed an association between multiple variants within the 15q24 region, in strong 
linkage disequilibrium with rs16969968, associated with cotinine level16 and explaining a 
larger proportion of the phenotypic variance.  
Despite studies demonstrating that genes contribute to tobacco use behaviors, current 
prevention and intervention approaches do not take the contribution of genetic factors to 
tobacco use into account. Instead, focus is placed on mean behavior change, either 
through advice and behavioral counseling at the individual level17 or through population-
level tobacco control measures such as tobacco advertising bans seeking to reduce 
smoking initiation and prevalence among minors and young adults or smoke-free policies 
aimed to reduce secondhand smoke exposure to nonsmokers and create an environment 
that aids smokers to quit18. Using datasets incorporating measured aspects of the 
environment into genetically informed studies allows for a greater understanding how 
specific environments are related to tobacco use outcomes, interact with genetic liability, 
and are helpful in identifying potential points of intervention. For example, studies have 
identified parental environment, parental monitoring19,20, maternal smoking during 
pregnancy21, peer smoking22, average neighborhood social cohesion23, traumatic 
events23, self-rated religiousness24, and marketing and vending machine restrictions22 as 
moderators of genetic and/or environmental factors influencing smoking behaviors, as 
summarized in two recently published systematic reviews25,26. 
Other studies suggest that notification of susceptibility for tobacco-related illness may 
influence individual-level tobacco use. Interestingly, awareness of the health hazards 
associated with cigarette consumption appears not to be sufficient in the initiation of 
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smoking cessation27. This could be due to tobacco users’ underestimation of personal 
risk of tobacco-related illness28. Research suggests that improvements in cessation rates 
may be achieved by providing personal feedback on susceptibility for tobacco-related 
illness29. Short-term benefits of this approach include: positive change in perceptions of 
risk and beliefs about quitting29–31 and increased attempts to quit/enhanced cessation 
rates at six months32. However, empirical data have not provided sufficient evidence that 
knowledge of genetic variants conferring susceptibility to tobacco-related illness yields 
long-term benefit in terms of quit rate33. Additionally, there are concerns that genotypic 
notification could demotivate high-risk individuals to change their behavior, due to feelings 
of fatalism or reduced sense of personal control over chances of getting smoking-related 
diseases, while individuals receiving low-risk results may be falsely reassured and 
become complacent34. Further research is needed to delineate the direction of effect of 
genetic notification of susceptibility for smoking-related outcomes.  
The current study tries to build on this existing research by providing information on the 
planning of a feasibility study involving an Internet-based educational intervention 
examining how providing college students with information on the influence of genes and 
the environment on tobacco use behaviors and nicotine dependence impacts subsequent 
patterns of tobacco use behavior. To date, few interventions are specifically aimed at 
young adult smokers, even though tobacco use is common among college students. 
College is a critical time in the development of tobacco use behaviors35, especially since 
young adults are at risk for experimenting with tobacco use and establishing tobacco use 
patterns. Furthermore, their current use may be predictive of tobacco use in years to 
come. As such, tobacco use prevention, reduction, and nicotine dependence treatment 
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efforts aimed at college students could have the potential to yield considerable benefits 
in reducing the overall health burden of nicotine dependence36. 
This study will apply the principles of the Health Belief Model (HBM), which assumes that 
health behavior is determined by perceptions of perceived threat, perceived susceptibility 
and severity, perceived benefits, and perceived barriers and the strategies available to 
decrease its occurrence37. By applying the HBM concept and constructs to our 
intervention, which seeks to reduce tobacco use (and risk for nicotine dependence) in 
young adult tobacco users, we seek to increase their perceived threat, susceptibility, and 
severity of nicotine dependence while decreasing their perceived barriers to reducing 
tobacco use among college student participants by providing knowledge of genetic and 
environmental risks for nicotine dependence and means to decrease barriers to reducing 
tobacco use. We hypothesize that personalizing the information presented (e.g. using the 
pronoun “you” in explanations of risk) will improve outcomes, relative to individuals in the 
control group and those receiving generalized risk information about tobacco use 
behaviors and risks for nicotine dependence. We also predict that this reduction of 
tobacco use will be the same or higher for those who also receive information on their 
genetic risk for developing nicotine dependence.   
METHODS 
Design. Participants will be recruited into a four-arm randomized control trial pilot study, 
from an ongoing study that investigates the role of genes and the environment on 
emotional health and substance use within a university setting. The four-arms of the study 
include a control, generalized risk information, personalized risk information, and 
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personalized risk information with added genetic component group. Baseline 
characteristics and outcomes of interest will be compared across each of the four arms 
of the study groups. Recruitment, study consent and enrollment, and data collection will 
all be conducted online, with no face-to-face contact. The registry of the parent study will 
initially contact eligible participants to determine interest in the study, and report back to 
this research study team. The research team will then ask those who indicated their 
interest in participation in the study to fill out an electronic consent form and continue with 
baseline assessment. The baseline assessment will be found as a survey link that 
participants can click on. However, before providing consent, participants will need to 
read study information that outlines procedures, inclusion criteria, and will be encouraged 
to contact the research team regarding any questions/comments they have regarding the 
study protocol. After providing electronic consent, participants will complete the baseline 
assessment and then be randomized to receive one of the study conditions. Participants 
who indicate that they are not comfortable with receiving any genetic risk information will 
not be allocated to the personalized risk with genetic component group. A few weeks after 
the completion of the baseline assessment, participants will be automatically followed-up 
through e-mail and asked to complete the internet-based educational intervention, which 
includes: online self-assessment questionnaires and viewing a set of three-minute videos. 
Participants who do not complete the internet-based educational intervention within a 
couple of weeks will be re-contacted via reminder e-mail. Thirty days following the 
completion of the internet-based educational intervention, participants are re-contacted 
to complete an online self-assessment follow-up questionnaire. Again, participants who 
do not complete the online follow-up were re-contacted via e-mail. Figure 12.1 depicts 
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study design and recruitment strategy. The university Institutional Review Board 
approved the study. 
Figure 12.1: Study Protocol 
 
Participants and Eligibility Criteria. We aim to recruit 140 participants (35 participants per 
arm). This estimate is based upon the available budget and expected recruitment rates, 
from previously conducted spin-off studies. To be eligible for the study, participants had 
to be: at least 18 years of age, previously enrolled in the parent study, Spit for Science, 
provided a DNA sample, and indicated that they had used any tobacco product (e.g. 
cigarettes, cigars/cigarillos, hookah/waterpipe, smokeless tobacco, and/or electronic 
cigarettes or other nicotine delivery systems) in the past 30 days on their most recent Spit 
for Science follow-up survey. Eligible participants must confirm that they either currently 
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use or intend to use tobacco products in the next six months (i.e. the duration of the study) 
during the consent process.  
Compensation. Participants will be compensated for participating in the study, which 
requires: one baseline assessment, an internet-based educational intervention (which 
includes a set of three-minute videos and surveys), and one follow-up assessment. 
Participants will be compensated $10 for each of these assessments and will be eligible 
to receive an additional $10 for the completion of all assessments. 
Recruitment Duration. Recruitment will end once we reach our desired sample size of 
140 participants, which is estimated to take about two months. Recruitment will be 
extended by one month, if the sample size is not reached. If, after three months, the 
desired sample size is not reached, study procedures will continue with whatever sample 
size is obtained and the analysis procedure will be adapted accordingly.  
Consent Process. Participants will be asked to answer questions to determine eligibility 
for this study and were told that by participating, they will be randomly assigned to one of 
four educational intervention groups: control group, generalized risk information, 
personalized risk information, and personalized risk information with genetic component. 
Participants will not be told what their assignment is, but will be given the opportunity to 
obtain information from the alternative condition(s) to which they were assigned, after the 
termination of the study. All participants will be told that they will be asked to watch a set 
of 2-3 minute videos and complete online survey questions regarding their own tobacco 
use behavior and life experiences. Participants will also be notified that by consenting to 
participate in this study, they will be granting researchers access to data from Spit for 
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Science38 surveys and the DNA sample that they provided previously. However, all 
responses will be stripped of identifiers, coded, and linked with survey data and the DNA 
sample provided for Spit for Science using only coded numbers. Research analyses will 
be done without names attached to the data. Participants will not receive any direct benefit 
from completing the study, other than compensation for their participation, and the study 
involves no more than minimal risks. Finally, participants will be reminded that as 
voluntary participants, they have the option to withdraw from the study at any time.  
Data Capture and Management. Participant data will be collected and maintained in 
REDCap39, the online survey tool that will send survey invitations and receive the survey 
data. All private identifiable information and data collected will be secured in a REDCap 
database that is accessible only to the research coordinator and staff. After the study is 
complete, REDCap data will be de-identified by the research coordinator and extracted 
for analysis. Only de-identified data will be shared with investigators. 
Outcome Measures of Interest. This study aims to explore the feasibility and efficacy of 
the proposed intervention. Feasibility outcomes included: recruitment and retention rates, 
acceptability of the intervention, and follow-up and adherence/compliance rates. Although 
many measures will be collected as a part of this project, primary efficacy outcomes 
included: tobacco use behaviors of participants (e.g. current use, frequency of use, and 
FTND following the intervention). Secondary outcome measures include measures that 
may influence the primary efficacy outcomes, such as: self-efficacy to quit using tobacco, 
perceived benefits to reducing tobacco use, perceived susceptibility to tobacco use, and 
perceived barriers to tobacco use. An overview of the collected measures is shown below, 
in Figure 12.2. 
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Figure 12.2: Overview of Survey Measures 
 
Baseline Assessment. Eligible participants will be asked to fill out a questionnaire 
immediately after consent is provided via a survey linked to REDCap that includes 
measures of: demographic characteristics (i.e. race/ethnicity, sex, year in college, health 
insurance status), family history of tobacco use, current tobacco use (i.e. tobacco 
products used, quantity, frequency, and quit attempts), FTND, self-efficacy to quit using 
tobacco, perceived benefits to reducing tobacco use, perceived susceptibility to tobacco 
use, perceived barriers to tobacco use, perceived severity of risks due to tobacco use, 
motivations to obtain genetic testing, and knowledge of nicotine dependence risk factors.  
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Randomization. Randomization will be conducted using the Randomization Module in 
REDCap using a 1:1:1:1 ratio, in blocks of 4 following the collection of consents and 
baseline assessments. 
Intervention Descriptions. Two weeks following randomization, participants will be 
contacted via e-mail to let them know that the internet-based educational intervention is 
ready to be completed. Again, the participants will not know to which intervention arm 
they are assigned. All groups will receive a set of surveys to complete, along with a set 
of four 2-3 minute videos. All groups, but the control group, will watch educational video 
modules describing risk factors for nicotine dependence. The control group will be shown 
a set of videos not related to risk factors for nicotine dependence.  
The main difference between the generalized risk group and the personalized risk groups 
(one with genetic component and the other without) will be the way the information is 
presented. For the personalized risk groups, information will be framed using the word 
“you” (e.g. You are at slight/mild/moderate/severe increased risk for nicotine dependence) 
and for the generalized risk group, information will be framed in terms of “an individual” 
(e.g. “Individuals who ____ are at slight/mild/moderate/severe increased risk of nicotine 
dependence”). In addition to receiving personalized feedback on risks for nicotine 
dependence, participants receiving the personalized risk with genetic component 
condition will also receive information regarding genetic variant(s) associated with 
nicotine dependence. Participants will be advised that having this genetic variant does 
not guarantee that they will develop nicotine dependence, but rather, having certain 
genetic variants increases their likelihood of developing nicotine dependence and this 
information should be regarded as preliminary research that is ongoing in the field of 
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behavior genetics. Participants will have one week to complete the educational 
intervention and brief questionnaires that go along with the educational intervention. Both 
groups will also be given the contact information of a genetic counselor, in case they have 
questions regarding the interpretation of genetic and environmental risks related to 
nicotine dependence.  
Video Modules and Questionnaires. Video modules will cover the following topics: (1) 
genetics and nicotine dependence, which explains how genetic factors contribute to 
tobacco use behavior, (2) family history and parental environment in adolescence, which 
explains how individual tobacco use is shaped by family history and environment, (3) early 
experiences with tobacco use, which explains how early experiences shape tobacco use 
patterns, and (4) environmental stressors, which provides information on the influence 
that stress may have on tobacco use. The short questionnaires following each module 
will be used to gauge comprehension and knowledge of genetic and environmental risk 
information provided in the online video modules. They will also be used to determine if 
a participant completed the educational modules and will be like quizzes commonly used 
in college-level courses. Participants will also be asked to answer a few questions on: 
how they define their tobacco use, potential exposure to nicotine in-utero, family tobacco 
use, symptoms they had when they first started using tobacco, parental monitoring, and 
stressful life events. Questionnaires will also contain measures on self-efficacy to quit 
using tobacco, perceived benefits to reducing tobacco use, perceived susceptibility to 
tobacco use, perceived barriers to tobacco use, perceived severity of risks due to tobacco 
use, and motivations to obtain genetic testing for comparison to baseline. It is estimated 
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that this one-time intervention will take 35-45 minutes (including educational videos and 
questionnaires).  
30-Day Follow-Up Assessment. Approximately 30 days following the completion of the 
educational intervention, participants will be invited to take a 30-minute follow-up survey 
via email with a link to the questionnaire which includes questions on: knowledge of 
nicotine dependence risk factors, current tobacco use, self-efficacy to quit using tobacco, 
perceived benefits to reducing tobacco use, perceived susceptibility to tobacco use, 
perceived barriers to tobacco use, perceived severity of risks due to tobacco use, and 
motivations to obtain genetic testing. This will serve as the second point of assessment, 
since the questions will be the same as those asked at baseline, and immediately 
following the educational intervention. Participants will also be asked to answer several 
questions regarding their perceptions of the proposed intervention and its acceptability, 
to serve as process evaluation measures. The follow-up survey will be available for two 
weeks. 
6-Month Follow-Up Assessment. As a third point of assessment, information will be 
gathered from the Spit for Science Spring follow-up survey regarding current tobacco use 
and the Fagerström Test for Nicotine Dependence.  
Data Analysis. Analyses regarding acceptability and feasibility outcomes will be mainly 
descriptive. Recruitment rate (i.e. ratio of individuals who complete the eligibility screener 
to those that are randomized) and retention rate (i.e. ratio of number of retained 
participants to number of participants enrolled in the study) will be reported. To assess 
whether outcomes are affected by attrition bias, we will examine the baseline 
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characteristics (obtained from parent survey registry data; e.g. sex, race/ethnicity, year in 
school, average frequency/quantity of tobacco use) of participants who were lost to follow-
up and those remaining and compare rates of loss to follow-up between the arms of the 
intervention. Baseline characteristics of participants’ tobacco use will be reported as 
means/standard deviations for continuous variables and frequencies/percentages for 
categorical variables. Chi-square tests, Mann-Whitney tests, or t-tests will be used to 
examine baseline differences between intervention arms in terms of demographic 
characteristics, tobacco use measures, and other assessment measures between the 
different intervention conditions. Regression models will be used to determine if there are 
differences between the outcomes of the intervention arms. Potential covariates included 
in these analyses include: sex, race/ethnicity, and type/ number of tobacco products used.  
The data will be analyzed on an intention-to-treat (ITT) basis, as if participants who do 
not complete the trial had not reduced tobacco use. Under ITT, data for all subjects 
randomized to a treatment is analyzed according to the treatment to which subjects were 
allocated, regardless of whether they received the treatment or not. Its purpose is to 
preserve the theoretical basis for the validity of statistical results, particularly by 
eliminating subjects with prognostic factors, which could systematically influence a 
participant’s selection to a given treatment40. This approach was selected because a 
previous study demonstrates that ITT gives unbiased estimates of treatment effects (e.g. 
effectiveness)41, while also preserving the sample size. However, the estimate of 
treatment effects is generally more conservative, relative to alternative approaches such 
as-treated (or per-protocol) analysis42.  
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As-treated analysis involves analyzing study data from only subjects who complete the 
study and adhere to protocol requirements. The main advantage of this approach is that 
only participants with complete data are examined, and the resulting information can be 
used to determine what the effect of treatment is, when taken in an optimal manner (e.g. 
efficacy). However, as-treated analysis could lead to a significant reduction in sample 
size, especially if many participants do not follow protocol, and is prone to potential bias, 
since participants might deviate from the protocol for non-random reasons, such as 
experiencing unpleasant side effects from treatment, or failure to see improvement in 
health43.  
The main outcome measure calculated would be the reduction in tobacco use incidence 
ratio, using two-tailed Fisher’s exact tests to compare the proportion of participants who 
reduced tobacco use between the intervention groups. Two-tailed paired t-tests will also 
be used to compare the change in the average use of tobacco overall (and if applicable, 
across each tobacco product). Tobacco reduction incidences will be computed at 30-day 
and 6-month follow-up. All analyses will be conducted using SAS 9.4. 
DISCUSSION 
Potential Limitations. Participant recruitment is essential to the success of this project. 
However, we are confident that we will be able to recruit the desired number of 
participants since procedures to recruit these participants have already been established 
and utilized successfully in the past. For example, of those invited to the most recent spin-
off study, 56.5% expressed interest and 40.4% were enrolled. Thus, a potential strategy 
to overcome this obstacle of participant recruitment is to contact many participants during 
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the recruitment period. There might also be concerns over whether there will be adequate 
power to conduct the planned analyses. Fortunately, the sample size of the brief 
intervention proposed is within the range of sample sizes found in related studies (range: 
61-697)35. However, since the suggested sample size for this study is towards the lower 
end of the range, results from this study should be regarded as preliminary and replication 
is needed for any effects that we identify. Related to sample size, are the concerns 
regarding participant drop-out. Short-term follow-up duration does protect the study 
against possible participant dropout; however, it may also mask the possibility of longer-
term effects. To get around this issue, it would be possible to look at long-term effects 
from responses provided in follow-up surveys conducted by the parent study, collected 
every spring semester. One last potential limitation can be found in our reliance on self-
reported data. Some individuals may feel uncomfortable sharing information about their 
substance use and/or answering questions about their previous tobacco use. However, 
since this study is being conducted over the Internet and there is minimal to no personal 
contact, there is unlikely to be any differential biases by intervention group44.  
Study Strengths and Potential Contributions. The contributions of this proposed project 
are potentially significant due to its focus on young adulthood, a critical period of change 
in the lifespan and the period when the use and abuse of substances peaks. Furthermore, 
this proposed project will be one of only a few tobacco reduction interventions aimed at 
non-treatment-seeking college students, a population with the highest prevalence of 
substance use and the greatest likelihood to quit following intervention. This is an 
especially important task to undertake, given that few studies examine how presenting 
genetic and environmental risk information to tobacco users will influence patterns of 
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tobacco use through increased knowledge of risk factors for nicotine dependence, as well 
as motivations and barriers to the reduction of tobacco use. Given that tobacco use 
among young adults is both common and associated with several adverse consequences 
(i.e. tobacco-related illness and addiction, cancer, and death), the potential impact of 
intervention on the overall disease burden of this group is large. This emphasizes the 
need to understand factors contributing to substance use in young adulthood, to which 
this study contributes by including longitudinal, repeated measures of tobacco use 
prevalence and behavior across multiple tobacco products. Furthermore, Spit for Science 
is one of just a few samples asking survey questions about more recent forms of tobacco 
use, such as electronic cigarettes and hookah use. Finally, studying college students 
allows for a unique opportunity to intervene, since all major life activities are concentrated 
in a single setting. 
Future Implications 
The present study will provide information on whether providing college students 
information about the risk factors for tobacco use behaviors and nicotine dependence 
impacts tobacco use behaviors, such as frequency and quantity of use, current use, and 
symptoms of nicotine dependence as measured by the Fagerström Test for Nicotine 
Dependence, through self-efficacy, perceived benefits to quitting, perceived susceptibility 
to risks, and perceived barriers to reducing tobacco use. Even if we find the effects of the 
intervention to be small, the information gained from the survey measures collected can 
be used to characterize motivations for tobacco use within young adults.  Process 
evaluation measures, such as program acceptability, can be used to inform follow-up 
studies and future interventions. 
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CHAPTER 13:  
GLOBAL DISCUSSION - THEMES, RESEARCH FINDINGS, AND FUTURE DIRECTIONS 
 
This dissertation thesis presents a comprehensive set of studies investigating genetic and 
environmental risk for tobacco use behaviors and nicotine dependence, using samples of 
adolescents and young adults, covering a broad range of methodologies. Altogether, this 
set of studies contributes to the existing literature by providing information on how genes, 
the environment, and their potential interactions may influence tobacco use behaviors.  
THEMES 
In conducting these studies, several overall themes emerge regarding the complexity of 
tobacco use behavior phenotypes specifically, and how we investigate risk factors for 
complex traits, such as tobacco use, more broadly. The themes resulting from this 
research, which integrates literature reviews, twin/family studies, population-based 
studies, epidemiology, and genomic analyses include:  
1. Behaviors are complex, and we need to develop better strategies for the 
harmonization and standardization of phenotypes. 
2. Although twin methods have been found to obtain higher heritability estimates than 
genomic approaches for complex traits, such as tobacco use behaviors, they are 
still very useful in determining genetic and environmental architecture, and 




3. Polygenic risk scores might account for more variance in traits than single genetic 
variants do individually, but the clinical utility of these genomic approaches are still 
to be determined. 
4. Public health planning needs to consider, and where possible, incorporate, 
knowledge regarding social and genetic influences on complex behaviors, such as 
tobacco use. 
RESEARCH FINDINGS 
The themes listed above were derived from examining each of the chapters presented in 
this thesis. Under each thematic heading are more specific details about how research 
findings from singular studies in this dissertation are related to the listed themes.  
Developing better strategies for harmonization and standardization of phenotypes  
Phenotype heterogeneity across studies represents a continuing obstacle that limits 
successful identification of (replicable) associations1. The narrative and systematic 
literature reviews conducted in chapters 2 and 3 of this dissertation which assess the 
existing literature on contributions of genes, the environment, and their interactions on 
tobacco use phenotypes, support this claim. By reviewing the choice of measurement for 
environmental variables, how main and interaction effects are tested and reported across 
existing studies, how covariates are treated in analyses, and how gene-by-environment 
correlations are reported, chapter 3 demonstrates that differences in the approach taken 
by studies seeking to answer similar research questions make it difficult to interpret and 
summarize findings.  
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Harmonization and standardization of phenotypes is especially important in the realm of 
genome wide association studies, like those described in chapters 9 and 10. As explained 
elsewhere, phenotype harmonization requires identifying common phenotypes, 
determining the feasibility of cross-study analysis for each, and preparing common 
definitions1.  These concerns are not limited to epidemiological studies, but extend to 
genetic studies as well. Although considerable time and effort has gone into reducing 
genotype measurement error and ensuring accuracy and consistency of results2, 
phenotype heterogeneity still represents a huge challenge to successful GWAS analyses 
of complex traits and replication studies. Despite continual efforts, some differences are 
inevitable3 due to differences in study design, what data is collected, and how data was 
collected. The implications of developing better strategies for harmonization and 
standardization of phenotypes are many; increasing sample size (and consequently, 
greater power to detect effects), allows for the optimization of power for discovering new 
associations3.   
Utility of twin analyses in determining the genetic architecture of traits  
Twin studies use correlations between pairs of relatives to parses the individual 
differences in a trait to latent (unmeasured) genetic and environmental influences, 
allowing for the estimation of heritability or the percentage of variance due to genetic 
influences. In the context of tobacco use behaviors, twin studies have been useful in 
determining the heritability of a range of phenotypes, including those examined in 
chapters 4 and 5: namely, smoking initiation and current quantity smoked. Results from 
the study conducted in chapter 4 demonstrate that various factors contribute to smoking 
initiation and current quantity smoked across mid-adolescence into early adulthood, such 
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that smoking initiation and current quantity smoked have independent liabilities until 
adulthood when liabilities are shared. This change might be attributed to access and 
availability to cigarettes, such that as access and availability of cigarettes increase, the 
expression of genetic predispositions towards increased smoking frequency and potential 
addiction may also increase, after initiation.  
Results from chapter 5 provide evidence for shared genetic and environmental liability for 
the association between stressful life events and smoking initiation and that this structure 
differs in early adolescence and young adulthood, but not by sex. This suggests that the 
same genes and environments are influencing both stressful life events and smoking 
initiation in males and females, such that the underlying factors influencing stressful life 
events and smoking initiation are influenced by partly shared environmental factors in 
young adolescents and by partly shared genetic risk factors in young adulthood. This 
might suggest that once an individual is exposed to the effects of stressful life events, 
genetic factors come into play, and that only individuals with a certain set of genes will 
choose to initiate tobacco use. 
The utility of studies is found in the fact that twin models allow for the testing of various 
hypotheses regarding the genetic architecture of traits, while also considering the 
potential influence of the environment. Twin studies such as the one conducted in chapter 
5, demonstrate that both genetic and environmental factors can have different effects on 
tobacco-related phenotypes, such as smoking initiation, across time. For example, there 
exists little evidence currently of common genetic effects that influence both initiation and 
persistence, implying that there are genetic processes contributing to experimentation 
and the initiation of tobacco use that are distinct from those influencing the development 
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and maintenance of tobacco use patterns. Although these studies do not provide 
information about what specific genes or environments are involved with these processes, 
they are useful in generating hypotheses for future studies.  
Clinical utility of (aggregated) measures of genetic risk  
The genetic analyses presented in chapters 9 and 10 demonstrate that genetic factors 
are involved with the liability of tobacco use behaviors among university students, at both 
the level of individual variants and at the aggregate level. Estimates of SNP-based 
heritability using genome wide complex trait analyses (GCTA)4 indicate that tobacco use 
behaviors are moderately heritable, and lower than those estimated from twin studies. 
Yet, estimates of heritability were non-zero and significant amongst those of European 
ancestry, suggesting that sample sizes for other ancestry groups found in Spit for Science 
were too small to detect significant heritability. At the level of individual variants, no 
findings from larger meta-analyses could be replicated. It was suggested in chapter 9, 
and described previously, that the failure to replicate might be attributed to variability of 
phenotype, inadequate sample size, false positive results, and population specific effects. 
Given that novel loci were identified in the Spit for Science sample, and no loci was 
replicated from the TAG Consortium data, we would deduce that either: the genetic 
architecture of tobacco use behaviors within these two studies are different, or that the 
current study is underpowered, making it less likely to find significant hits while also 
making it more likely that the significant hits found are false positives. In either case, these 
findings contribute to the existing literature by demonstrating the polygenic nature of the 
phenotypes investigated.  
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Chapter 10 expands upon the aims of chapter 9 in efforts to find evidence for common 
genetic risk variation through the aggregation of genetic effects that do not individually 
achieve significance in large-scale GWAS. In conducting the analyses for chapter 10, 
polygenic risk scores were constructed and then put into predictive models of tobacco 
use behavior. Regression analyses indicated that polygenic risk scores were predictive 
of some tobacco use behavior phenotypes. The analyses from this chapter also indicate 
that environmental variables, as well as interactions between polygenic risk and 
environmental variables (e.g. parental autonomy granting, parental involvement, physical 
abuse prior to university enrollment) also contribute to the variability in tobacco use 
behavior phenotypes. 
Although polygenic risk scores can be useful for examining the cumulative predictive 
ability of genetic variation of a trait, there is limited clinical utility for these scores beyond 
risk prediction due to concerns regarding predictive accuracy, as well as the cost and 
ability of clinicians and patients to effectively use this information5. In addition to varied 
predictive power based upon methodological approach, we do not yet have enough 
information regarding specific variants contributing to tobacco use behaviors for clinical 
risk prediction. Expanding the number of replicated variants associated with tobacco use 
behaviors, such as nicotine dependence, would improve risk prediction models. However, 
a prediction tool based upon genetic information alone would probably not be sufficient 
for clinical use, especially since environmental factors have been found to account for a 
considerable portion of variability in tobacco use behaviors. Additionally, many of the 
previous studies have only been conducted within those of European ancestry and still 
need to be tested within other ancestry groups – especially since the genetic architecture 
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of tobacco-related phenotypes may differ across populations (and ages). Thus, more 
research needs to be done to identify genetic factors associated with subclinical 
phenotypes, especially among non-European ancestry groups6.  
Public health planning and future directions 
As explained in chapter 6, despite public health successes in reducing the consumption 
of cigarettes, the increasing popularity of alternative tobacco products and nicotine 
delivery systems poses new challenges for researchers and policymakers alike. This is 
especially true, given that these products contribute to negative outcomes similar to 
cigarette use and may make it more difficult to quit if used concurrently with cigarettes. 
As described in chapter 11, national survey data collected in 2014 demonstrate that one 
in four current cigarette smokers use other tobacco products and nicotine delivery 
systems7. Thus, one of the main challenges for public health research and planning is 
how to address the growing availability and use of alternative tobacco products and 
nicotine delivery systems. To reduce and/or prevent the use of these products, more data 
needs to be collected on the use of all tobacco products as they are being developed, 
rather than solely focusing on cigarette use8. Furthermore, a two-pronged approach may 
be necessary: one focused on how to alter existing social norms and perceptions 
regarding alternative tobacco products and nicotine delivery systems and one focused on 
the reduction of harm caused by products currently and/or will be brought to market. One 
such direction to take is to educate young adults – a population with the highest 
prevalence of substance use and the greatest likelihood to quit following intervention – 
on genetic and environmental risk factors contributing to certain tobacco use behaviors 
and nicotine dependence, as outlined in chapter 12.  
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Another approach would be to consider what we know about the correlates and predictors 
of tobacco use behaviors, including nicotine dependence, and identify potential areas of 
prevention and intervention. For example, from chapter 7, we know that initial reactions 
to tobacco differ by tobacco type, and by sex and that age of onset, sex, and positive 
initial experiences predict both recent use and meeting criteria for nicotine dependence. 
Thus, it would be beneficial to conduct further research to identify genetic and biological 
pathways influencing initial experiences with nicotine and the social contexts that 
influence initial experiences with tobacco use in efforts to delay the overall age of onset 
for tobacco use and reduce individual risk for nicotine dependence. The information 
gained from such studies can be used to characterize motivating factors for (alternative) 
tobacco product use and use reduction within young adults and inform the planning and 
implementation of future studies.  
LIMITATIONS OF THE CURRENT SET OF STUDIES 
Like all other studies, this dissertation is not free from limitations. To some extent, these 
limitations are attributed to study design, which are described in greater detail below. 
Concerns regarding power to detect effects of genetic factors influencing tobacco  
Power to detect effects is influenced by the size of the effect and the size of the sample 
used to detect it. In the case where prevalence is low, like in chapter 4 where the 
prevalence of smoking behavior among early adolescents is low, the power to detect 
effects is also low. The issue of power is also of importance in the genomic studies 
conducted in chapters 9 and 10. Previous studies investigating the genetic architecture 
of tobacco use behaviors that have reported significant SNP associations with tobacco 
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use phenotypes report much larger sample sizes than those found in the current study. 
This is a concern since low-powered studies tend to produce more false negatives relative 
to higher-powered studies and have reduced probabilities of observing effects that pass 
the required threshold of significance. And, when true effects are found within low 
powered studies, it is likely that the estimate of the magnitude of the effect is exaggerated. 
However, after conducting power analyses, it was determined that we did have sufficient 
power (e.g. >80%) to detect aggregate effects of all SNPs, using GCTA – but only for 
sample sizes of >1500 individuals.  
Interpretation of heritability 
GCTA yielded significant, non-zero estimates for SNP-based heritability (at p-value 
≤0.05), but only amongst those of European ancestry for ever tobacco use and age of 
initiation. However, once we corrected for multiple testing, these effects were no longer 
significant. This suggests that the total variance explained by all SNPs is zero; however, 
this does not necessarily mean that genes are unimportant for the specific traits studied. 
Rather, it might suggest that the genetic markers used in these studies might not be able 
to explain the existing phenotypic differences in the population that we are examining or 
that factors, other than the genetic variants being investigated contribute more to the 
variation in phenotypic differences.  
Inability to infer causality 
Due to cross-sectional nature, none of the current studies can infer causality. To get 
around this issue, the exposure time for the experience of stressful life events, parental 
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autonomy granting, and parental involvement were limited to prior to university enrollment 
(chapter 6).  
Self-reported data and the potential for recall bias 
Across each of the studies, participants were asked to answer questions about their 
experiences in the past. For example, students were asked to retrospectively report their 
parental environment and stressful life events prior to university enrollment (chapter 6). 
Since recall of information is solely dependent on memory, self-reports may be imperfect 
and potentially unreliable. It is possible that using self-reported data underestimates the 
prevalence of smoking behaviors across each of the studies included in this dissertation, 
because of social desirability bias, which has downstream effects on genetic analyses. 
Variability in phenotype definitions. Since measurement protocols differ across 
studies, it is inevitable that there will be variability in phenotype definitions. In efforts to 
address this problem, we attempted harmonize phenotypes in related analyses, and 
make measures as comparable as possible.  
Generalizability of findings. Many of the studies included in this dissertation have 
focused on samples of White/Caucasian Americans and Black/African Americans due to 
concerns regarding sample size and power to detect effects in other race/ethnicity and 
ancestral groups. Thus, more research needs to be done to assess whether the findings 
of these studies are generalizable to other groups of young adults who do not fall within 
these race/ethnicities or ancestral groups. These concerns are also shared across 
genetic studies, since disparate patterns of linkage disequilibrium and differences in 
marker allele frequencies between discovery and target samples could attenuate genetic 
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effects. This is a critical point, since our genomic analyses are conducted on an ethnically-
diverse population that is very different from a majority of genomic studies conducted on 
individuals of European descent.   
CLOSING REMARKS 
Despite these limitations, the findings from this dissertation contribute to the literature by 
providing a better comprehensive understanding of how genes, the environment, and 
their potential interactions influence many tobacco use behavior phenotypes. A key 
strength of this dissertation project is the variety in the methodologies explored in 
untangling the influences of genes and the environment on tobacco use behaviors in 
young adulthood – an understudied population – and the amount of training opportunities 
afforded from the conducting analyses for and writing up this dissertation.  
The studies included in this project focused primarily on the transition from adolescence 
to young adulthood, to capture the critical period of change during the lifespan and a time 
at which the use and abuse of substances peak. Given that tobacco use among young 
adults is both prevalent and associated with several adverse consequences, it is 
important to understand factors contributing to tobacco use behaviors. This dissertation 
accomplishes this through multiple methodologies, including: reviews of existing literature 
on genes, environment, and tobacco use; twin studies of genetic and environmental 
influences on tobacco use behavior phenotypes; epidemiological studies of prevalence, 
correlates, and predictors of tobacco use behaviors; genomic analyses of tobacco use 
behaviors; a commentary on the emergence of alternative nicotine delivery systems and 
its public health impacts; and, plans for an internet-based educational intervention 
seeking to reduce tobacco use (and nicotine dependence) by providing students 
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attending university with information on genetic and environmental risk factors for nicotine 
dependence.  
Of course, although the work accomplished in this set of studies is extensive, it is far from 
exhaustive. With the changing climate of tobacco use behaviors and available products, 
further research is needed to not only uncover new environmental risk factors contributing 
to tobacco use in a broader sense, but also to investigate more deeply the genetic and 
environmental influences on tobacco use that are already known – which I hope comes 
across clearly from reading this dissertation thesis. 
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